Juno Therapeutics, Inc. v. Kite Pharma, Inc.
2:17-cv-07639
Overview
Case Number
2:17-cv-07639
Filing Date
2017-10-18
Status
Litigation filed
Court
District Court, C.D. California
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, C.D. California
Presiding Judge
George H. Wu
Patents Involved
There is a single patent involved in this case.
| Application Number | Patent Number | External Links |
|---|---|---|
| - | US7446190 |
Docket Entries
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
1
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
COMPLAINT Receipt No: 0973-20685642 - Fee: $400, filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14) (Attorney Morgan Chu added to party Juno Therapeutics, Inc.(pty:pla), Attorney Morgan Chu added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Morgan Chu added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
2
CIVIL COVER SHEET filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
1
Request for Clerk to Issue Summons on Complaint (Attorney Civil Case Opening),, 1 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
1
CERTIFICATE of Interested Parties filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, (Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
1
CORPORATE DISCLOSURE STATEMENT filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research (Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
1
NOTICE of Related Case(s) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Related Case(s): 2:17-CV-06496-SJO-RAO (Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
1
NOTICE of Related Case(s) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
1
REPORT ON THE FILING OF AN ACTION Regarding a Patent or a Trademark (Initial Notification) filed by Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Chu, Morgan) (Entered: 10/18/2017)
2017-10-18
1
NOTICE OF ASSIGNMENT to District Judge Manuel L. Real and Magistrate Judge Jacqueline Chooljian. (et) (Entered: 10/19/2017)
2017-10-19
1
21 DAY Summons Issued re Complaint (Attorney Civil Case Opening) 1 as to Defendant Kite Pharma, Inc. (et) (Entered: 10/19/2017)
2017-10-19
1
ORDER RE TRANSFER PURSUANT TO GENERAL ORDER 16-05-Related Case- filed. Related Case No: 2:17-cv-06496 SJO(RAOx). Case transferred from Magistrate Judge Jacqueline Chooljian and Judge Manuel L. Real to Judge S. James Otero and Magistrate Judge Rozella A. Oliver for all further proceedings. The case number will now reflect the initials of the transferee Judge 2:17-cv-07639 SJO(RAOx). Signed by Judge S. James Otero (rn) (Entered: 10/23/2017)
2017-10-23
1
INITIAL STANDING ORDER upon filing of the complaint by Judge S. James Otero. (vcr) (Entered: 10/25/2017)
2017-10-25
1
NOTICE of Appearance filed by attorney Jeffrey T Thomas on behalf of Defendant Kite Pharma, Inc. (Attorney Jeffrey T Thomas added to party Kite Pharma, Inc.(pty:dft))(Thomas, Jeffrey) (Entered: 10/26/2017)
2017-10-26
1
NOTICE of Appearance filed by attorney Michael A Sitzman on behalf of Defendant Kite Pharma, Inc. (Attorney Michael A Sitzman added to party Kite Pharma, Inc.(pty:dft))(Sitzman, Michael) (Entered: 10/26/2017)
2017-10-26
1
NOTICE of Appearance filed by attorney Timothy P Best on behalf of Defendant Kite Pharma, Inc. (Attorney Timothy P Best added to party Kite Pharma, Inc.(pty:dft))(Best, Timothy) (Entered: 10/26/2017)
2017-10-26
1
NOTICE of Appearance filed by attorney Jaysen Samuel Chung on behalf of Defendant Kite Pharma, Inc. (Attorney Jaysen Samuel Chung added to party Kite Pharma, Inc.(pty:dft))(Chung, Jaysen) (Entered: 10/26/2017)
2017-10-26
1
STIPULATION for Extension of Time to File Answer to 11/27/2017 re Complaint (Attorney Civil Case Opening),, 1 filed by Defendant Kite Pharma, Inc..(Chung, Jaysen) (Entered: 10/27/2017)
2017-10-27
1
PROOF OF SERVICE Executed by Plaintiff Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, upon Defendant Kite Pharma, Inc. served on 10/25/2017, answer due 11/15/2017. Service of the Summons and Complaint were executed upon Catherine Webb (CSC Lawyers Incorporating Service) - Registered Agent for Service of Process in compliance with Federal Rules of Civil Procedure by personal service.Original Summons NOT returned. (Tuan, Elizabeth) (Entered: 10/30/2017)
2017-10-30
1
PROOF OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, re Initial Order upon Filing of Complaint - form only 12 served on 10/26/2017. (Tuan, Elizabeth) (Entered: 10/30/2017)
2017-10-30
1
STIPULATION for Extension of Time to File Answer to 11/27/2017 re Complaint (Attorney Civil Case Opening),, 1 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order Extending Deadline to Respond to Complaint and Dismissing Case No. 17-cv-06496)(Chung, Jaysen) (Entered: 11/06/2017)
2017-11-06
1
STIPULATION for Extension of Time to File Answer to 11/27/2017 re Complaint (Attorney Civil Case Opening),, 1 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order Extending Deadline to Respond to Complaint and Dismissing Case No. 17-cv-06496)(Chung, Jaysen) (Entered: 11/06/2017)
2017-11-06
2
ORDER EXTENDING DEADLINE TO RESPOND TO COMPLAINT AND DISMISSING CASE NO. 17-cv-06496 20 Kite Pharma, Inc. answer due 11/27/2017/ IT IS FURTHER ORDERED that Plaintiffs shall file a dismissal without prejudice in Case No. 2:17-cv-06496 within 5 days of the stipulation, and Defendant is hereby excused from having to respond to said Complaint by Judge S. James Otero (lc) (Entered: 11/21/2017)
2017-11-20
1
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
1
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMANDDefendant Kite Pharma, Inc.'s Answer, Affirmative Defenses, and Counterclaims to Complaint for Patent Infringement, **COUNTERCLAIM ONLY WAS STRICKEN PER 11/28/17 COURT G112B RESPONSE)against Kite Pharma, Inc. filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) Modified on 11/28/2017 (lc). Modified on 11/28/2017 (lc). (Entered: 11/27/2017)
2017-11-27
2
CORPORATE DISCLOSURE STATEMENT filed by Defendant Kite Pharma, Inc., Counter Claimant Kite Pharma, Inc. identifying Gilead Sciences, Inc. as Corporate Parent. (Sitzman, Michael) (Entered: 11/27/2017)
2017-11-27
1
Certification and Notice of Interested Parties CERTIFICATE of Interested Parties filed by Defendant Kite Pharma, Inc., identifying Gilead Sciences, Inc.. (Sitzman, Michael) (Entered: 11/27/2017)
2017-11-27
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: ONLY THE COUNTERCLAIM PORTION of combined Answer to Complaint (Attorney Civil Case Opening),,, Counterclaim,, 22 . The following error(s) was/were found: FRCP 10, Formal separate caption of the counterclaim missing, instead filer added description under plaintiffs m "counterdefendants" and "Counterclaimant" under Defendant. However filer did not correctly select the parties, as a result created an Erroneous counterclaim against itself. Case docket and docket entry no. 22 erroneously reflects Kite Parma Inc. t vs. Kite Parma, Inc In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 11/28/2017)
2017-11-28
1
RESPONSE BY THE COURT TO NOTICE TO FILER OF DEFICIENCIES IN ELECTRONICALLY FILED DOCUMENTS RE: Counterclaim portion ONLY 22 by Clerk of Court. The document is stricken and counsel is ordered to file an amended or corrected document by 11/29/17. (lc) (Entered: 11/28/2017)
2017-11-28
1
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
1
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
CORRECTED ANSWER to Complaint (Attorney Civil Case Opening),, 1 with JURY DEMAND, COUNTERCLAIM against Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Sitzman, Michael) (Entered: 11/28/2017)
2017-11-28
2
ORDER SETTING SCHEDULING CONFERENCE by Judge S. James Otero. Rule 26 Meeting Report due by 1/29/2018. Scheduling Conference set for 2/12/2018 at 08:30 AM before Judge S. James Otero. (vcr) (Entered: 11/29/2017)
2017-11-29
1
APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20928898) filed by Defen dant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Sitzman, Michael) (Entered: 12/06/2017)
2017-12-06
1
APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20928898) filed by Defen dant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Sitzman, Michael) (Entered: 12/06/2017)
2017-12-06
2
NOTICE of Deficiency in Electronically Filed Pro Hac Vice Application RE: APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-20928898) 29 . The following error(s) was/were found: Local Rule 83-2.1.3.3(a) Application not complete: state and/or federal courts to which the applicant has been admitted are not listed. (lt) (Entered: 12/07/2017)
2017-12-07
1
RESPONSE BY THE COURT TO NOTICE TO FILER OF DEFICIENCIES IN ELECTRONICALLY FILED DOCUMENTS RE: APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. 29 by Clerk of the Court. The document is accepted as filed.Counsel shall immediately update the record and comply with Local Rule 83-2.1.3.3(a) Application not complete: state and/or federal courts to which the applicant has been admitted are not listed. (lc) (Entered: 12/13/2017)
2017-12-13
1
ORDER GRANTING APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. and designating Michael A Sitzman as local counsel 29 by Judge S. James Otero (lc) (Entered: 12/13/2017)
2017-12-13
1
Corrected APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - $325.00 Previously Paid on 12/6/2017, Receipt No. 0973-20928898) filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Sitzman, Michael) (Entered: 12/14/2017)
2017-12-14
1
Corrected APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - $325.00 Previously Paid on 12/6/2017, Receipt No. 0973-20928898) filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Sitzman, Michael) (Entered: 12/14/2017)
2017-12-14
2
NOTICE of Deficiency in Electronically Filed Pro Hac Vice Application RE: Corrected APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - $325.00 Previously Paid on 12/6/2017, Receipt 33 . The following error(s) was/were found: Local Rule 83-2.1.3.3(a) Application not complete: state and/or federal courts to which the applicant has been admitted are not listed. CT is not listed. (lt) (Entered: 12/15/2017)
2017-12-15
1
NOTICE OF MOTION AND MOTION to Dismiss Kite's Counterclaims, NOTICE OF MOTION AND MOTION to Strike Kite's Affirmative Defenses of Non-Infringement, Invalidity, No Injunctive Relief, Unclean Hands, and Reservation of Additional Defenses filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order) (Tuan, Elizabeth) (Entered: 12/19/2017)
2017-12-19
1
NOTICE OF MOTION AND MOTION to Dismiss Kite's Counterclaims, NOTICE OF MOTION AND MOTION to Strike Kite's Affirmative Defenses of Non-Infringement, Invalidity, No Injunctive Relief, Unclean Hands, and Reservation of Additional Defenses filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order) (Tuan, Elizabeth) (Entered: 12/19/2017)
2017-12-19
2
MEMORANDUM in Support of NOTICE OF MOTION AND MOTION to Dismiss Kite's Counterclaims NOTICE OF MOTION AND MOTION to Strike Kite's Affirmative Defenses of Non-Infringement, Invalidity, No Injunctive Relief, Unclean Hands, and Reservation of Additional Defenses 35 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Tuan, Elizabeth) (Entered: 12/19/2017)
2017-12-19
1
NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order, # 2 Memorandum, # 3 Declaration of Michael A. Sitzman, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4) (Sitzman, Michael) (Entered: 12/22/2017)
2017-12-22
1
NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order, # 2 Memorandum, # 3 Declaration of Michael A. Sitzman, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4) (Sitzman, Michael) (Entered: 12/22/2017)
2017-12-22
2
NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order, # 2 Memorandum, # 3 Declaration of Michael A. Sitzman, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4) (Sitzman, Michael) (Entered: 12/22/2017)
2017-12-22
2
NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order, # 2 Memorandum, # 3 Declaration of Michael A. Sitzman, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4) (Sitzman, Michael) (Entered: 12/22/2017)
2017-12-22
2
NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order, # 2 Memorandum, # 3 Declaration of Michael A. Sitzman, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4) (Sitzman, Michael) (Entered: 12/22/2017)
2017-12-22
2
NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order, # 2 Memorandum, # 3 Declaration of Michael A. Sitzman, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4) (Sitzman, Michael) (Entered: 12/22/2017)
2017-12-22
2
NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order, # 2 Memorandum, # 3 Declaration of Michael A. Sitzman, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4) (Sitzman, Michael) (Entered: 12/22/2017)
2017-12-22
2
NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 1/29/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order, # 2 Memorandum, # 3 Declaration of Michael A. Sitzman, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4) (Sitzman, Michael) (Entered: 12/22/2017)
2017-12-22
2
OPPOSITION to NOTICE OF MOTION AND MOTION to Dismiss Kite's Counterclaims NOTICE OF MOTION AND MOTION to Strike Kite's Affirmative Defenses of Non-Infringement, Invalidity, No Injunctive Relief, Unclean Hands, and Reservation of Additional Defenses 35 filed by Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc.. (Sitzman, Michael) (Entered: 01/08/2018)
2018-01-08
1
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
1
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
MEMORANDUM in Opposition to NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15)(Tuan, Elizabeth) (Entered: 01/08/2018)
2018-01-08
2
Corrected APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - $325.00 Previously Paid on 12/6/2017, Receipt No. 0973-20928898) filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Sitzman, Michael) (Entered: 01/10/2018)
2018-01-10
1
Corrected APPLICATION of Non-Resident Attorney Jane M. Love to Appear Pro Hac Vice on behalf of Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - $325.00 Previously Paid on 12/6/2017, Receipt No. 0973-20928898) filed by Defendant and Counterclaim Plaintiff Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Sitzman, Michael) (Entered: 01/10/2018)
2018-01-10
2
REPLY IN SUPPORT OF NOTICE OF MOTION AND MOTION to Dismiss Kite's Counterclaims NOTICE OF MOTION AND MOTION to Strike Kite's Affirmative Defenses of Non-Infringement, Invalidity, No Injunctive Relief, Unclean Hands, and Reservation of Additional Defenses 35 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Tuan, Elizabeth) (Entered: 01/12/2018)
2018-01-12
1
RESPONSE IN SUPPORT of NOTICE OF MOTION AND MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States 37 filed by Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc.. (Sitzman, Michael) (Entered: 01/12/2018)
2018-01-12
1
The Court finds the following motions suitable for disposition without oral argument and vacates the MOTION to Dismiss Kite's Counterclaims, NOTICE OF MOTION AND MOTION to Strike Kite's Affirmative Defenses of Non-Infringement, Invalidity, No Injunctive Relief, Unclean Hands, and Reservation of Additional Defenses filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research [ECF #35] and the MOTION to Stay Case pending resolution of IPR proceedings and Supreme Court decision in Oil States filed by Defendant Kite Pharma, Inc. [ECF #37]., set for hearing on January 29, 2018. See Fed. R. Civ. P. 78(b). No appearance is required. The briefing schedule remains as set by Local Rule.THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 01/17/2018)
2018-01-17
1
Text Only Scheduling Notice
2018-01-17
1
No Actions
ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE by Judge S. James Otero: granting 33 Non-Resident Attorney Love, Jane M. APPLICATION to Appear Pro Hac Vice on behalf of Kite Pharma, Inc., designating Sitzman, Michael A. as local counsel. (yl) (Entered: 01/19/2018)
2018-01-18
1
ORDER/REFERRAL to ADR Procedure No 2 by Judge S. James Otero. Case ordered to Court Mediation Panel for mediation. (lc) (Entered: 01/29/2018)
2018-01-29
1
JOINT REPORT Rule 26(f) Discovery Plan ; estimated length of trial 5-12 days, filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.. (Attachments: # 1 Appendix 2)(Chu, Morgan) (Entered: 01/29/2018)
2018-01-29
1
JOINT REPORT Rule 26(f) Discovery Plan ; estimated length of trial 5-12 days, filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.. (Attachments: # 1 Appendix 2)(Chu, Morgan) (Entered: 01/29/2018)
2018-01-29
2
REQUEST for ADR Procedure No. 3. Parties request for private mediation. Filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research(Chu, Morgan) (Entered: 01/29/2018)
2018-01-29
1
SCHEDULING NOTICE OF CONTINUANCE by Judge S. James Otero. The Court continues the Scheduling Conference from 2/12/18 to Friday, 3/2/2018 at 10:00 AM before Judge S. James Otero. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 02/01/2018)
2018-02-01
1
Text Only Scheduling Notice
2018-02-01
1
No Actions
TEXT ONLY ENTRY ORDER by Judge S. James Otero: During the Scheduling Conference, the Court wishes to have the parties provide a technology tutorial and overview of likely contested and potentially dispositive issues. The parties will have 30 minutes each to present their tutorials. The Court is particularly interested in hearing from Plaintiffs which features of Defendant's products are alleged to practice each of the limitations of the '190 Patent. The Court is interested in hearing from Defendant regarding (1) a preview of its noninfringement arguments and (2) a high-level overview of its invalidity arguments. The Court is also interested in hearing from both parties (1) which claim term(s) are most likely to be disputed, (2) an overview of the parties' prior litigation history relating to the '190 Patent, and (3) any prior efforts to settle this dispute. The Parties are encouraged to permit less experienced lawyers (those with five or fewer years of experience) to present during the technology tutorial. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vv) (Entered: 02/02/2018)
2018-02-02
1
Text Only Scheduling Notice
2018-02-02
1
No Actions
APPLICATION of Non-Resident Attorney Omar Farooq Amin to Appear Pro Hac Vice on behalf of Counter Claimant Kite Pharma, Inc. (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-21315992) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Sitzman, Michael) (Entered: 02/26/2018)
2018-02-26
1
APPLICATION of Non-Resident Attorney Omar Farooq Amin to Appear Pro Hac Vice on behalf of Counter Claimant Kite Pharma, Inc. (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-21315992) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Sitzman, Michael) (Entered: 02/26/2018)
2018-02-26
2
NOTICE of Deficiency in Electronically Filed Pro Hac Vice Application RE: APPLICATION of Non-Resident Attorney Omar Farooq Amin to Appear Pro Hac Vice on behalf of Counter Claimant Kite Pharma, Inc. (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-21315992) 50 . The following error(s) was/were found: Local Rule 83-2.1.3.4 Local counsel does not maintain an office within the District. (lt) (Entered: 02/27/2018)
2018-02-27
1
ORDER GRANTING APPLICATION of Non-Resident Attorney Omar Farooq Amin to Appear Pro Hac Vice on behalf of defendant Kite Pharma, Inc and designating Michael A Sitzman as local counsel 50 by Judge S. James Otero (lc) (Entered: 02/28/2018)
2018-02-27
1
MINUTES OF Scheduling Conference held before Judge S. James Otero. Each side presents their respective tutorial. The Court sets the following schedule Discovery cut-off 9/24/2018. Motions due by 12/17/2018. Last date to conduct settlement conference is 3/4/2019. Pretrial Conference set for 3/18/2019 09:00 AM. Jury Trial set for 3/26/2019 09:00 AM/ Markman Hearing set on 9/17/2018 at 10:00 AM. (SEE DOCUMENT FOR ALL OTHER SPECIFIC DEADLINES AND RE MARKMAN HEARING DEADLINES) Settlement is referred to Private Mediation for all further proceedings. The Court orders that a transcript of todays proceeding shall be produced. Costs to be shared by the parties.All discovery dispute to be brought before the Magistrate Judge assigned to the case; parties reminded of requirements of FRCP 26-1(a); counsel are advised all pretrial documents (as listed) must be filed in compliance with Courts Initial Standing order. Court Reporter: Carol Zurborg. (lc). Modified on 5/9/2018. (lc). (Entered: 05/09/2018)
2018-03-02
1
MINUTES (in chambers): ORDER GRANTING PLAINTIFFS' MOTION TO DISMISS COUNTERCLAIMS AND STRIKE AFFIRMATIVE DEFENSES [Docket No. 35]; ORDER DENYING DEFENDANT'S MOTION TO STAY PROCEEDINGS [Docket No. 37] by Judge S. James Otero. For the foregoing reasons, Plaintiffs' Motion to Dismiss Counterclaims and Strike Affirmative Defenses is GRANTED 35 . Defendant Kite Pharma's Motion to Stay Proceedings is DENIED 37 . Defendant has FOURTEEN (14) DAYS to file an Amended Complaint. Plaintiffs have TEN (10) DAYS thereafter to respond. IT IS SO ORDERED. (lom) (Entered: 03/08/2018)
2018-03-08
1
TRANSCRIPT ORDER as to Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research for Court Reporter. Court will contact Casey Curran at ccurran@irell.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the court reporter. (Tuan, Elizabeth) (Entered: 03/08/2018)
2018-03-08
1
TRANSCRIPT ORDER as to Defendant Kite Pharma, Inc. for Court Reporter. Court will contact Anna Tumanova at atumanova@gibsondunn.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the court reporter. (Thomas, Jeffrey) (Entered: 03/09/2018)
2018-03-09
1
ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE by Judge S. James Otero: granting 40 Non-Resident Attorney Jane M Love APPLICATION to Appear Pro Hac Vice on behalf of Kite Pharma, Inc., designating Michael A Sitzman as local counsel. (jp) (Entered: 03/15/2018)
2018-03-15
1
Amended CERTIFICATE of Interested Parties filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, identifying Celgene Corporation. (Tuan, Elizabeth) (Entered: 03/20/2018)
2018-03-20
1
CORPORATE DISCLOSURE STATEMENT Amended filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research identifying Celgene Corporation as Corporate Parent. (Tuan, Elizabeth) (Entered: 03/20/2018)
2018-03-20
1
REQUEST TO SUBSTITUTE ATTORNEY Peter E. Gratzinger in place of attorney Jeffrey T. Thomas filed by Defendant Kite Pharma, Inc.. (Attorney Peter E Gratzinger added to party Kite Pharma, Inc.(pty:cd), Attorney Peter E Gratzinger added to party Kite Pharma, Inc.(pty:cc), Attorney Peter E Gratzinger added to party Kite Pharma, Inc.(pty:dft), Attorney Peter E Gratzinger added to party Kite Pharma, Inc.(pty:cc)) (Gratzinger, Peter) (Entered: 03/21/2018)
2018-03-21
1
STIPULATION for Extension of Time to Amend filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 03/21/2018)
2018-03-21
1
STIPULATION for Extension of Time to Amend filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 03/21/2018)
2018-03-21
2
NOTICE OF LODGING filed March 22, 2018 by Defendant Kite Pharma, Inc. re REQUEST TO SUBSTITUTE ATTORNEY Peter E. Gratzinger in place of attorney Jeffrey T. Thomas 59 (Attachments: # 1 Proposed Order On Request for Approval of Substitution or Withdrawal of Attorney)(Gratzinger, Peter) (Entered: 03/22/2018)
2018-03-22
1
NOTICE OF LODGING filed March 22, 2018 by Defendant Kite Pharma, Inc. re REQUEST TO SUBSTITUTE ATTORNEY Peter E. Gratzinger in place of attorney Jeffrey T. Thomas 59 (Attachments: # 1 Proposed Order On Request for Approval of Substitution or Withdrawal of Attorney)(Gratzinger, Peter) (Entered: 03/22/2018)
2018-03-22
2
ORDER EXTENDING DEFENDANT KITE PHARMA, INC'S TIME TO FILE FIRST AMENDED ANSWER AND COUNTERCLAIM TO MARCH 29, 2018 60 by Judge S. James Otero: (lc) (Entered: 03/22/2018)
2018-03-22
1
NOTICE of Appearance filed by attorney Jeffrey I Weinberger on behalf of Defendant Kite Pharma, Inc. (Attorney Jeffrey I Weinberger added to party Kite Pharma, Inc.(pty:dft))(Weinberger, Jeffrey) (Entered: 03/26/2018)
2018-03-26
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Notice of Appearance 63 . The following error(s) was/were found: Incorrect event selected. Correct event to be used is: Notice of Appearance or Withdrawal G123. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (ak) (Entered: 03/26/2018)
2018-03-26
1
Notice of Appearance or Withdrawal of Counsel: for attorney Adam R Lawton counsel for Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc.. Adding Adam R. Lawton as counsel of record for Kite Pharma, Inc. for the reason indicated in the G-123 Notice. Filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attorney Adam R Lawton added to party Kite Pharma, Inc.(pty:cc), Attorney Adam R Lawton added to party Kite Pharma, Inc.(pty:dft))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
1
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
1
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
AMENDED ANSWER and AMENDED COUNTERCLAIM to Complaint (Attorney Civil Case Opening),, 1 filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Appendix (redline version of amended pleading))(Lawton, Adam) (Entered: 03/29/2018)
2018-03-29
2
ORDER GRANTING REQUEST TO SUBSTITUTE ATTORNEY Peter E. Gratzinger in place and instead of of attorneys Jeffrey T. Thomas, Michael A. Sitzman, Jane M. Love, Timothy P. Best, Jaysen Samuel Chung, Omar F. Amin for Defendant Kite Pharma, Inc. 59 by Judge S. James Otero (lc) (Entered: 04/05/2018)
2018-04-05
1
ANSWER to Complaint (Attorney Civil Case Opening),, 1 Answer to Counterclaim Defendant's Counterclaim filed by Plaintiffs and Counterclaim Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.(Chu, Morgan) (Entered: 04/09/2018)
2018-04-09
1
NOTICE TO PARTIES: Effective April 17, 2018, Magistrate Judge Rozella A. Oliver will be located at the Edward R. Roybal Federal Building and U.S. Courthouse, COURTROOM 590 on the 5th floor, located at 255 East Temple Street, Los Angeles, California 90012. All Court appearances shall be made in Courtroom 590 of the Roybal Federal Building, and all mandatory chambers copies shall be hand delivered to the judge's mail box located outside the Clerk's Office on the 12th floor of the Roybal Federal Building. The location for filing civil and criminal documents in paper format exempted from electronic filing and for viewing case files and other records services is located at the Roybal Federal Building, 255 East Temple Street, Room 180 (Terrace Level), Los Angeles, California 90012. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (rrey) TEXT ONLY ENTRY (Entered: 04/11/2018)
2018-04-11
1
Generic Text Only Entry
2018-04-11
1
No Actions
Notice of Appearance or Withdrawal of Counsel: for attorney Geoffrey D Biegler counsel for Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc.. Adding Geoffrey D. Biegler as counsel of record for Kite Pharma, Inc. for the reason indicated in the G-123 Notice. Filed by Defendant-Counterclaimant Kite Pharma, Inc.. (Attorney Geoffrey D Biegler added to party Kite Pharma, Inc.(pty:cc), Attorney Geoffrey D Biegler added to party Kite Pharma, Inc.(pty:dft))(Biegler, Geoffrey) (Entered: 04/16/2018)
2018-04-16
1
APPLICATION of Non-Resident Attorney Grant T. Rice to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-21724925) filed by Defe ndant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order On Application of Non-Resident Attorney To Appear In A Specific Case Pro Hac Vice) (Gratzinger, Peter) (Entered: 05/09/2018)
2018-05-09
1
APPLICATION of Non-Resident Attorney Grant T. Rice to Appear Pro Hac Vice on behalf of Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-21724925) filed by Defe ndant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order On Application of Non-Resident Attorney To Appear In A Specific Case Pro Hac Vice) (Gratzinger, Peter) (Entered: 05/09/2018)
2018-05-09
2
STIPULATION for Discovery as to Electronically Stored Information filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Tuan, Elizabeth) (Entered: 05/10/2018)
2018-05-10
1
STIPULATION for Discovery as to Electronically Stored Information filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Tuan, Elizabeth) (Entered: 05/10/2018)
2018-05-10
2
STIPULATION for Protective Order filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Tuan, Elizabeth) (Entered: 05/11/2018)
2018-05-11
1
STIPULATION for Protective Order filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Tuan, Elizabeth) (Entered: 05/11/2018)
2018-05-11
2
ORDER GRANTING PROTECTIVE ORDER by Magistrate Judge Rozella A. Oliver re Stipulation for Protective Order 74 (dml)
2018-05-14
1
Notice of Appearance or Withdrawal of Counsel: for attorney Andrea Weiss Jeffries counsel for Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Adding Andrea Weiss Jeffries as counsel of record for Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center for the reason indicated in the G-123 Notice. Filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attorney Andrea Weiss Jeffries added to party Juno Therapeutics, Inc.(pty:pla), Attorney Andrea Weiss Jeffries added to party Juno Therapeutics, Inc.(pty:cd), Attorney Andrea Weiss Jeffries added to party Memorial Sloan Kettering Cancer Center(pty:cd), Attorney Andrea Weiss Jeffries added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Andrea Weiss Jeffries added to party Sloan Kettering Institute for Cancer Research(pty:pla), Attorney Andrea Weiss Jeffries added to party Sloan Kettering Institute for Cancer Research(pty:cd))(Jeffries, Andrea) (Entered: 05/16/2018)
2018-05-16
1
APPLICATION of Non-Resident Attorney Christopher J. Harnett to Appear Pro Hac Vice on behalf of Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-21762927) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order) (Jeffries, Andrea) (Entered: 05/16/2018)
2018-05-16
1
APPLICATION of Non-Resident Attorney Christopher J. Harnett to Appear Pro Hac Vice on behalf of Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research (Pro Hac Vice Fee - Fee Paid, Receipt No. 0973-21762927) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order) (Jeffries, Andrea) (Entered: 05/16/2018)
2018-05-16
2
NOTICE of Deficiency in Electronically Filed Pro Hac Vice Application RE: APPLICATION of Non-Resident Attorney Christopher J. Harnett to Appear Pro Hac Vice on behalf of Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeu 77 . The following error(s) was/were found: Local Rule 83-2.1.3.3(a) Application not complete: state and/or federal courts to which the applicant has been admitted are not listed. (lt) (Entered: 05/17/2018)
2018-05-17
1
ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE by Judge S. James Otero: granting 77 Non-Resident Attorney Christopher J Harnett APPLICATION to Appear Pro Hac Vice on behalf of Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute for Cancer Research, designating Andrea Weiss Jeffries as local counsel. (lom) (Entered: 05/24/2018)
2018-05-24
1
NOTICE of Decision: Federal Circuit IPR Appeal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1)(Tuan, Elizabeth) (Entered: 06/07/2018)
2018-06-07
1
NOTICE of Decision: Federal Circuit IPR Appeal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1)(Tuan, Elizabeth) (Entered: 06/07/2018)
2018-06-07
2
STATEMENT Joint Claim Construction and Prehearing Statement filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Chu, Morgan) (Entered: 06/29/2018)
2018-06-29
1
STATEMENT Joint Claim Construction and Prehearing Statement filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Chu, Morgan) (Entered: 06/29/2018)
2018-06-29
2
STATEMENT Joint Claim Construction and Prehearing Statement filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Chu, Morgan) (Entered: 06/29/2018)
2018-06-29
2
STIPULATION to Continue Case Management Deadlines Re: Scheduling Conference - optional html form,,,, Set/Reset Deadlines/Hearings,,, 71 filed by Defendant-Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 08/07/2018)
2018-08-07
1
STIPULATION to Continue Case Management Deadlines Re: Scheduling Conference - optional html form,,,, Set/Reset Deadlines/Hearings,,, 71 filed by Defendant-Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 08/07/2018)
2018-08-07
2
SCHEDULING ORDER 82 by Judge S. James Otero. The Court hereby vacates the remaining case management deadlines in the current scheduling order (Dkt. 71) and sets the following schedule: Pretrial Conference - Monday, Oct. 7, 2019 at 9:00 a.m.; Jury Trial - Tuesday, Oct. 15, 2019 at 9:00 a.m. See attached document for other set dates and deadlines. (lom) (Entered: 08/10/2018)
2018-08-09
1
BRIEF filed by Plaintiffs and Counterclaim Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Claim Construction Brief (Attachments: # 1 Proposed Order)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
1
BRIEF filed by Plaintiffs and Counterclaim Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Claim Construction Brief (Attachments: # 1 Proposed Order)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
1
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
DECLARATION of Alan J. Heinrich re Brief (non-motion non-appeal), 84 ISO Juno's Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit Exhibit 1, # 2 Exhibit Exhibit 2, # 3 Exhibit Exhibit 3, # 4 Exhibit Exhibit 4, # 5 Exhibit Exhibit 5, # 6 Exhibit Exhibit 6, # 7 Exhibit Exhibit 7, # 8 Exhibit Exhibit 8, # 9 Exhibit Exhibit 9, # 10 Exhibit Exhibit 10, # 11 Exhibit Exhibit 11)(Heinrich, Alan) (Entered: 08/13/2018)
2018-08-13
2
Notice of Appearance or Withdrawal of Counsel: for attorney Edward George Dane counsel for Defendant Kite Pharma, Inc.. Adding Ted G. Dane as counsel of record for Defendant and Counterclaimant Kite Pharma, Inc. for the reason indicated in the G-123 Notice. Filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attorney Edward George Dane added to party Kite Pharma, Inc.(pty:dft))(Dane, Edward) (Entered: 08/15/2018)
2018-08-15
1
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
1
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
BRIEF filed by Defendant Kite Pharma, Inc.. Claim Construction Brief regarding Brief (non-motion non-appeal), 84 . (Attachments: # 1 Declaration of Dr. Richard P. Junghans, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8)(Lawton, Adam) (Entered: 08/27/2018)
2018-08-27
2
REPLY Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Appendix 1, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D)(Heinrich, Alan) (Entered: 09/03/2018)
2018-09-03
1
REPLY Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Appendix 1, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D)(Heinrich, Alan) (Entered: 09/03/2018)
2018-09-03
2
REPLY Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Appendix 1, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D)(Heinrich, Alan) (Entered: 09/03/2018)
2018-09-03
2
REPLY Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Appendix 1, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D)(Heinrich, Alan) (Entered: 09/03/2018)
2018-09-03
2
REPLY Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Appendix 1, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D)(Heinrich, Alan) (Entered: 09/03/2018)
2018-09-03
2
REPLY Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Appendix 1, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D)(Heinrich, Alan) (Entered: 09/03/2018)
2018-09-03
2
REPLY Claim Construction Brief filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Appendix 1, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D)(Heinrich, Alan) (Entered: 09/03/2018)
2018-09-03
2
SCHEDULING NOTICE OF CHANGE OF HEARING TIME by Judge S. James Otero. The Court changes the hearing time of the Markman hearing set for Monday, September 17, 2018 from 10:00 a.m. to 2:00 p.m. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 09/10/2018)
2018-09-10
1
ORDER GRANTING APPLICATION of Non-Resident Attorney Grant T. Rice to Appear Pro Hac Vice on behalf of Counter Claimant and Defendant Kite Pharma, Inc. and designating Peter E Gratzinger as local counsel 72 by Judge S. James Otero (lc) (Entered: 09/11/2018)
2018-09-11
1
NOTICE OF ERRATA filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. correcting Declaration,, 85 of Alan J. Heinrich ISO Plaintiffs' Claim Construction Brief, Exhibit 2 (Attachments: # 1 Exhibit 2, Volume I (Claim Construction Declaration of Prof. Thomas Brocker), # 2 Exhibit 2, Volume II (Brocker Declaration, Exhibits 1-8), # 3 Exhibit 2, Volume III (Brocker Declaration, Exhibits 9-20), # 4 Exhibit 2, Volume IV (Brocker Declaration, Exhibits 21-29))(Heinrich, Alan) (Entered: 09/13/2018)
2018-09-13
1
NOTICE OF ERRATA filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. correcting Declaration,, 85 of Alan J. Heinrich ISO Plaintiffs' Claim Construction Brief, Exhibit 2 (Attachments: # 1 Exhibit 2, Volume I (Claim Construction Declaration of Prof. Thomas Brocker), # 2 Exhibit 2, Volume II (Brocker Declaration, Exhibits 1-8), # 3 Exhibit 2, Volume III (Brocker Declaration, Exhibits 9-20), # 4 Exhibit 2, Volume IV (Brocker Declaration, Exhibits 21-29))(Heinrich, Alan) (Entered: 09/13/2018)
2018-09-13
2
NOTICE OF ERRATA filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. correcting Declaration,, 85 of Alan J. Heinrich ISO Plaintiffs' Claim Construction Brief, Exhibit 2 (Attachments: # 1 Exhibit 2, Volume I (Claim Construction Declaration of Prof. Thomas Brocker), # 2 Exhibit 2, Volume II (Brocker Declaration, Exhibits 1-8), # 3 Exhibit 2, Volume III (Brocker Declaration, Exhibits 9-20), # 4 Exhibit 2, Volume IV (Brocker Declaration, Exhibits 21-29))(Heinrich, Alan) (Entered: 09/13/2018)
2018-09-13
2
NOTICE OF ERRATA filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. correcting Declaration,, 85 of Alan J. Heinrich ISO Plaintiffs' Claim Construction Brief, Exhibit 2 (Attachments: # 1 Exhibit 2, Volume I (Claim Construction Declaration of Prof. Thomas Brocker), # 2 Exhibit 2, Volume II (Brocker Declaration, Exhibits 1-8), # 3 Exhibit 2, Volume III (Brocker Declaration, Exhibits 9-20), # 4 Exhibit 2, Volume IV (Brocker Declaration, Exhibits 21-29))(Heinrich, Alan) (Entered: 09/13/2018)
2018-09-13
2
NOTICE OF ERRATA filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. correcting Declaration,, 85 of Alan J. Heinrich ISO Plaintiffs' Claim Construction Brief, Exhibit 2 (Attachments: # 1 Exhibit 2, Volume I (Claim Construction Declaration of Prof. Thomas Brocker), # 2 Exhibit 2, Volume II (Brocker Declaration, Exhibits 1-8), # 3 Exhibit 2, Volume III (Brocker Declaration, Exhibits 9-20), # 4 Exhibit 2, Volume IV (Brocker Declaration, Exhibits 21-29))(Heinrich, Alan) (Entered: 09/13/2018)
2018-09-13
2
TRANSCRIPT for proceedings held on 3/2/18 10:02 a.m. Court Reporter: Carol Jean Zurborg, phone number (213) 894-3539. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 10/5/2018. Redacted Transcript Deadline set for 10/15/2018. Release of Transcript Restriction set for 12/13/2018. (Zurborg, Carol) (Entered: 09/14/2018)
2018-09-14
1
NOTICE OF FILING TRANSCRIPT filed for proceedings 3/2/18 10:02 a.m. re Transcript 92 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Zurborg, Carol) TEXT ONLY ENTRY (Entered: 09/14/2018)
2018-09-14
1
SCHEDULING NOTICE by Judge S. James Otero. The Court continues the Markman Hearing set for hearing on 9/17/18 to Tuesday, 9/18/2018 @ 10:00 AM before Judge S. James Otero. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 09/14/2018)
2018-09-14
1
MINUTES OF Markman Hearing held before Judge S. James Otero: The matter stands submitted. The Court orders that an expedited copy of todays transcript shall be produced, costs to be shared by the parties. Court Reporter: Carol Zurborg. (lc) (Entered: 10/19/2018)
2018-09-18
1
TRANSCRIPT ORDER as to Defendant Kite Pharma, Inc. for Court Reporter. Court will contact Adam R. Lawton at adam.lawton@mto.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the court reporter. (Lawton, Adam) (Entered: 09/19/2018)
2018-09-19
1
TRANSCRIPT ORDER as to Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research for Court Reporter. Court will contact Elizabeth Tuan at etuan@irell.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the court reporter. (Tuan, Elizabeth) (Entered: 09/19/2018)
2018-09-19
1
TRANSCRIPT for proceedings held on 9/18/18 10:03 a.m. Court Reporter: Carol Jean Zurborg, phone number (213) 894-3539. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 10/12/2018. Redacted Transcript Deadline set for 10/22/2018. Release of Transcript Restriction set for 12/20/2018. (Zurborg, Carol) (Entered: 09/21/2018)
2018-09-21
1
NOTICE OF FILING TRANSCRIPT filed for proceedings 9/18/18 10:03 a.m. re Transcript 97 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Zurborg, Carol) TEXT ONLY ENTRY (Entered: 09/21/2018)
2018-09-21
1
Notice of Appearance or Withdrawal of Counsel: for attorney Emily Moore Whitcher counsel for Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Adding Emily M. Whitcher as counsel of record for Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center for the reason indicated in the G-123 Notice. Filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center. (Attorney Emily Moore Whitcher added to party Juno Therapeutics, Inc.(pty:pla), Attorney Emily Moore Whitcher added to party Juno Therapeutics, Inc.(pty:cd), Attorney Emily Moore Whitcher added to party Memorial Sloan Kettering Cancer Center(pty:cd), Attorney Emily Moore Whitcher added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Emily Moore Whitcher added to party Sloan Kettering Institute for Cancer Research(pty:pla), Attorney Emily Moore Whitcher added to party Sloan Kettering Institute for Cancer Research(pty:cd))(Whitcher, Emily) (Entered: 09/26/2018)
2018-09-26
1
MINUTE IN CHAMBERS CLAIM CONSTRUCTION ORDER by Judge S. James Otero: The Court finds that a POSITA encountering the 190 Patent prior to the CoC would have understood SEQ ID NO:6 to begin with nucleotide 336 of the CD28 protein. The Court construes the disputed claim terms as follows: 1. The amino acid sequence encoded by SEQ ID NO:6 before the Certificate of Correction means Amino Acids 113-220 of CD28 (starting with lysine (K)) and after the Certificate of Correction means Amino Acids 114-220 of CD28 (starting with isoleucine (I)). 2. nucleic acid polymer encoding... a binding element that specifically interacts with a selected target is given its plain and ordinary meaning. (shb) (Entered: 10/10/2018)
2018-10-09
1
NOTICE of Association of Counsel associating attorney Crawford Maclain Wells on behalf of Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research (Attorney Crawford Maclain Wells added to party Juno Therapeutics, Inc.(pty:pla), Attorney Crawford Maclain Wells added to party Juno Therapeutics, Inc.(pty:cd), Attorney Crawford Maclain Wells added to party Memorial Sloan Kettering Cancer Center(pty:cd), Attorney Crawford Maclain Wells added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Crawford Maclain Wells added to party Sloan Kettering Institute for Cancer Research(pty:pla), Attorney Crawford Maclain Wells added to party Sloan Kettering Institute for Cancer Research(pty:cd))(Wells, Crawford) (Entered: 11/12/2018)
2018-11-12
1
APPLICATION to file document Exhibits to MTD under seal filed by Plaintiff Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Wells, Crawford) (Entered: 11/12/2018)
2018-11-12
1
APPLICATION to file document Exhibits to MTD under seal filed by Plaintiff Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Wells, Crawford) (Entered: 11/12/2018)
2018-11-12
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Exhibits to MTD under seal 103 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Ex. A, # 2 Unredacted Document Ex. B, # 3 Unredacted Document Ex. C, # 4 Unredacted Document Ex. D)(Wells, Crawford) (Entered: 11/12/2018)
2018-11-12
1
NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 12/17/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit I, # 7 Proposed Order) (Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
1
NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 12/17/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit I, # 7 Proposed Order) (Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
2
NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 12/17/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit I, # 7 Proposed Order) (Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
2
NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 12/17/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit I, # 7 Proposed Order) (Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
2
NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 12/17/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit I, # 7 Proposed Order) (Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
2
NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 12/17/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit I, # 7 Proposed Order) (Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
2
NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 12/17/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit I, # 7 Proposed Order) (Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
2
NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 12/17/2018 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit I, # 7 Proposed Order) (Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
2
APPLICATION to file document (Memorandum in Support of Motion to Dismiss and Exhibits A, F, G, and H) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Motion to Dismiss)(Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
1
APPLICATION to file document (Memorandum in Support of Motion to Dismiss and Exhibits A, F, G, and H) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Motion to Dismiss)(Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
2
APPLICATION to file document (Memorandum in Support of Motion to Dismiss and Exhibits A, F, G, and H) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Motion to Dismiss)(Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document (Memorandum in Support of Motion to Dismiss and Exhibits A, F, G, and H) under seal 106 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Memorandum in Support of Motion to Dismiss, # 2 Unredacted Document Exhibit A, # 3 Unredacted Document Exhibit F, # 4 Unredacted Document Exhibit G, # 5 Unredacted Document Exhibit H)(Lawton, Adam) (Entered: 11/12/2018)
2018-11-12
1
ORDER DENIED AS MOOT PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTSUNDER SEAL IN CONNECTION WITH KITE PHARMA INC.S MOTION TO DISMISS 103 by Judge S. James Otero: (lc) (Entered: 11/15/2018)
2018-11-15
1
ORDER GRANTING APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS IN SUPPORT OF MOTION TO DISMISS MEMORIAL SLOANKETTERING CANCER CENTER AND JUNO THERAPEUTICS, INC. FOR LACK OF STANDING 106 by Judge S. James Otero (lc) (Entered: 11/15/2018)
2018-11-15
1
SEALED DOCUMENT Memorandum in Support re NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105, Order on Motion for Leave to File Document Under Seal 109 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit F, # 3 Exhibit G, # 4 Exhibit H)(Lawton, Adam) (Entered: 11/16/2018)
2018-11-16
1
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
1
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
OPPOSITION in opposition to re: NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Declaration of Elizabeth C. Tuan, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 11)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
APPLICATION to file document Plaintiffs' Opposition to Defendant's Motion to Dismiss and Accompanying Exhibits under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Defendant's Motion to Dismiss, # 3 Redacted Document Declaration of Dr. Gregory Raskin)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
1
APPLICATION to file document Plaintiffs' Opposition to Defendant's Motion to Dismiss and Accompanying Exhibits under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Defendant's Motion to Dismiss, # 3 Redacted Document Declaration of Dr. Gregory Raskin)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
APPLICATION to file document Plaintiffs' Opposition to Defendant's Motion to Dismiss and Accompanying Exhibits under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Defendant's Motion to Dismiss, # 3 Redacted Document Declaration of Dr. Gregory Raskin)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
APPLICATION to file document Plaintiffs' Opposition to Defendant's Motion to Dismiss and Accompanying Exhibits under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Defendant's Motion to Dismiss, # 3 Redacted Document Declaration of Dr. Gregory Raskin)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Plaintiffs' Opposition to Defendant's Motion to Dismiss and Accompanying Exhibits under seal 112 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Plaintiffs' Opposition to Defendant's Motion to Dismiss, # 2 Unredacted Document Declaration of Dr. Gregory Raskin, # 3 Unredacted Document Exhibit 4, # 4 Unredacted Document Exhibit 5, # 5 Unredacted Document Exhibit 9, # 6 Unredacted Document Exhibit 10)(Tuan, Elizabeth) (Entered: 11/26/2018)
2018-11-26
1
APPLICATION to file document (Reply in Support of Motion to Dismiss and Exhibits J-M) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion to Dismiss)(Lawton, Adam) (Entered: 12/03/2018)
2018-12-03
1
APPLICATION to file document (Reply in Support of Motion to Dismiss and Exhibits J-M) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion to Dismiss)(Lawton, Adam) (Entered: 12/03/2018)
2018-12-03
2
APPLICATION to file document (Reply in Support of Motion to Dismiss and Exhibits J-M) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion to Dismiss)(Lawton, Adam) (Entered: 12/03/2018)
2018-12-03
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document (Reply in Support of Motion to Dismiss and Exhibits J-M) under seal 114 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Reply in Support of Motion to Dismiss, # 2 Unredacted Document Exhibit J, # 3 Unredacted Document Exhibit K, # 4 Unredacted Document Exhibit L, # 5 Unredacted Document Exhibit M)(Lawton, Adam) (Entered: 12/03/2018)
2018-12-03
1
SCHEDULING NOTICE by Judge S. James Otero. The Court finds the following motion suitable for disposition without oral argument and vacates the hearing on MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing filed by Defendant Kite Pharma, Inc. [ECF # 105], set for December 17, 2018. See Fed. R. Civ. P. 78(b). No appearance is required. The briefing schedule remains as set by Local Rule. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 12/12/2018)
2018-12-12
1
STIPULATION to AMEND Protective Order 75 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Amended Protective Order, # 2 Proposed Order)(Lawton, Adam) (Entered: 01/04/2019)
2019-01-04
1
STIPULATION to AMEND Protective Order 75 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Amended Protective Order, # 2 Proposed Order)(Lawton, Adam) (Entered: 01/04/2019)
2019-01-04
2
STIPULATION to AMEND Protective Order 75 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Amended Protective Order, # 2 Proposed Order)(Lawton, Adam) (Entered: 01/04/2019)
2019-01-04
2
ORDER GRANTING AMENDED PROTECTIVE ORDER by Magistrate Judge Rozella A. Oliver, re Stipulation to Amend Protective Order 117 (dml) (Entered: 01/07/2019)
2019-01-07
1
AMENDED PROTECTIVE ORDER by Magistrate Judge Rozella A. Oliver, re Order Granting 118 (dml) (Entered: 01/07/2019)
2019-01-07
1
Joint STIPULATION for Order Setting Briefing Schedule for Defendant's Motion for Summary Judgment filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
1
Joint STIPULATION for Order Setting Briefing Schedule for Defendant's Motion for Summary Judgment filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
1
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/1/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Statement of Undisputed Material Facts and Conclusions of Law, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Proposed Judgment) (Lawton, Adam) (Entered: 01/22/2019)
2019-01-22
2
Joint STIPULATION to Extend Discovery Cut-Off Date to March 29, 2019 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Heinrich, Alan) (Entered: 01/24/2019)
2019-01-24
1
Joint STIPULATION to Extend Discovery Cut-Off Date to March 29, 2019 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Heinrich, Alan) (Entered: 01/24/2019)
2019-01-24
2
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: ONLY the attached proposed order to the Stipulation to Extend Discovery Cut-Off Date, [122-1]. The following error(s) was/were found: Last page has only signature line of Judge. Other error(s) with document(s): L.R. 58-10 at least 2 lines of text must accompany the Signature Line of Judge on a last page of proposed order. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 01/24/2019)
2019-01-24
1
NOTICE OF LODGING filed [Proposed] Order re Stipulation to Extend Discovery Cut-Off Date, 122 (Attachments: # 1 Proposed Order)(Heinrich, Alan) (Entered: 01/24/2019)
2019-01-24
1
NOTICE OF LODGING filed [Proposed] Order re Stipulation to Extend Discovery Cut-Off Date, 122 (Attachments: # 1 Proposed Order)(Heinrich, Alan) (Entered: 01/24/2019)
2019-01-24
2
Notice of Appearance or Withdrawal of Counsel: for attorney Graham Berres Cole counsel for Defendant Kite Pharma, Inc.. Adding Graham Berres Cole as counsel of record for Kite Pharma, Inc. for the reason indicated in the G-123 Notice. Filed by Defendant Kite Pharma, Inc.. (Attorney Graham Berres Cole added to party Kite Pharma, Inc.(pty:dft))(Cole, Graham) (Entered: 02/08/2019)
2019-02-08
1
First APPLICATION of Non-Resident Attorney Sarah A. Geers to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-23182573) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Proposed Order On Application of Non-Resident Attorney To Appear In A Specific Case Pro Hac Vice) (Jeffries, Andrea) (Entered: 02/08/2019)
2019-02-08
1
First APPLICATION of Non-Resident Attorney Sarah A. Geers to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-23182573) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Proposed Order On Application of Non-Resident Attorney To Appear In A Specific Case Pro Hac Vice) (Jeffries, Andrea) (Entered: 02/08/2019)
2019-02-08
2
First APPLICATION of Non-Resident Attorney Kevin V. McCarthy to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-23182976) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Proposed Order On Application of Non-Resident Attorney To Appear In A Specific Case Pro Hac Vice) (Jeffries, Andrea) (Entered: 02/08/2019)
2019-02-08
1
First APPLICATION of Non-Resident Attorney Kevin V. McCarthy to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-23182976) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Proposed Order On Application of Non-Resident Attorney To Appear In A Specific Case Pro Hac Vice) (Jeffries, Andrea) (Entered: 02/08/2019)
2019-02-08
2
ORDER REGARDING CASE SCHEDULE 122 by Judge S. James Otero: The Court hereby vacates the remaining case management deadlines in the current scheduling order and sets the following schedule: Amended Pleadings due by 3/22/2019., Motions due by 6/24/2019.,Last date of hearing motions 8/12/2019 10:00 AM., Last date to conduct settlement conference is 9/16/2019., Pretrial Conference set for 11/26/2019 09:00 AM., Jury Trial set for 12/3/2019 09:00 AM. (SEE DOCUMENT FOR OTHER SPECIFIC DEADLINES). (lc) Modified on 5/3/2019 (lc). Modified on 5/3/2019 (lc). (Entered: 02/11/2019)
2019-02-11
1
ORDER GRANTING APPLICATION of Non-Resident Attorney Kevin V. McCarthy to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc, designating Andrea Weiss Jeffries as local counsel 127 by Judge S. James Otero. (lc) (Entered: 02/15/2019)
2019-02-15
1
ORDER by Judge S. James Otero: granting 126 Non-Resident Attorney Sarah A. Geers APPLICATION to Appear Pro Hac Vice on behalf of Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center and Sloan Kettering Institute for Cancer Research, designating Andrea Weiss Jeffries as local counsel. (lom) (Entered: 02/28/2019)
2019-02-15
1
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
1
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Statement of Genuine Disputes of Material Fact, # 2 Plaintiffs' Statement of Additional Material Facts, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit 1, # 5 Exhibit 2, # 6 Exhibit 3, # 7 Exhibit 4, # 8 Exhibit 5, # 9 Exhibit 6, # 10 Exhibit 7, # 11 Exhibit 8, # 12 Exhibit 9)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Marina Larson, Esq., Ph.D. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
1
DECLARATION of Marina Larson, Esq., Ph.D. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Marina Larson, Esq., Ph.D. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Marina Larson, Esq., Ph.D. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Marina Larson, Esq., Ph.D. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Marina Larson, Esq., Ph.D. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Marina Larson, Esq., Ph.D. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Marina Larson, Esq., Ph.D. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
1
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Bruce H. Stoner, Jr. in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
1
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. John Quackenbush in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. Thomas Brocker in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
1
DECLARATION of Prof. Thomas Brocker in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. Thomas Brocker in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. Thomas Brocker in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. Thomas Brocker in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. Thomas Brocker in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
DECLARATION of Prof. Thomas Brocker in opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Heinrich, Alan) (Entered: 02/19/2019)
2019-02-19
2
ORDER RETURNING CASE FOR REASSIGNMENT UPON RECUSAL by Magistrate Judge Rozella A. Oliver. ORDER case returned to the Clerk for random reassignment Discovery pursuant to General Order 05-07. Case randomly reassigned from Magistrate Judge Rozella A. Oliver to Magistrate Judge Karen L. Stevenson for all further proceedings. The case number will now reflect the initials of the transferee Judge 2:17-cv-07639 SJO(KSx). (rn) (Entered: 02/20/2019)
2019-02-20
1
Notice of Appearance or Withdrawal of Counsel: for attorney Garth T Vincent counsel for Defendant Kite Pharma, Inc.. Adding Garth Tyler Vincent as counsel of record for Kite Pharma, Inc. for the reason indicated in the G-123 Notice. Filed by Defendant Kite Pharma, Inc.. (Attorney Garth T Vincent added to party Kite Pharma, Inc.(pty:dft))(Vincent, Garth) (Entered: 02/21/2019)
2019-02-21
1
Notice of Appearance or Withdrawal of Counsel: for attorney Moon Hee Lee counsel for Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Adding Moon Hee Lee as counsel of record for Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research for the reason indicated in the G-123 Notice. Filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attorney Moon Hee Lee added to party Juno Therapeutics, Inc.(pty:pla), Attorney Moon Hee Lee added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Moon Hee Lee added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Lee, Moon) (Entered: 02/25/2019)
2019-02-25
1
MINUTES OF PRE-MOTION TELEPHONIC DISCOVERY CONFERENCE held before Magistrate Judge Karen L. Stevenson. The Court directs counsel to promptly email to the Courtroom Deputy, Chris Silva, the subpoena in question, along with non-party Bristol-Myers's objections, and any correspondence indicating that Defendant has agreed to narrow the dispute. The parties are directed to promptly submit a joint stipulation before Judge Otero, requesting an extension of the deadline for written discovery. The Court continues today's pre-motion telephonic discovery conference to Monday, March 4, 2019, at 1:00 pm. (see document for further detials) Court Recorder: XTR 02-26-19. (hr) (Entered: 02/26/2019)
2019-02-26
1
Motion Re: Informal Discovery Dispute. The Court sets a Telephonic Conference Re Discovery for 3/4/2019 at 1:00 pm. (csi) (Entered: 02/26/2019)
2019-02-26
1
APPLICATION to Exceed Page Limitation for Summary Judgment Reply Brief filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Lawton, Adam) (Entered: 02/27/2019)
2019-02-27
1
APPLICATION to Exceed Page Limitation for Summary Judgment Reply Brief filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Lawton, Adam) (Entered: 02/27/2019)
2019-02-27
2
PLAINTIFFS OPPOSITION TO DEFENDANTS APPLICATION FOR LEAVE TO FILE A 10- PAGE REPLY BRIEF IN SUPPORT OF MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT yes re: APPLICATION to Exceed Page Limitation for Summary Judgment Reply Brief 140 filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A To Juno's Opposition, # 2 Exhibit B To Juno's Opposiiton)(Jeffries, Andrea) (Entered: 02/27/2019)
2019-02-27
1
PLAINTIFFS OPPOSITION TO DEFENDANTS APPLICATION FOR LEAVE TO FILE A 10- PAGE REPLY BRIEF IN SUPPORT OF MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT yes re: APPLICATION to Exceed Page Limitation for Summary Judgment Reply Brief 140 filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A To Juno's Opposition, # 2 Exhibit B To Juno's Opposiiton)(Jeffries, Andrea) (Entered: 02/27/2019)
2019-02-27
2
PLAINTIFFS OPPOSITION TO DEFENDANTS APPLICATION FOR LEAVE TO FILE A 10- PAGE REPLY BRIEF IN SUPPORT OF MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT yes re: APPLICATION to Exceed Page Limitation for Summary Judgment Reply Brief 140 filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A To Juno's Opposition, # 2 Exhibit B To Juno's Opposiiton)(Jeffries, Andrea) (Entered: 02/27/2019)
2019-02-27
2
ORDER GRANTING-IN-PART DEFENDANT KITE PHARMA, INC.'S APPLICATION FOR LEAVE TO FILE A 10-PAGE REPLY BRIEF IN SUPPORT OF MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT 140 by Judge S. James Otero. It is hereby ordered that Defendant Kite Pharma, Inc. may file a reply brief of no more than 10 pages in support of its motion for summary judgment of noninfringement. Plaintiffs are permitted to file a sur-reply, not to exceed 7 pages, addressing the admissibility of the expert declarations submitted in support of its opposition to Defendant's motion for summary judgment of noninfringement. The sur-reply shall be filed no later than 5 days from Defendant's reply. IT IS SO ORDERED. (lom) (Entered: 02/28/2019)
2019-02-28
1
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
1
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16) (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
2
DECLARATION of Adam R. Lawton (Corrected) in support of EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses 144 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 03/04/2019)
2019-03-04
1
MINUTES OF CONTINUED PRE-MOTION TELEPHONIC DISCOVERY CONFERENCE settling 139 Motion re: Informal Discovery Dispute held before Magistrate Judge Karen L. Stevenson. Should Judge Otero grant Kite's Ex Parte Application, Kite may file a motion to compel. In the interim, at the request of counsel for non-party BMS, who does not receive the CM/ECF notifications in this case, the Court ORDERS Defendant Kite, to provide copies to BMS counsel of the following: (1) Minutes of Pre-Motion Telephonic Discovery Conference held on February 26, 2019, (Dkt. No. 138) (see document for further details). Court Recorder: XTR 03-04-19. (hr) (Entered: 03/06/2019)
2019-03-04
1
OPPOSITION Ex Parte Application re: EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses 144 Opposition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration, # 2 Exhibit 1)(Wells, Crawford) (Entered: 03/05/2019)
2019-03-05
1
OPPOSITION Ex Parte Application re: EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses 144 Opposition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration, # 2 Exhibit 1)(Wells, Crawford) (Entered: 03/05/2019)
2019-03-05
2
OPPOSITION Ex Parte Application re: EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses 144 Opposition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration, # 2 Exhibit 1)(Wells, Crawford) (Entered: 03/05/2019)
2019-03-05
2
REPLY in support of EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses 144 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Reply Declaration of Adam R. Lawton)(Lawton, Adam) (Entered: 03/05/2019)
2019-03-05
1
REPLY in support of EX PARTE APPLICATION for Order for Extension of Time for the Magistrate Judge to Hear Motions to Compel Production of Documents and Witnesses 144 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Reply Declaration of Adam R. Lawton)(Lawton, Adam) (Entered: 03/05/2019)
2019-03-05
2
TRANSCRIPT ORDER as to Defendant Kite Pharma, Inc. for Court Smart (CS). Court will contact Adam R. Lawton at adam.lawton@mto.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the transcription company. (Lawton, Adam) (Entered: 03/06/2019)
2019-03-06
1
ORDER GRANTING DEFENDANT KITE PHARMA, INC.S EX PARTE APPLICATION FOR AN EXTENSION OF TIME FOR THE MAGISTRATE JUDGE TO HEAR MOTIONS TO COMPEL PRODUCTION OF DOCUMENTS AND WITNESSES 144 by Judge S. James Otero: 1. Time is extended until April 17, 2019, for the Magistrate Judge to hear (a) any motions to compel Plaintiffs to produce documents that Kite has already identified as deficient in Plaintiffs production and Plaintiffs have not yet produced, and (b) a motion to compel Bristol-Myers Squibb Company to produce documents in response to Kites subpoena; and 2. Time is extended until May 10, 2019, for the Magistrate Judge to hear a motion to compel deposition testimony regarding the documents described in paragraph 1 above. (lc) Modified on 3/7/2019 (lc). (Entered: 03/07/2019)
2019-03-07
1
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Response to Statement of Additional Material Facts, # 2 Objections to Evidence, # 3 Declaration of Adam R. Lawton, # 4 Exhibit 13, # 5 Exhibit 14)(Lawton, Adam) (Entered: 03/11/2019)
2019-03-11
1
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Response to Statement of Additional Material Facts, # 2 Objections to Evidence, # 3 Declaration of Adam R. Lawton, # 4 Exhibit 13, # 5 Exhibit 14)(Lawton, Adam) (Entered: 03/11/2019)
2019-03-11
2
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Response to Statement of Additional Material Facts, # 2 Objections to Evidence, # 3 Declaration of Adam R. Lawton, # 4 Exhibit 13, # 5 Exhibit 14)(Lawton, Adam) (Entered: 03/11/2019)
2019-03-11
2
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Response to Statement of Additional Material Facts, # 2 Objections to Evidence, # 3 Declaration of Adam R. Lawton, # 4 Exhibit 13, # 5 Exhibit 14)(Lawton, Adam) (Entered: 03/11/2019)
2019-03-11
2
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Response to Statement of Additional Material Facts, # 2 Objections to Evidence, # 3 Declaration of Adam R. Lawton, # 4 Exhibit 13, # 5 Exhibit 14)(Lawton, Adam) (Entered: 03/11/2019)
2019-03-11
2
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Response to Statement of Additional Material Facts, # 2 Objections to Evidence, # 3 Declaration of Adam R. Lawton, # 4 Exhibit 13, # 5 Exhibit 14)(Lawton, Adam) (Entered: 03/11/2019)
2019-03-11
2
MOTION RE: INFORMAL DISCOVERY DISPUTE (hr) (Entered: 03/13/2019)
2019-03-13
1
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
1
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
NOTICE OF MOTION AND MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/3/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order, # 2 Declaration of Adam R. Lawton, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Certificate of Service)(Lawton, Adam) (Entered: 03/13/2019)
2019-03-13
2
MINUTES OF TELEPHONIC CONFERENCE RE: DISCOVERY DISPUTE held before Magistrate Judge Karen L. Stevenson. After discussion with the parties, the Court directed Plaintiff to complete any further production of responsive documents consistent with the parties' most current meet and confer discussions by 6:00 p.m. on Monday, March 18, 2019. If any disputed issues remain, the Court will hold a follow-up discovery conference on Thursday, March 21, 2019 at 10:00 a.m. and, if necessary, will set an expedited briefing schedule for any motion to compel at that time. The parties are directed to further meet and confer on this issue and if they cannot resolve the dispute, the parties must submit a joint email to the Court outlining the nature of dispute and the parties' positions by 4:00 p.m. on Wednesday, March 20, 2019. The Court will address the deposition dispute, during the further telephonic conference scheduled for Thursday, March 21, 2019 at 10:00 a.m. 152 [SEE DOCUMENT FOR FURTHER INFORMATION] Court Recorder: XTR-3/15/2019. (gr) (Entered: 03/15/2019)
2019-03-15
1
REPLY opposition NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 SUR-REPLY IN OPPOSITION TO DEFENDANTS MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries In Support Of Plaintiffs' Sur-Reply, # 2 Exhibit 1, # 3 Exhibit 2)(Jeffries, Andrea) (Entered: 03/18/2019)
2019-03-18
1
REPLY opposition NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 SUR-REPLY IN OPPOSITION TO DEFENDANTS MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries In Support Of Plaintiffs' Sur-Reply, # 2 Exhibit 1, # 3 Exhibit 2)(Jeffries, Andrea) (Entered: 03/18/2019)
2019-03-18
2
REPLY opposition NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 SUR-REPLY IN OPPOSITION TO DEFENDANTS MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries In Support Of Plaintiffs' Sur-Reply, # 2 Exhibit 1, # 3 Exhibit 2)(Jeffries, Andrea) (Entered: 03/18/2019)
2019-03-18
2
REPLY opposition NOTICE OF MOTION AND MOTION for Summary Judgment as to Noninfringement 121 SUR-REPLY IN OPPOSITION TO DEFENDANTS MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries In Support Of Plaintiffs' Sur-Reply, # 2 Exhibit 1, # 3 Exhibit 2)(Jeffries, Andrea) (Entered: 03/18/2019)
2019-03-18
2
MOTION RE: INFORMAL DISCOVERY DISPUTE (hr) (Entered: 03/18/2019)
2019-03-18
1
Notice of Appearance or Withdrawal of Counsel: for attorney Lauren Nicole Drake counsel for Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attorney Lauren Nicole Drake added to party Juno Therapeutics, Inc.(pty:pla), Attorney Lauren Nicole Drake added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Lauren Nicole Drake added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Drake, Lauren) (Entered: 03/20/2019)
2019-03-20
1
Notice of Appearance or Withdrawal of Counsel: for attorney Joseph N Akrotirianakis counsel for Respondent Bristol-Myers Squibb Company. Adding Joseph N. Akrotirianakis as counsel of record for Bristol-Myers Squibb Company for the reason indicated in the G-123 Notice. Filed by Respondent Bristol-Myers Squibb Company. (Attorney Joseph N Akrotirianakis added to party Bristol-Myers Squibb Company(pty:res))(Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
1
NOTICE of Interested Parties filed by Respondent Bristol-Myers Squibb Company, identifying Bristol-Myers Squibb Company. (Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
1
NOTICE OF MOTION AND MOTION for Protective Order for Subpoena filed by Respondent Bristol-Myers Squibb Company. Motion set for hearing on 4/17/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order Granting Non-Party Bristol-Myers Squibb Company for Protective Order)(Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
1
NOTICE OF MOTION AND MOTION for Protective Order for Subpoena filed by Respondent Bristol-Myers Squibb Company. Motion set for hearing on 4/17/2019 at 10:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Proposed Order Granting Non-Party Bristol-Myers Squibb Company for Protective Order)(Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
2
EX PARTE APPLICATION to Shorten Time for Hearing to April 10, 2019 filed by Respondent Bristol-Myers Squibb Company. (Attachments: # 1 Proposed Order Granting Non-Party Bristol-Myers Squibb Company's Ex Parte Application for an Order Shortening Notice and Resetting Hearing On Motion to Compel)(Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
1
EX PARTE APPLICATION to Shorten Time for Hearing to April 10, 2019 filed by Respondent Bristol-Myers Squibb Company. (Attachments: # 1 Proposed Order Granting Non-Party Bristol-Myers Squibb Company's Ex Parte Application for an Order Shortening Notice and Resetting Hearing On Motion to Compel)(Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
2
MEMORANDUM in Opposition to MOTION for Protective Order for Subpoena 160, MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents 153 filed by Respondent Bristol-Myers Squibb Company. (Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
1
DECLARATION of Joseph N. Akrotirianakis In Support of MOTION for Protective Order for Subpoena 160, EX PARTE APPLICATION to Shorten Time for Hearing to April 10, 2019 161, MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents 153 filed by Respondent Bristol-Myers Squibb Company. (Attachments: # 1 Exhibit 1-14)(Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
1
DECLARATION of Joseph N. Akrotirianakis In Support of MOTION for Protective Order for Subpoena 160, EX PARTE APPLICATION to Shorten Time for Hearing to April 10, 2019 161, MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents 153 filed by Respondent Bristol-Myers Squibb Company. (Attachments: # 1 Exhibit 1-14)(Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
2
DECLARATION of Brian Heaphy In Support of MOTION for Protective Order for Subpoena 160, MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents 153 filed by Respondent Bristol-Myers Squibb Company. (Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
1
EX PARTE APPLICATION to file document Declaration and Exhibits under seal filed by Respondent Bristol-Myers Squibb Company.(Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
1
SEALED DECLARATION IN SUPPORT OF EX PARTE APPLICATION to file document Declaration and Exhibits under seal 165 filed by Respondent Bristol-Myers Squibb Company. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Akrotirianakis, Joseph) (Entered: 03/20/2019)
2019-03-20
1
NOTICE OF LODGING filed re Sealed Declaration in SupportDeclaration, 166, EX PARTE APPLICATION to file document Declaration and Exhibits under seal 165 (Attachments: # 1 Proposed Order Granting Bristol-Myers Squibb Company's Ex Parte Application for Leave to File Documents Under Seal)(Akrotirianakis, Joseph) (Entered: 03/21/2019)
2019-03-21
1
NOTICE OF LODGING filed re Sealed Declaration in SupportDeclaration, 166, EX PARTE APPLICATION to file document Declaration and Exhibits under seal 165 (Attachments: # 1 Proposed Order Granting Bristol-Myers Squibb Company's Ex Parte Application for Leave to File Documents Under Seal)(Akrotirianakis, Joseph) (Entered: 03/21/2019)
2019-03-21
2
MINUTES OF TELEPHONIC DISCOVERY CONFERENCE RE: DISCOVERY DISPUTE held before Magistrate Judge Karen L. Stevenson: The Court held a telephonic conference with counsel for Plaintiffs and Defendants regarding three discovery-related issues. (1) Adequacy of Plaintiff's Document Production. A hearing on the motion to compel will be held on Friday, April 12, 2019 at 11:00 a.m. The parties shall confer on a mutually agreed expediated briefing schedule by Friday, March 22, 2019. (2) Plaintiff's Compliance with ESI Protocol re: Identification of Document Custodians. (3) Ex Parte Application by Non-party Bristol-Myers Squibb Company. The Court orders Defendant to file its opposition consistent with the Local Rules. (See document for further information) Court Recorder: XTR 03/21/2019. (es) (Entered: 03/21/2019)
2019-03-21
1
SCHEDULING NOTICE by Judge S. James Otero. The Court finds the following motion suitable for disposition without oral argument and vacates the hearing on the MOTION for Summary Judgment as to Noninfringement filed by Defendant Kite Pharma, Inc [ECF No. 121]., set for hearing on April 1, 2019. See Fed. R. Civ. P. 78(b). No appearance is required. The briefing schedule remains as set by Local Rule. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 03/21/2019)
2019-03-21
1
PROOF OF SERVICE filed by Respondent Bristol-Myers Squibb Company, re MOTION for Protective Order for Subpoena 160, MEMORANDUM in Opposition to Motion, 162, Notice of Appearance or Withdrawal of Counsel (G-123), 158, EX PARTE APPLICATION to Shorten Time for Hearing to April 10, 2019 161, Sealed Declaration in SupportDeclaration, 166, EX PARTE APPLICATION to file document Declaration and Exhibits under seal 165, Certificate/Notice of Interested Parties 159, Declaration (Motion related), 163, Declaration (Motion related), 164 served on March 20, 2019. (Akrotirianakis, Joseph) (Entered: 03/21/2019)
2019-03-21
1
Text Only Scheduling Notice
2019-03-21
1
No Actions
OPPOSITION to EX PARTE APPLICATION to Shorten Time for Hearing to April 10, 2019 161 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 03/22/2019)
2019-03-22
1
REPLY EX PARTE APPLICATION to Shorten Time for Hearing to April 10, 2019 161 filed by Respondent Bristol-Myers Squibb Company. (Akrotirianakis, Joseph) (Entered: 03/22/2019)
2019-03-22
1
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
1
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
STRICKEN, see docket entry no. 186 - FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) Modified on 3/28/2019 (lom). (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
1
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
FIRST AMENDED COMPLAINT against defendant Kite Pharma, Inc. amending Complaint (Attorney Civil Case Opening),, 1, filed by plaintiffs Sloan Kettering Institute for Cancer Research, Memorial Sloan Kettering Cancer Center, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17)(Chu, Morgan) (Entered: 03/22/2019)
2019-03-22
2
TRANSCRIPT ORDER as to Defendant Kite Pharma, Inc. for Court Smart (CS). Court will contact Carol Parrish at carol.parrish@mto.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the transcription company. (Gratzinger, Peter) (Entered: 03/25/2019)
2019-03-25
1
MINUTE (IN CHAMBERS): ORDER RE: EXPEDITED BRIEFING SCHEDULE FOR DEFENDANT KITE PHARMA INC.'S MOTION TO COMPEL 153 by Magistrate Judge Karen L. Stevenson. Kite to send Juno its portions of the joint stipulation (L.R. 37-2.2): March 27, 2019; Juno to send its portions of the joint stipulation to Kite (L.R. 37-2.2): April 2, 2019; Kite to File Joint Stipulation (L.R. 37-2.2): April 3, 2019; Parties to File Any Supplemental Memorandum (L.R. 27-2.3): April 8, 2019. A hearing on the Motion to Compel will take place on Friday, April 12, 2019 at 11:00 a.m. (see document for further details) (hr) (Entered: 03/25/2019)
2019-03-25
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Amended Complaint/Petition 173 . The following error(s) was/were found: Title page is missing. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lom) (Entered: 03/25/2019)
2019-03-25
1
TRANSCRIPT ORDER as to Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research for Court Smart (CS). Court will contact Jim Manzano at jmanzano@irell.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the transcription company. (Tuan, Elizabeth) (Entered: 03/25/2019)
2019-03-25
1
ORDER GRANTING NON-PARTY BRISTOL-MYERS SQUIBB COMPANY'S UNOPPOSED EX PARTE APPLICATION FOR LEAVE TO FILE DOCUMENTS UNDER SEAL 165 by Magistrate Judge Karen L. Stevenson. The Declaration of Aaron S. Craig and the documents appended thereto as Exhibits 1, 2, and 3 shall be filed under seal as follows: (see document for details). (hr) (Entered: 03/26/2019)
2019-03-26
1
MINUTE (IN CHAMBERS) ORDER VACATING HEARING ON DEFENDANT'S MOTION TO COMPEL NONPARTY BRISTOL-MYERS SQUIBB COMPANY TO PRODUCE DOCUMENTS 153 by Magistrate Judge Karen L. Stevenson. The hearing scheduled for April 3, 2019 is HEREBY VACATED. No appearance is required. The briefing schedule remains unchanged. (see document for details) (hr) (Entered: 03/26/2019)
2019-03-26
1
MINUTES (IN CHAMBERS) ORDER DENYING NONPARTY BRISTOL-MYERS SQUIBB COMPANYS EX PARTE APPLICATION 161 AND VACATING HEARING ON MOTION FOR PROTECTIVE ORDER 160 by Magistrate Judge Karen L. Stevenson. BMS's Ex Parte Application is DENIED. The hearing date on BMS's Motion for Protective Order is VACATED and the matter will be taken under submission for decision without oral argument. No appearance is required. The briefing schedule remains unchanged. (see document for details) (hr) (Entered: 03/26/2019)
2019-03-26
1
TRANSCRIPT for proceedings held on 3/21/2019. Court Reporter/Electronic Court Recorder: Exceptional Reporting Services, Inc., phone number (361) 949-2988. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 4/16/2019. Redacted Transcript Deadline set for 4/26/2019. Release of Transcript Restriction set for 6/24/2019. (at) (Entered: 03/27/2019)
2019-03-26
1
NOTICE OF FILING TRANSCRIPT filed for proceedings 3/21/2019 re Transcript 182 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (at) TEXT ONLY ENTRY (Entered: 03/27/2019)
2019-03-26
1
RESPONSE IN SUPPORT of MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents 153 in Response to Subpoena, and (2) Opposition to Motion for Protective Order filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A)(Cole, Graham) (Entered: 03/27/2019)
2019-03-27
1
Notice of Filing Transcript
2019-03-27
1
No Actions
REQUEST to file document ECF No. 184 under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Version of ECF No. 184)(Lawton, Adam) (Entered: 03/28/2019)
2019-03-28
1
REQUEST to file document ECF No. 184 under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Version of ECF No. 184)(Lawton, Adam) (Entered: 03/28/2019)
2019-03-28
2
MINUTE ORDER IN CHAMBERS by Judge S. James Otero. The Court strikes document No. 173 as moot. Document No. 174, First Amended Complaint, shall be the controlling pleading. (lom) (Entered: 03/28/2019)
2019-03-28
1
REPLY MOTION for Protective Order for Subpoena 160 filed by Respondent Bristol-Myers Squibb Company. (Akrotirianakis, Joseph) (Entered: 03/28/2019)
2019-03-28
1
NOTICE Errata to Motion for Summary Judgment (ECF No. 121) filed by Defendant Kite Pharma, Inc.. (Gratzinger, Peter) (Entered: 03/29/2019)
2019-03-29
1
MINUTES (IN CHAMBERS) ORDER PROVISIONALLY DENYING DEFENDANT'S REQUEST TO FILE DOCUMENTS UNDER SEAL 185 by Magistrate Judge Karen L. Stevenson. The Request is provisionally DENIED unless within three Court days of the date of this order, Defendant shows good cause, in writing, why the Reply Brief should be filed under seal. If Defendant has not filed any such response by the applicable date, the Request will be DENIED. (see document for further details) (hr) (Entered: 04/02/2019)
2019-04-02
1
NOTICE of Appearance filed by attorney Megan Alexandra Chacon on behalf of Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Attorney Megan Alexandra Chacon added to party Kite Pharma, Inc.(pty:cc), Attorney Megan Alexandra Chacon added to party Kite Pharma, Inc.(pty:dft))(Chacon, Megan) (Entered: 04/03/2019)
2019-04-03
1
NOTICE OF MOTION AND MOTION to Compel Production of Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/12/2019 at 11:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Joint Stipulation (L.R. 37-2) Re: Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 2 Declaration Decl. of P. Gratzinger ISO Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 3 Exhibit Exhs. 1 to 6 to Gratzinger Decl., # 4 Exhibit 7 to 16 to Gratzinger Decl., # 5 Declaration Decl. of C. Wells ISO Plaintiffs' Opp. to Def.'s Mot. to Compel Production of Documents, # 6 Proposed Order (Proposed) Order Granting Defendant Kite Pharma, Inc.'s Mot. to Compel Production of Documents)(Gratzinger, Peter) (Entered: 04/03/2019)
2019-04-03
1
NOTICE OF MOTION AND MOTION to Compel Production of Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/12/2019 at 11:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Joint Stipulation (L.R. 37-2) Re: Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 2 Declaration Decl. of P. Gratzinger ISO Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 3 Exhibit Exhs. 1 to 6 to Gratzinger Decl., # 4 Exhibit 7 to 16 to Gratzinger Decl., # 5 Declaration Decl. of C. Wells ISO Plaintiffs' Opp. to Def.'s Mot. to Compel Production of Documents, # 6 Proposed Order (Proposed) Order Granting Defendant Kite Pharma, Inc.'s Mot. to Compel Production of Documents)(Gratzinger, Peter) (Entered: 04/03/2019)
2019-04-03
2
NOTICE OF MOTION AND MOTION to Compel Production of Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/12/2019 at 11:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Joint Stipulation (L.R. 37-2) Re: Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 2 Declaration Decl. of P. Gratzinger ISO Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 3 Exhibit Exhs. 1 to 6 to Gratzinger Decl., # 4 Exhibit 7 to 16 to Gratzinger Decl., # 5 Declaration Decl. of C. Wells ISO Plaintiffs' Opp. to Def.'s Mot. to Compel Production of Documents, # 6 Proposed Order (Proposed) Order Granting Defendant Kite Pharma, Inc.'s Mot. to Compel Production of Documents)(Gratzinger, Peter) (Entered: 04/03/2019)
2019-04-03
2
NOTICE OF MOTION AND MOTION to Compel Production of Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/12/2019 at 11:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Joint Stipulation (L.R. 37-2) Re: Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 2 Declaration Decl. of P. Gratzinger ISO Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 3 Exhibit Exhs. 1 to 6 to Gratzinger Decl., # 4 Exhibit 7 to 16 to Gratzinger Decl., # 5 Declaration Decl. of C. Wells ISO Plaintiffs' Opp. to Def.'s Mot. to Compel Production of Documents, # 6 Proposed Order (Proposed) Order Granting Defendant Kite Pharma, Inc.'s Mot. to Compel Production of Documents)(Gratzinger, Peter) (Entered: 04/03/2019)
2019-04-03
2
NOTICE OF MOTION AND MOTION to Compel Production of Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/12/2019 at 11:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Joint Stipulation (L.R. 37-2) Re: Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 2 Declaration Decl. of P. Gratzinger ISO Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 3 Exhibit Exhs. 1 to 6 to Gratzinger Decl., # 4 Exhibit 7 to 16 to Gratzinger Decl., # 5 Declaration Decl. of C. Wells ISO Plaintiffs' Opp. to Def.'s Mot. to Compel Production of Documents, # 6 Proposed Order (Proposed) Order Granting Defendant Kite Pharma, Inc.'s Mot. to Compel Production of Documents)(Gratzinger, Peter) (Entered: 04/03/2019)
2019-04-03
2
NOTICE OF MOTION AND MOTION to Compel Production of Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/12/2019 at 11:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Joint Stipulation (L.R. 37-2) Re: Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 2 Declaration Decl. of P. Gratzinger ISO Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 3 Exhibit Exhs. 1 to 6 to Gratzinger Decl., # 4 Exhibit 7 to 16 to Gratzinger Decl., # 5 Declaration Decl. of C. Wells ISO Plaintiffs' Opp. to Def.'s Mot. to Compel Production of Documents, # 6 Proposed Order (Proposed) Order Granting Defendant Kite Pharma, Inc.'s Mot. to Compel Production of Documents)(Gratzinger, Peter) (Entered: 04/03/2019)
2019-04-03
2
NOTICE OF MOTION AND MOTION to Compel Production of Documents filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 4/12/2019 at 11:00 AM before Magistrate Judge Karen L. Stevenson. (Attachments: # 1 Joint Stipulation (L.R. 37-2) Re: Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 2 Declaration Decl. of P. Gratzinger ISO Kite Pharma, Inc.'s Mot. to Compel Production of Documents, # 3 Exhibit Exhs. 1 to 6 to Gratzinger Decl., # 4 Exhibit 7 to 16 to Gratzinger Decl., # 5 Declaration Decl. of C. Wells ISO Plaintiffs' Opp. to Def.'s Mot. to Compel Production of Documents, # 6 Proposed Order (Proposed) Order Granting Defendant Kite Pharma, Inc.'s Mot. to Compel Production of Documents)(Gratzinger, Peter) (Entered: 04/03/2019)
2019-04-03
2
STIPULATION for Extension of Time to File Response as to Amended Complaint/Petition,, 174 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 04/03/2019)
2019-04-03
1
STIPULATION for Extension of Time to File Response as to Amended Complaint/Petition,, 174 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 04/03/2019)
2019-04-03
2
RESPONSE filed by Respondent Bristol-Myers Squibb Companyto REQUEST to file document ECF No. 184 under seal 185, Response in Support of Motion, 184, Order on Motion for Leave to File Document Under Seal, 189 (Akrotirianakis, Joseph) (Entered: 04/04/2019)
2019-04-04
1
NOTICE of Change of Attorney Business or Contact Information: for attorney Joseph N Akrotirianakis counsel for Respondent Bristol-Myers Squibb Company. Changing Address - Suite Number to 1600. Filed by Respondent Bristol-Myers Squibb Company. (Akrotirianakis, Joseph) (Entered: 04/04/2019)
2019-04-04
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Notice of Appearance, 190 . The following error(s) was/were found: Incorrect event selected. Correct event to be used is: Notice of Appearance or Withdrawal of Counsel G123. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (ak) (Entered: 04/05/2019)
2019-04-05
1
MINUTE ORDER (IN CHAMBERS) ORDER GRANTING DEFENDANT'S REQUEST TO SEAL DKT. NO. 184 by Magistrate Judge Karen L. Stevenson: re: Response in Support of Motion, 184 . The Court is now in receipt of Nonparty Bristol- Myers Squibb Companys Response filed on April 4, 2019. (Dkt. No. 193.) For good cause shown, IT IS HEREBY ORDERED that Defendant's Request to Seal is GRANTED. Defendant is ordered to file the redacted version of Dkt. No. 184 immediately. IT IS SO ORDERED. (yl) (Entered: 04/05/2019)
2019-04-05
1
TEXT ONLY ENTRY: RE: RE-SCHEDULED TIME FOR MOTION HEARING by Magistrate Judge Karen L. Stevenson. Due to a scheduling conflict, the Court advances the time of the Motion hearing previously scheduled for Friday, April 12, 2019 at 11:00am, to Friday, April 12, 2019 at 11:30am. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (gr) (Entered: 04/05/2019)
2019-04-05
1
REPLY in support of MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents 153 and Opposition to Motion for Protective Order [REDACTED VERSION] filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 04/05/2019)
2019-04-05
1
Text Only Scheduling Notice
2019-04-05
1
No Actions
ORDER EXTENDING DEFENDANT'S TIME TO RESPOND TO FIRST AMENDED COMPLAINT TO APRIL 12, 2019 192 by Judge S. James Otero (lc) (Entered: 04/10/2019)
2019-04-07
1
MEMORANDUM in Opposition to MOTION to Compel Production of Documents 191 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration M. Wells ISO Plaintiffs' Supplemental Memorandum, # 2 Exhibit 1)(Wells, Crawford) (Entered: 04/08/2019)
2019-04-08
1
MEMORANDUM in Opposition to MOTION to Compel Production of Documents 191 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration M. Wells ISO Plaintiffs' Supplemental Memorandum, # 2 Exhibit 1)(Wells, Crawford) (Entered: 04/08/2019)
2019-04-08
2
MEMORANDUM in Opposition to MOTION to Compel Production of Documents 191 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration M. Wells ISO Plaintiffs' Supplemental Memorandum, # 2 Exhibit 1)(Wells, Crawford) (Entered: 04/08/2019)
2019-04-08
2
MEMORANDUM in Support of MOTION to Compel Production of Documents 191 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 04/08/2019)
2019-04-08
1
MOTION RE: INFORMAL DISCOVERY DISPUTE. (et) (Entered: 04/10/2019)
2019-04-10
1
TRANSCRIPT ORDER as to Defendant-Counterclaimant Kite Pharma, Inc. for Court Smart (CS). Court will contact Carol Parrish at carol.parrish@mto.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the transcription company. (Gratzinger, Peter) (Entered: 04/12/2019)
2019-04-12
1
NOTICE OF MOTION AND MOTION to Strike First Amended Complaint Amended Complaint/Petition,, 174 filed by Defendant-Counterclaimant Kite Pharma, Inc.. Motion set for hearing on 5/13/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order to Strike First Amended Complaint) (Gratzinger, Peter) (Entered: 04/12/2019)
2019-04-12
1
NOTICE OF MOTION AND MOTION to Strike First Amended Complaint Amended Complaint/Petition,, 174 filed by Defendant-Counterclaimant Kite Pharma, Inc.. Motion set for hearing on 5/13/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Proposed Order to Strike First Amended Complaint) (Gratzinger, Peter) (Entered: 04/12/2019)
2019-04-12
2
MINUTES OF HEARING RE: DEFENDANT'S MOTION TO COMPEL (DKT. NO. 191) Motion Hearing held before Magistrate Judge Karen L. Stevenson: After further discussion with the parties and at the request of defense counsel, the Court directs Defendant to submit an amended proposed order, outlining with particularity the relief Defendant seeks, by the close of business on Friday, April 12, 2019. The Court takes the matter under submission. An order will issue. IT IS SO ORDERED. Court Recorder: CS 04/12//2019. (yl) (Entered: 04/12/2019)
2019-04-12
1
NOTICE OF LODGING filed (Amended Proposed) Order re MOTION to Compel Production of Documents 191 (Attachments: # 1 Proposed Order (Amended Proposed) Order Granting Kite Pharma's Mot to Compel Production of Documents)(Gratzinger, Peter) (Entered: 04/12/2019)
2019-04-12
1
NOTICE OF LODGING filed (Amended Proposed) Order re MOTION to Compel Production of Documents 191 (Attachments: # 1 Proposed Order (Amended Proposed) Order Granting Kite Pharma's Mot to Compel Production of Documents)(Gratzinger, Peter) (Entered: 04/12/2019)
2019-04-12
2
SUPPLEMENT to MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents 153 Notice of Supplemental Evidence filed by Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Gratzinger, Peter) (Entered: 04/12/2019)
2019-04-12
1
SUPPLEMENT to MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents 153 Notice of Supplemental Evidence filed by Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Gratzinger, Peter) (Entered: 04/12/2019)
2019-04-12
2
SUPPLEMENT to MOTION to Compel Nonparty Bristol-Myers Squibb Company to Produce Documents 153 Notice of Supplemental Evidence filed by Counter Claimants Kite Pharma, Inc., Kite Pharma, Inc., Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Gratzinger, Peter) (Entered: 04/12/2019)
2019-04-12
2
TRANSCRIPT for proceedings held on 4/12/19 11:23 a.m.. Court Reporter/Electronic Court Recorder: BABYKIN COURTHOUSE SERVICES, phone number (626) 963-0566. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 5/8/2019. Redacted Transcript Deadline set for 5/20/2019. Release of Transcript Restriction set for 7/16/2019. (ha) (Entered: 04/17/2019)
2019-04-17
1
NOTICE OF FILING TRANSCRIPT filed for proceedings 4/12/19 11:23 A.M. re Transcript 208 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ha) TEXT ONLY ENTRY (Entered: 04/17/2019)
2019-04-17
1
NOTICE OF FILING TRANSCRIPT filed for proceedings 4/12/19 11:23 A.M. re Transcript 208 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ha) TEXT ONLY ENTRY (Entered: 04/17/2019)
2019-04-17
1
TRANSCRIPT ORDER as to Plaintiffs Juno Therapeutics, Inc. for Court Smart (CS). Court will contact Jim Manzano at jmanzano@irell.com with further instructions regarding this order. Transcript preparation will not begin until payment has been satisfied with the transcription company. (Tuan, Elizabeth) (Entered: 04/17/2019)
2019-04-17
1
Notice of Filing Transcript
2019-04-17
1
No Actions
TRANSCRIPT for proceedings held on 3/4/19. Court Reporter/Electronic Court Recorder: EXCEPTIONAL REPORTING SERVICES, INC, phone number (361) 949-2988. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 5/10/2019. Redacted Transcript Deadline set for 5/20/2019. Release of Transcript Restriction set for 7/18/2019. (ha) (Entered: 04/19/2019)
2019-04-19
1
NOTICE OF FILING TRANSCRIPT filed for proceedings 3/4/19 re Transcript 212 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ha) TEXT ONLY ENTRY (Entered: 04/19/2019)
2019-04-19
1
Notice of Filing Transcript
2019-04-19
1
No Actions
OPPOSITION to re: NOTICE OF MOTION AND MOTION to Strike First Amended Complaint Amended Complaint/Petition,, 174 204 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Tuan, Elizabeth) (Entered: 04/22/2019)
2019-04-22
1
OPPOSITION to re: NOTICE OF MOTION AND MOTION to Strike First Amended Complaint Amended Complaint/Petition,, 174 204 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Tuan, Elizabeth) (Entered: 04/22/2019)
2019-04-22
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION to Strike First Amended Complaint Amended Complaint/Petition,, 174 204 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Tuan, Elizabeth) (Entered: 04/22/2019)
2019-04-22
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION to Strike First Amended Complaint Amended Complaint/Petition,, 174 204 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Tuan, Elizabeth) (Entered: 04/22/2019)
2019-04-22
2
OPPOSITION to re: NOTICE OF MOTION AND MOTION to Strike First Amended Complaint Amended Complaint/Petition,, 174 204 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Tuan, Elizabeth) (Entered: 04/22/2019)
2019-04-22
2
MINUTES (IN CHAMBERS) ORDER DENYING DEFENDANT'S MOTION TO COMPEL 191 by Magistrate Judge Karen L. Stevenson. On April 12, 2019, the Court held oral argument. At the conclusion of the hearing, the Court took the matter under submission. For the reasons outlined below, the Motion is DENIED. (see document for further details) (hr) (Entered: 04/24/2019)
2019-04-24
1
EX PARTE APPLICATION of Non-Resident Attorney Gregory R. Booker to Appear Pro Hac Vice on behalf of Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-23608554) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order Granting Application to Appear PHV - Booker) (Biegler, Geoffrey) (Entered: 04/24/2019)
2019-04-24
1
EX PARTE APPLICATION of Non-Resident Attorney Gregory R. Booker to Appear Pro Hac Vice on behalf of Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-23608554) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order Granting Application to Appear PHV - Booker) (Biegler, Geoffrey) (Entered: 04/24/2019)
2019-04-24
2
ORDER GRANTING APPLICATION of Non-Resident Attorney Gregory R. Booker to Appear Pro Hac Vice on behalf of Defendant Kite Pharma, Inc. and designating Geoff D. Biegler as local counsel 216 by Judge S. James Otero (lc) (Entered: 04/26/2019)
2019-04-25
1
REPLY in support of NOTICE OF MOTION AND MOTION to Strike First Amended Complaint Amended Complaint/Petition,, 174 204 filed by Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc.. (Gratzinger, Peter) (Entered: 04/29/2019)
2019-04-29
1
MINUTES (IN CHAMBERS) ORDER RE: (1) DEFENDANT KITE PHARMA, INC.'S MOTION TO COMPEL NON-PARTY BRISTOL MYERS SQUIBB TO PRODUCE DOCUMENTS IN RESPONSE TO SUBPOENA (DKT NO. 153 ); AND (2) NON-PARTY BRISTOL MYERS SQUIBB'S MOTION FOR PROTECTIVE ORDER FOR SUBPOENA (DKT. NO. 160 ) by Magistrate Judge Karen L. Stevenson. Kite's Motion to Compel is GRANTED. Within ten (10) days of the date of this Order, non-party BMS shall comply with the Subpoena to produce. Non-party BMS's Motion for Protective Order is GRANTED in part and DENIED in part (see document for further details). (hr) (Entered: 04/29/2019)
2019-04-29
1
SCHEDULING NOTICE by Judge S. James Otero. The Court finds the following motion is suitable for disposition without oral argument and vacates the hearing on the MOTION to Strike First Amended Complaint Amended Complaint/Petition,, 174 filed by Defendant-Counterclaimant Kite Pharma, Inc.. [ECF No. 204]., set for hearing on May 13, 2019. See Fed. R. Civ. P. 78(b). No appearance is required. The briefing schedule remains as set by Local Rule. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 05/03/2019)
2019-05-03
1
Text Only Scheduling Notice
2019-05-03
1
No Actions
NOTICE OF LODGING filed re: Proposed Protective Order re Order on Motion to Compel,,, Order on Motion for Protective Order,, 219 (Attachments: # 1 Proposed Second Amended Protective Order)(Lawton, Adam) (Entered: 05/06/2019)
2019-05-06
1
NOTICE OF LODGING filed re: Proposed Protective Order re Order on Motion to Compel,,, Order on Motion for Protective Order,, 219 (Attachments: # 1 Proposed Second Amended Protective Order)(Lawton, Adam) (Entered: 05/06/2019)
2019-05-06
2
SECOND AMENDED PROTECTIVE ORDER by Magistrate Judge Karen L. Stevenson re Notice of Lodging Proposed Second Amended Protective Order 221 . (see document for details) (hr) (Entered: 05/07/2019)
2019-05-07
1
Joint STIPULATION for Judgment as to Literal Infringement filed by Plaintiffs Juno Therapeutics, Inc..(Jeffries, Andrea) (Entered: 06/24/2019)
2019-06-24
1
Joint STIPULATION for Order [PROPOSED] ORDER GRANTING STIPULATION RE: LITERAL INFRINGEMENT filed by Plaintiff Juno Therapeutics, Inc..(Jeffries, Andrea) (Entered: 06/24/2019)
2019-06-24
1
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
1
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 8/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Statement of Undisputed Material Facts ISO Motion for Summary Judgment, # 3 Declaration of Elizabeth C. Tuan ISO Motion for Summary Judgment, # 4 Exhibit 1 to Tuan Declaration, # 5 Exhibit 2 to Tuan Declaration, # 6 Exhibit 3 to Tuan Declaration, # 7 Exhibit 4 to Tuan Declaration, # 8 Exhibit 5 to Tuan Declaration, # 9 Exhibit 6 to Tuan Declaration, # 10 Exhibit 7 to Tuan Declaration, # 11 Exhibit 8 to Tuan Declaration, # 12 Exhibit 9 to Tuan Declaration, # 13 Exhibit 10 to Tuan Declaration, # 14 Exhibit 11 to Tuan Declaration, # 15 Exhibit 12 to Tuan Declaration, # 16 Proposed Order) (Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
APPLICATION to file document (Memorandum of Points and Authorities ISO Motion for Summary Judgment and Exhibits 11 and 12) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document)(Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
1
APPLICATION to file document (Memorandum of Points and Authorities ISO Motion for Summary Judgment and Exhibits 11 and 12) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document)(Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
APPLICATION to file document (Memorandum of Points and Authorities ISO Motion for Summary Judgment and Exhibits 11 and 12) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document)(Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document (Memorandum of Points and Authorities ISO Motion for Summary Judgment and Exhibits 11 and 12) under seal 226 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Memorandum of Points and Authorities ISO Motion for Summary Judgment, # 2 Unredacted Document Exhibit 11, # 3 Unredacted Document Exhibit 12)(Tuan, Elizabeth) (Entered: 06/24/2019)
2019-06-24
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Stipulation for Order 224 . The following error(s) was/were found: Incorrect event selected. Correct event to be used is: SEE BELOW UNDER OTHER. Proposed Document was not submitted as separate attachment. Other error(s) with document(s): pdf document is the Proposed order to the actual stipualtion docket no. 223. Proposed order should have been submitted as a separate attachment to a main document. As an alternative, prepare and e-file a formal Notice of Lodging, to be docketed only under its specific event: Notice of Lodging, to which the formal proposed order is submitted as Separate Attachment thereto.. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 06/25/2019)
2019-06-25
1
STATEMENT of Genuine Disputes in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
1
APPLICATION for Leave to file Under Seal Documents In Connection With Kite's Opposition to Plaintiffs' MSJ filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan ISO Application to Seal, # 2 Exhibit 1 to Tuan Declaration, # 3 Proposed Order) (Tuan, Elizabeth) (Entered: 07/15/2019)
2019-07-15
1
APPLICATION for Leave to file Under Seal Documents In Connection With Kite's Opposition to Plaintiffs' MSJ filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan ISO Application to Seal, # 2 Exhibit 1 to Tuan Declaration, # 3 Proposed Order) (Tuan, Elizabeth) (Entered: 07/15/2019)
2019-07-15
2
APPLICATION for Leave to file Under Seal Documents In Connection With Kite's Opposition to Plaintiffs' MSJ filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan ISO Application to Seal, # 2 Exhibit 1 to Tuan Declaration, # 3 Proposed Order) (Tuan, Elizabeth) (Entered: 07/15/2019)
2019-07-15
2
APPLICATION for Leave to file Under Seal Documents In Connection With Kite's Opposition to Plaintiffs' MSJ filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Elizabeth C. Tuan ISO Application to Seal, # 2 Exhibit 1 to Tuan Declaration, # 3 Proposed Order) (Tuan, Elizabeth) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
1
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
DECLARATION of Adam R. Lawton in Support of Opposition to NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
APPLICATION to file document (Opposition to Motion for Summary Judgment, Statement of Additional Material Facts, Declaration of Dr. Richard P. Junghans, and Exhibits 13 and 15) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Motion for Summary Judgment, # 3 Redacted Document Statement of Additional Material Facts, # 4 Redacted Document Declaration of Dr. Richard P. Junghans, # 5 Redacted Document Exhibit 13)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
1
APPLICATION to file document (Opposition to Motion for Summary Judgment, Statement of Additional Material Facts, Declaration of Dr. Richard P. Junghans, and Exhibits 13 and 15) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Motion for Summary Judgment, # 3 Redacted Document Statement of Additional Material Facts, # 4 Redacted Document Declaration of Dr. Richard P. Junghans, # 5 Redacted Document Exhibit 13)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
APPLICATION to file document (Opposition to Motion for Summary Judgment, Statement of Additional Material Facts, Declaration of Dr. Richard P. Junghans, and Exhibits 13 and 15) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Motion for Summary Judgment, # 3 Redacted Document Statement of Additional Material Facts, # 4 Redacted Document Declaration of Dr. Richard P. Junghans, # 5 Redacted Document Exhibit 13)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
APPLICATION to file document (Opposition to Motion for Summary Judgment, Statement of Additional Material Facts, Declaration of Dr. Richard P. Junghans, and Exhibits 13 and 15) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Motion for Summary Judgment, # 3 Redacted Document Statement of Additional Material Facts, # 4 Redacted Document Declaration of Dr. Richard P. Junghans, # 5 Redacted Document Exhibit 13)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
APPLICATION to file document (Opposition to Motion for Summary Judgment, Statement of Additional Material Facts, Declaration of Dr. Richard P. Junghans, and Exhibits 13 and 15) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Motion for Summary Judgment, # 3 Redacted Document Statement of Additional Material Facts, # 4 Redacted Document Declaration of Dr. Richard P. Junghans, # 5 Redacted Document Exhibit 13)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
APPLICATION to file document (Opposition to Motion for Summary Judgment, Statement of Additional Material Facts, Declaration of Dr. Richard P. Junghans, and Exhibits 13 and 15) under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Motion for Summary Judgment, # 3 Redacted Document Statement of Additional Material Facts, # 4 Redacted Document Declaration of Dr. Richard P. Junghans, # 5 Redacted Document Exhibit 13)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document (Opposition to Motion for Summary Judgment, Statement of Additional Material Facts, Declaration of Dr. Richard P. Junghans, and Exhibits 13 and 15) under seal 232 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Opposition to Motion for Summary Judgment, # 2 Unredacted Document Statement of Additional Material Facts, # 3 Unredacted Document Declaration of Dr. Richard P. Junghans, # 4 Unredacted Document Exhibit 13, # 5 Unredacted Document Exhibit 15)(Lawton, Adam) (Entered: 07/15/2019)
2019-07-15
1
APPLICATION of Non-Resident Attorney Lance E. Wyatt to Appear Pro Hac Vice on behalf of Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-24086254) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Biegler, Geoffrey) (Entered: 07/15/2019)
2019-07-15
1
APPLICATION of Non-Resident Attorney Lance E. Wyatt to Appear Pro Hac Vice on behalf of Defendant Kite Pharma, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-24086254) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Biegler, Geoffrey) (Entered: 07/15/2019)
2019-07-15
2
ORDER GRANTING APPLICATION of Non-Resident Attorney Lance E. Wyatt to Appear Pro Hac Vice on behalf of Defendant Kite Pharma, Inc. and designating Geoffrey D. Biegler as local counsel 234 by Judge S. James Otero (lc) (Entered: 07/17/2019)
2019-07-17
1
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Response to Kite's Statement of Additional Facts, # 2 Declaration ISO Reply ISO Plaintiffs' MSJ, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
1
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Response to Kite's Statement of Additional Facts, # 2 Declaration ISO Reply ISO Plaintiffs' MSJ, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
2
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Response to Kite's Statement of Additional Facts, # 2 Declaration ISO Reply ISO Plaintiffs' MSJ, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
2
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Response to Kite's Statement of Additional Facts, # 2 Declaration ISO Reply ISO Plaintiffs' MSJ, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
2
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Response to Kite's Statement of Additional Facts, # 2 Declaration ISO Reply ISO Plaintiffs' MSJ, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
2
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Response to Kite's Statement of Additional Facts, # 2 Declaration ISO Reply ISO Plaintiffs' MSJ, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
2
REPLY in support of NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Plaintiffs' Response to Kite's Statement of Additional Facts, # 2 Declaration ISO Reply ISO Plaintiffs' MSJ, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
2
APPLICATION to file document in connection with reply ISO Plaintiffs' motion for summary judgment on Kite's inventorship invalidity defense under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
1
APPLICATION to file document in connection with reply ISO Plaintiffs' motion for summary judgment on Kite's inventorship invalidity defense under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document in connection with reply ISO Plaintiffs' motion for summary judgment on Kite's inventorship invalidity defense under seal 237 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1 to Tuan Decl.)(Tuan, Elizabeth) (Entered: 07/29/2019)
2019-07-29
1
TEXT ONLY ENTRY by Judge S. James Otero. On the Court's motion, the Court takes off calendar and under submission the Motion for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225, previously scheduled for 8/12/2019 at 10:00 AM. No appearance is necessary. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (smo) (Entered: 08/07/2019)
2019-08-07
1
Text Only Scheduling Notice
2019-08-07
1
No Actions
Notice of Appearance or Withdrawal of Counsel: for attorney Rebecca Carson counsel for Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Adding Rebecca Carson as counsel of record for Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, and Sloan Kettering Institute for Cancer Research for the reason indicated in the G-123 Notice. Filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, and Sloan Kettering Institute for Cancer Research. (Attorney Rebecca Carson added to party Juno Therapeutics, Inc.(pty:pla), Attorney Rebecca Carson added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Rebecca Carson added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Carson, Rebecca) (Entered: 09/26/2019)
2019-09-26
1
Notice of Appearance or Withdrawal of Counsel: for attorney Elizabeth Chenyi Tuan counsel for Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Lauren Drake is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, and Sloan Kettering Institute for Cancer Research. (Tuan, Elizabeth) (Entered: 09/26/2019)
2019-09-26
1
Notice of Appearance or Withdrawal of Counsel: for attorney Elizabeth Chenyi Tuan counsel for Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Moon Hee Lee is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, and Sloan Kettering Institute for Cancer Research. (Tuan, Elizabeth) (Entered: 09/26/2019)
2019-09-26
1
Notice of Appearance or Withdrawal of Counsel: for attorney Andrea Weiss Jeffries counsel for Plaintiff Juno Therapeutics, Inc.. Emily Moore Whitcher is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiff Juno Therapeutics, Inc.,. (Jeffries, Andrea) (Entered: 09/27/2019)
2019-09-27
1
APPLICATION to Exceed Page Limitation for Motion to Exclude Expert Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Lawton, Adam) (Entered: 09/27/2019)
2019-09-27
1
APPLICATION to Exceed Page Limitation for Motion to Exclude Expert Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order) (Lawton, Adam) (Entered: 09/27/2019)
2019-09-27
2
Notice of Appearance or Withdrawal of Counsel: for attorney Blanca F Young counsel for Defendant Kite Pharma, Inc.. Adding Blanca F. Young as counsel of record for Kite Pharma, Inc. for the reason indicated in the G-123 Notice. Filed by Defendant Kite Pharma, Inc.. (Attorney Blanca F Young added to party Kite Pharma, Inc.(pty:dft))(Young, Blanca) (Entered: 09/27/2019)
2019-09-27
1
MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER (1) GRANTING-IN-PART AND DENYING-IN-PART DEFENDANT'S MOTION FOR SUMMARY JUDGMENT OF NONINFRINGEMENT 121 ; (2) GRANTING PLAINTIFFS MOTION FOR SUMMARY JUDGMENT ON KITE'S INVALIDITY DEFENSE UNDER 102(F) 225 . (lc) (Entered: 09/30/2019)
2019-09-27
1
OPPOSITION to APPLICATION to Exceed Page Limitation for Motion to Exclude Expert Testimony 244 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Carson, Rebecca) (Entered: 09/30/2019)
2019-09-30
1
Joint STIPULATION for Order Regarding Disclosure of Trial Demonstratives filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order Regarding Disclosure of Trial Demonstratives)(Heinrich, Alan) (Entered: 10/02/2019)
2019-10-02
1
Joint STIPULATION for Order Regarding Disclosure of Trial Demonstratives filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order Regarding Disclosure of Trial Demonstratives)(Heinrich, Alan) (Entered: 10/02/2019)
2019-10-02
2
MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER GRANTING-IN-PART DEFENDANT KITE PHARMA, INC.'S APPLICATION FOR LEAVE TO FILE A 20-PAGE MOTION TO EXCLUDE EXPERT TESTIMONY 244 . The page limits for Defendant's Daubert motion to exclude testimony of Dr. Ryan Sullivan are extended to 12 pages (memoranda in support of, and in opposition to), and 7 pages (reply in support of). (lc) (Entered: 10/02/2019)
2019-10-02
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS MOTION FOR SUMMARY JUDGMENT ON KITES INVENTORSHIP INVALIDITY DEFENSE UNDER 102(f) 226 by Judge S. James Otero (lc) (Entered: 10/02/2019)
2019-10-02
1
ORDER GRANTING APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS RE: OPPOSITION TO MOTION FOR SUMMARY JUDGMENT 232 by Judge S. James Otero (lc) (Entered: 10/02/2019)
2019-10-02
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH REPLY IN SUPPORT OF PLAINTIFFS MOTION FOR SUMMARY JUDGMENT ON KITES INVENTORSHIP INVALIDITY DEFENSE UNDER 102(f) 237 by Judge S. James Otero (lc) (Entered: 10/02/2019)
2019-10-02
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH KITES OPPOSITION TO PLAINTIFFS MOTION FOR SUMMARY JUDGMENT ON KITES INVENTORSHIP INVALIDITY DEFENSE UNDER 102(f) 230 by Judge S. James Otero (lc) (Entered: 10/02/2019)
2019-10-02
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS MEMORANDUM IN OPPOSITION TO DEFENDANTS MOTION TO DISMISS 112 by Judge S. James Otero (lc) (Entered: 10/07/2019)
2019-10-07
1
ORDER REGARDING DISCLOSURE OF TRIAL DEMONSTRATIVES (SEE DOCUMENT FOR SPECIFICS) 248 by Judge S. James Otero (lc) (Entered: 10/07/2019)
2019-10-07
1
DECLARATION of Elizabeth Tuan re APPLICATION to file document (Reply in Support of Motion to Dismiss and Exhibits J-M) under seal 114 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Tuan, Elizabeth) (Entered: 10/07/2019)
2019-10-07
1
ORDER GRANTING APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS RE: REPLY IN SUPPORT OF MOTION TO DISMISS MEMORIAL SLOAN-KETTERING CANCER CENTER AND JUNOTHERAPEUTICS, INC. FOR LACK OF STANDING 114 by Judge S. James Otero (lc) (Entered: 10/08/2019)
2019-10-08
1
SEALED REPLY RE NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105, Order on Motion for Leave to File Document Under Seal 257 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit J, # 2 Exhibit K, # 3 Exhibit L, # 4 Exhibit M)(Lawton, Adam) (Entered: 10/09/2019)
2019-10-09
1
SEALED OPPOSITION RE NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225, Order on Motion for Leave to File Document Under Seal 251 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Statement of Additional Material Facts, # 2 Declaration of Dr. Richard P. Junghans, # 3 Exhibit 13, # 4 Exhibit 15)(Lawton, Adam) (Entered: 10/09/2019)
2019-10-09
1
SEALED OPPOSITION RE NOTICE OF MOTION AND MOTION to Dismiss Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center for Lack of Standing 105, Order on Motion for Leave to File Document Under Seal 254 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Dr. Gregory Raskin, # 2 Exhibit 4, # 3 Exhibit 5, # 4 Exhibit 9, # 5 Exhibit 10)(Tuan, Elizabeth) (Entered: 10/10/2019)
2019-10-10
1
SEALED DOCUMENT Exhibit 1 re NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225, Order on Motion for Leave to File Document Under Seal 252 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.(Tuan, Elizabeth) (Entered: 10/10/2019)
2019-10-10
1
SEALED DOCUMENT Memorandum of Points and Authorities re NOTICE OF MOTION AND MOTION for Summary Judgment as to Kite's Inventorship Invalidity Defense Under Section 102(f) 225, Order on Motion for Leave to File Document Under Seal 250 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 11, # 2 Exhibit 12)(Tuan, Elizabeth) (Entered: 10/10/2019)
2019-10-10
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Sealed Document: exhibit 1 by plaintiff ( docket no 261). The following error(s) was/were found: Title page is missing. Other error(s) with document(s): MISSING Formal title page and its LR-11-3.8 required filer, attorney, court and case information. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 10/11/2019)
2019-10-11
1
NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 11/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities in support of Plaintiffs' Motion for Partial Reconsideration, # 2 Declaration of Andrea W. Jeffries in support of Plaintiffs' Motion for Partial Reconsideration, # 3 Proposed Order) (Jeffries, Andrea) (Entered: 10/14/2019)
2019-10-14
1
NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 11/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities in support of Plaintiffs' Motion for Partial Reconsideration, # 2 Declaration of Andrea W. Jeffries in support of Plaintiffs' Motion for Partial Reconsideration, # 3 Proposed Order) (Jeffries, Andrea) (Entered: 10/14/2019)
2019-10-14
2
NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 11/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities in support of Plaintiffs' Motion for Partial Reconsideration, # 2 Declaration of Andrea W. Jeffries in support of Plaintiffs' Motion for Partial Reconsideration, # 3 Proposed Order) (Jeffries, Andrea) (Entered: 10/14/2019)
2019-10-14
2
NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 11/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities in support of Plaintiffs' Motion for Partial Reconsideration, # 2 Declaration of Andrea W. Jeffries in support of Plaintiffs' Motion for Partial Reconsideration, # 3 Proposed Order) (Jeffries, Andrea) (Entered: 10/14/2019)
2019-10-14
2
NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 11/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit 1) (Lawton, Adam) (Entered: 10/15/2019)
2019-10-15
1
NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 11/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit 1) (Lawton, Adam) (Entered: 10/15/2019)
2019-10-15
2
NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 11/12/2019 at 10:00 AM before Judge S. James Otero. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit 1) (Lawton, Adam) (Entered: 10/15/2019)
2019-10-15
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification 265 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries i/s/o Plaintiffs' Opposition to Defendant's Motion for Partial Reconsideration, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 10/22/2019)
2019-10-22
1
OPPOSITION re: NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification 265 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries i/s/o Plaintiffs' Opposition to Defendant's Motion for Partial Reconsideration, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 10/22/2019)
2019-10-22
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification 265 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries i/s/o Plaintiffs' Opposition to Defendant's Motion for Partial Reconsideration, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 10/22/2019)
2019-10-22
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification 265 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries i/s/o Plaintiffs' Opposition to Defendant's Motion for Partial Reconsideration, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 10/22/2019)
2019-10-22
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification 265 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries i/s/o Plaintiffs' Opposition to Defendant's Motion for Partial Reconsideration, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 10/22/2019)
2019-10-22
2
OPPOSITION to NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 264 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 10/22/2019)
2019-10-22
1
REPLY in support of NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 264 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
1
REPLY in Support of NOTICE OF MOTION AND MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification 265 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 11/26/2019 at 09:00 AM before Judge S. James Otero.(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 11/26/2019 at 09:00 AM before Judge S. James Otero.(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 11/26/2019 at 09:00 AM before Judge S. James Otero.(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power filed by Defendant Kite Pharma, Inc.. Motion set for hearing on 11/26/2019 at 09:00 AM before Judge S. James Otero.(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities, # 2 Proposed Order, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit A, # 5 Exhibit B, # 6 Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities, # 2 Proposed Order, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit A, # 5 Exhibit B, # 6 Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities, # 2 Proposed Order, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit A, # 5 Exhibit B, # 6 Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities, # 2 Proposed Order, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit A, # 5 Exhibit B, # 6 Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities, # 2 Proposed Order, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit A, # 5 Exhibit B, # 6 Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities, # 2 Proposed Order, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit A, # 5 Exhibit B, # 6 Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum of Points and Authorities, # 2 Proposed Order, # 3 Declaration of Alan J. Heinrich, # 4 Exhibit A, # 5 Exhibit B, # 6 Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
1
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 10, # 3 Exhibit 11, # 4 Exhibit 12, # 5 Exhibit 13, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 20, # 9 Exhibit 21, # 10 Exhibit 22, # 11 Exhibit 23, # 12 Exhibit 24, # 13 Exhibit 25, # 14 Exhibit 26, # 15 Exhibit 27, # 16 Exhibit 28, # 17 Exhibit 29, # 18 Exhibit 30, # 19 Exhibit 31, # 20 Exhibit 32, # 21 Exhibit 33)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Redacted Document Memorandum in support of MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Declaration of A. Jefferies is support of MIL No. 2, # 3 Exhibit - 1 [LODGED UNDER SEAL], # 4 Exhibit - 2 [LODGED UNDER SEAL], # 5 Exhibit - 3 [LODGED UNDER SEAL], # 6 Exhibit - 4 [LODGED UNDER SEAL], # 7 Exhibit - 5 (Garcia deposition), # 8 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Redacted Document Memorandum in support of MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Declaration of A. Jefferies is support of MIL No. 2, # 3 Exhibit - 1 [LODGED UNDER SEAL], # 4 Exhibit - 2 [LODGED UNDER SEAL], # 5 Exhibit - 3 [LODGED UNDER SEAL], # 6 Exhibit - 4 [LODGED UNDER SEAL], # 7 Exhibit - 5 (Garcia deposition), # 8 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Redacted Document Memorandum in support of MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Declaration of A. Jefferies is support of MIL No. 2, # 3 Exhibit - 1 [LODGED UNDER SEAL], # 4 Exhibit - 2 [LODGED UNDER SEAL], # 5 Exhibit - 3 [LODGED UNDER SEAL], # 6 Exhibit - 4 [LODGED UNDER SEAL], # 7 Exhibit - 5 (Garcia deposition), # 8 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Redacted Document Memorandum in support of MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Declaration of A. Jefferies is support of MIL No. 2, # 3 Exhibit - 1 [LODGED UNDER SEAL], # 4 Exhibit - 2 [LODGED UNDER SEAL], # 5 Exhibit - 3 [LODGED UNDER SEAL], # 6 Exhibit - 4 [LODGED UNDER SEAL], # 7 Exhibit - 5 (Garcia deposition), # 8 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Redacted Document Memorandum in support of MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Declaration of A. Jefferies is support of MIL No. 2, # 3 Exhibit - 1 [LODGED UNDER SEAL], # 4 Exhibit - 2 [LODGED UNDER SEAL], # 5 Exhibit - 3 [LODGED UNDER SEAL], # 6 Exhibit - 4 [LODGED UNDER SEAL], # 7 Exhibit - 5 (Garcia deposition), # 8 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Redacted Document Memorandum in support of MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Declaration of A. Jefferies is support of MIL No. 2, # 3 Exhibit - 1 [LODGED UNDER SEAL], # 4 Exhibit - 2 [LODGED UNDER SEAL], # 5 Exhibit - 3 [LODGED UNDER SEAL], # 6 Exhibit - 4 [LODGED UNDER SEAL], # 7 Exhibit - 5 (Garcia deposition), # 8 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Redacted Document Memorandum in support of MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Declaration of A. Jefferies is support of MIL No. 2, # 3 Exhibit - 1 [LODGED UNDER SEAL], # 4 Exhibit - 2 [LODGED UNDER SEAL], # 5 Exhibit - 3 [LODGED UNDER SEAL], # 6 Exhibit - 4 [LODGED UNDER SEAL], # 7 Exhibit - 5 (Garcia deposition), # 8 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Redacted Document Memorandum in support of MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Declaration of A. Jefferies is support of MIL No. 2, # 3 Exhibit - 1 [LODGED UNDER SEAL], # 4 Exhibit - 2 [LODGED UNDER SEAL], # 5 Exhibit - 3 [LODGED UNDER SEAL], # 6 Exhibit - 4 [LODGED UNDER SEAL], # 7 Exhibit - 5 (Garcia deposition), # 8 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Redacted Document Memorandum in support of MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Declaration of A. Jefferies is support of MIL No. 2, # 3 Exhibit - 1 [LODGED UNDER SEAL], # 4 Exhibit - 2 [LODGED UNDER SEAL], # 5 Exhibit - 3 [LODGED UNDER SEAL], # 6 Exhibit - 4 [LODGED UNDER SEAL], # 7 Exhibit - 5 (Garcia deposition), # 8 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Motion in Limine No. 1, # 3 Redacted Document Memorandum in Support of Motion in Limine No. 2, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 5)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
1
APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Motion in Limine No. 1, # 3 Redacted Document Memorandum in Support of Motion in Limine No. 2, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 5)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Motion in Limine No. 1, # 3 Redacted Document Memorandum in Support of Motion in Limine No. 2, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 5)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Motion in Limine No. 1, # 3 Redacted Document Memorandum in Support of Motion in Limine No. 2, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 5)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Motion in Limine No. 1, # 3 Redacted Document Memorandum in Support of Motion in Limine No. 2, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 5)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Motion in Limine No. 1, # 3 Redacted Document Memorandum in Support of Motion in Limine No. 2, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 5)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document Plaintiffs' Memorandum in Support of its Motion in Limine No. 2 and Exhibits under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Redacted Document Memorandum in Support of Plaintiffs' MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
1
APPLICATION to file document Plaintiffs' Memorandum in Support of its Motion in Limine No. 2 and Exhibits under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Redacted Document Memorandum in Support of Plaintiffs' MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document Plaintiffs' Memorandum in Support of its Motion in Limine No. 2 and Exhibits under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Redacted Document Memorandum in Support of Plaintiffs' MIL No. 2 regarding Evidence and Argument Relating to the Rocket Clinical Trial, # 2 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document in Connection with Plaintiffs' Motion to Exclude Dr. Mohan Rao's Testimony Regarding Damages under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum of Points and Authorities, # 3 Redacted Document Exhibit A, # 4 Redacted Document Exhibit B, # 5 Redacted Document Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
1
APPLICATION to file document in Connection with Plaintiffs' Motion to Exclude Dr. Mohan Rao's Testimony Regarding Damages under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum of Points and Authorities, # 3 Redacted Document Exhibit A, # 4 Redacted Document Exhibit B, # 5 Redacted Document Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document in Connection with Plaintiffs' Motion to Exclude Dr. Mohan Rao's Testimony Regarding Damages under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum of Points and Authorities, # 3 Redacted Document Exhibit A, # 4 Redacted Document Exhibit B, # 5 Redacted Document Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document in Connection with Plaintiffs' Motion to Exclude Dr. Mohan Rao's Testimony Regarding Damages under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum of Points and Authorities, # 3 Redacted Document Exhibit A, # 4 Redacted Document Exhibit B, # 5 Redacted Document Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document in Connection with Plaintiffs' Motion to Exclude Dr. Mohan Rao's Testimony Regarding Damages under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum of Points and Authorities, # 3 Redacted Document Exhibit A, # 4 Redacted Document Exhibit B, # 5 Redacted Document Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
APPLICATION to file document in Connection with Plaintiffs' Motion to Exclude Dr. Mohan Rao's Testimony Regarding Damages under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum of Points and Authorities, # 3 Redacted Document Exhibit A, # 4 Redacted Document Exhibit B, # 5 Redacted Document Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal 277 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Memorandum in Support of Motion in Limine No. 1, # 2 Unredacted Document Memorandum in Support of Motion in Limine No. 2, # 3 Unredacted Document Exhibit 1, # 4 Unredacted Document Exhibit 2, # 5 Unredacted Document Exhibit 3, # 6 Unredacted Document Exhibit 4, # 7 Unredacted Document Exhibit 5, # 8 Unredacted Document Exhibit 6, # 9 Unredacted Document Exhibit 7, # 10 Unredacted Document Exhibit 9, # 11 Unredacted Document Exhibit 16, # 12 Unredacted Document Exhibit 17, # 13 Unredacted Document Exhibit 18, # 14 Unredacted Document Exhibit 19, # 15 Unredacted Document Certificate of Service)(Lawton, Adam) (Entered: 10/29/2019)
2019-10-29
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Plaintiffs' Memorandum in Support of its Motion in Limine No. 2 and Exhibits under seal 278 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Memorandum in Support of Plaintiffs' MIL No. 2, # 2 Unredacted Document Exhibit 1 (Gilbert Deposition), # 3 Unredacted Document Exhibit 2 (Jain Deposition), # 4 Unredacted Document Exhibit 3 (Rao Expert Report), # 5 Unredacted Document Exhibit 4 (Garcia Expert Report))(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document in Connection with Plaintiffs' Motion to Exclude Dr. Mohan Rao's Testimony Regarding Damages under seal 279 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Memorandum of Points and Authorities, # 2 Unredacted Document Exhibit A, # 3 Unredacted Document Exhibit B, # 4 Unredacted Document Exhibit C)(Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in support of Plaintiffs' MIL No. 3, # 2 Declaration of A. Jefferies in support of Plaintiffs' MIL No. 3, # 3 Exhibit - 1 (BMS press release 2019-01-03), # 4 Exhibit - 2 (BMS press release 2019-10-18), # 5 Exhibit - 3 (email dated 2019-05-09), # 6 Exhibit - 4 (Sullivan Deposition excerpt), # 7 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in support of Plaintiffs' MIL No. 3, # 2 Declaration of A. Jefferies in support of Plaintiffs' MIL No. 3, # 3 Exhibit - 1 (BMS press release 2019-01-03), # 4 Exhibit - 2 (BMS press release 2019-10-18), # 5 Exhibit - 3 (email dated 2019-05-09), # 6 Exhibit - 4 (Sullivan Deposition excerpt), # 7 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in support of Plaintiffs' MIL No. 3, # 2 Declaration of A. Jefferies in support of Plaintiffs' MIL No. 3, # 3 Exhibit - 1 (BMS press release 2019-01-03), # 4 Exhibit - 2 (BMS press release 2019-10-18), # 5 Exhibit - 3 (email dated 2019-05-09), # 6 Exhibit - 4 (Sullivan Deposition excerpt), # 7 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in support of Plaintiffs' MIL No. 3, # 2 Declaration of A. Jefferies in support of Plaintiffs' MIL No. 3, # 3 Exhibit - 1 (BMS press release 2019-01-03), # 4 Exhibit - 2 (BMS press release 2019-10-18), # 5 Exhibit - 3 (email dated 2019-05-09), # 6 Exhibit - 4 (Sullivan Deposition excerpt), # 7 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in support of Plaintiffs' MIL No. 3, # 2 Declaration of A. Jefferies in support of Plaintiffs' MIL No. 3, # 3 Exhibit - 1 (BMS press release 2019-01-03), # 4 Exhibit - 2 (BMS press release 2019-10-18), # 5 Exhibit - 3 (email dated 2019-05-09), # 6 Exhibit - 4 (Sullivan Deposition excerpt), # 7 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in support of Plaintiffs' MIL No. 3, # 2 Declaration of A. Jefferies in support of Plaintiffs' MIL No. 3, # 3 Exhibit - 1 (BMS press release 2019-01-03), # 4 Exhibit - 2 (BMS press release 2019-10-18), # 5 Exhibit - 3 (email dated 2019-05-09), # 6 Exhibit - 4 (Sullivan Deposition excerpt), # 7 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in support of Plaintiffs' MIL No. 3, # 2 Declaration of A. Jefferies in support of Plaintiffs' MIL No. 3, # 3 Exhibit - 1 (BMS press release 2019-01-03), # 4 Exhibit - 2 (BMS press release 2019-10-18), # 5 Exhibit - 3 (email dated 2019-05-09), # 6 Exhibit - 4 (Sullivan Deposition excerpt), # 7 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in support of Plaintiffs' MIL No. 3, # 2 Declaration of A. Jefferies in support of Plaintiffs' MIL No. 3, # 3 Exhibit - 1 (BMS press release 2019-01-03), # 4 Exhibit - 2 (BMS press release 2019-10-18), # 5 Exhibit - 3 (email dated 2019-05-09), # 6 Exhibit - 4 (Sullivan Deposition excerpt), # 7 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in Support of Plaintiffs' MIL No. 1, # 2 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
1
NOTICE OF MOTION AND MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in Support of Plaintiffs' MIL No. 1, # 2 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
NOTICE OF MOTION AND MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Motion set for hearing on 12/3/2019 at 08:30 AM before Judge S. James Otero. (Attachments: # 1 Memorandum in Support of Plaintiffs' MIL No. 1, # 2 Proposed Order)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
1
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
DECLARATION of Andrea W. Jeffries in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - 1, # 2 Exhibit - 2, # 3 Exhibit - 3, # 4 Exhibit - 5, # 5 Exhibit - 6, # 6 Exhibit - 7, # 7 Exhibit - 8, # 8 Exhibit - 9, # 9 Exhibit - 10, # 10 Exhibit - 11, # 11 Exhibit - 12, # 12 Exhibit - 13, # 13 Exhibit - 14)(Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
2
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,, 282 served on 10/29/2019. (Heinrich, Alan) (Entered: 10/29/2019)
2019-10-29
1
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Exhibit - 4 as to Declaration (Motion related),, 285 . (Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,,, 281 served on October 29, 2019. (Jeffries, Andrea) (Entered: 10/29/2019)
2019-10-29
1
Notice of Appearance or Withdrawal of Counsel: for attorney William Chad Shear counsel for Defendant Kite Pharma, Inc.. Adding W. Chad Shear as counsel of record for Kite Pharma, Inc. for the reason indicated in the G-123 Notice. Filed by Defendant Kite Pharma, Inc.. (Attorney William Chad Shear added to party Kite Pharma, Inc.(pty:dft))(Shear, William) (Entered: 10/31/2019)
2019-10-31
1
Notice of Appearance or Withdrawal of Counsel: for attorney John M Farrell counsel for Defendant Kite Pharma, Inc.. Adding John M. Farrell as counsel of record for Kite Pharma, Inc. for the reason indicated in the G-123 Notice. Filed by Defendant Kite Pharma, Inc.. (Attorney John M Farrell added to party Kite Pharma, Inc.(pty:dft))(Farrell, John) (Entered: 10/31/2019)
2019-10-31
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal 277 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.(Tuan, Elizabeth) (Entered: 11/02/2019)
2019-11-02
1
DECLARATION of Katharine Rice in Support of APPLICATION to file document in Connection with Plaintiffs' Motion to Exclude Dr. Mohan Rao's Testimony Regarding Damages under seal 279, APPLICATION to file document Plaintiffs' Memorandum in Support of its Motion in Limine No. 2 and Exhibits under seal 278, APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal 277 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 11/04/2019)
2019-11-04
1
DECLARATION of Katharine Rice in Support of APPLICATION to file document in Connection with Plaintiffs' Motion to Exclude Dr. Mohan Rao's Testimony Regarding Damages under seal 279, APPLICATION to file document Plaintiffs' Memorandum in Support of its Motion in Limine No. 2 and Exhibits under seal 278, APPLICATION to file document Memoranda and Exhibits in Support of Motions in Limine under seal 277 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 11/04/2019)
2019-11-04
2
Joint STIPULATION for Extension of Time to File Joint Exhibit List filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 11/04/2019)
2019-11-04
1
Joint STIPULATION for Extension of Time to File Joint Exhibit List filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 11/04/2019)
2019-11-04
2
MEMORANDUM of CONTENTIONS of FACT and LAW filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 11/05/2019)
2019-11-05
1
APPLICATION to file document Memorandum of Contentions of Law and Fact under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum of Contentions of Law and Fact)(Lawton, Adam) (Entered: 11/05/2019)
2019-11-05
1
APPLICATION to file document Memorandum of Contentions of Law and Fact under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum of Contentions of Law and Fact)(Lawton, Adam) (Entered: 11/05/2019)
2019-11-05
2
APPLICATION to file document Memorandum of Contentions of Law and Fact under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum of Contentions of Law and Fact)(Lawton, Adam) (Entered: 11/05/2019)
2019-11-05
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Memorandum of Contentions of Law and Fact under seal 295 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Memorandum of Contentions of Law and Fact, # 2 Certificate of Service)(Lawton, Adam) (Entered: 11/05/2019)
2019-11-05
1
ORDER EXTENDING TIME TO FILE JOINT EXHIBIT LIST 293 by Judge S. James Otero. It is hereby ordered that the deadline for the parties to file the joint exhibit list be extended to and including November 12, 2019. (lom) (Entered: 11/05/2019)
2019-11-05
1
Witness List filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.. (Tuan, Elizabeth) (Entered: 11/05/2019)
2019-11-05
1
SCHEDULING NOTICE by Judge S. James Otero. The Court finds the following motions suitable for disposition without oral argument and vacates the hearing on the MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. [ECF no. 264] and the MOTION for Reconsideration re Order on Motion for Summary Judgment,,, 246 and Motion for Clarification filed by Defendant Kite Pharma, Inc. [ECF No. 256], set for hearing on November 12, 2019. No appearance is required. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 11/06/2019)
2019-11-06
1
ORDER GRANTING PLAINTIFFS' APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS' MOTION TO EXCLUDE DR. MOHAN RAO'S TESTIMONY REGARDING DAMAGES 279 by Judge S. James Otero. See order for details. (lom) (Entered: 11/06/2019)
2019-11-06
1
ORDER GRANTING APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS IN SUPPORT OF DEFENDANT KITE PHARMA, INC.'S MOTIONS IN LIMINE 277 by Judge S. James Otero. See order for details. (lom) (Entered: 11/06/2019)
2019-11-06
1
ORDER GRANTING PLAINTIFFS' APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS' MOTIONS IN LIMINE 278 by Judge S. James Otero. See order for details. (lom) (Entered: 11/06/2019)
2019-11-06
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: APPLICATION to file document Memorandum of Contentions of Law and Fact under seal 295 . The following error(s) was/were found: Local Rule 11-6 Memorandum/brief exceeds 25 pages. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lom) (Entered: 11/06/2019)
2019-11-06
1
SEALED PROCEEDINGS (in chambers): ORDER GRANTING-IN-PART DEFENDANT KITE PHARMA, INC.'S MOTION TO DISMISS MEMORIAL SLOAN KETTERING CANCER CENTER AND JUNO THERAPEUTICS, INC. AS PLAINTIFFS FOR LACK OF STANDING [ECF No. 105] by Judge S. James Otero (es) (Entered: 11/07/2019)
2019-11-06
1
MINUTE ORDER IN CHAMBERS (REDACTED) by Judge S. James Otero:ORDER GRANTING-IN-PART DEFENDANT KITE PHARMA, INC.'S MOTION TO DISMISS MEMORIAL SLOAN KETTERING CANCER CENTER AND JUNO THERAPEUTICS, INC. AS PLAINTIFFS FOR LACK OF STANDING [ECF No. 105] (lc) (Entered: 11/14/2019)
2019-11-06
1
Text Only Scheduling Notice
2019-11-06
1
No Actions
NOTICE of Appearance filed by attorney Vincent Ling on behalf of Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc. (Attorney Vincent Ling added to party Kite Pharma, Inc.(pty:cc), Attorney Vincent Ling added to party Kite Pharma, Inc.(pty:dft))(Ling, Vincent) (Entered: 11/08/2019)
2019-11-08
1
NOTICE of Association of Counsel associating attorney Eric A. Shumsky on behalf of Defendant Kite Pharma, Inc.. Filed by Defendant Kite Pharma, Inc. (Lawton, Adam) (Entered: 11/08/2019)
2019-11-08
1
NOTICE of Appearance filed by attorney Eric Alan Shumsky on behalf of Defendant Kite Pharma, Inc. (Attorney Eric Alan Shumsky added to party Kite Pharma, Inc.(pty:dft))(Shumsky, Eric) (Entered: 11/08/2019)
2019-11-08
1
SEALED DOCUMENT Plaintiffs' Memorandum in support of Motion in Limine #2 re MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, Order on Motion for Leave to File Document Under Seal 302 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1 to Plaintiffs' Motion in Limine #2, # 2 Exhibit 2 to Plaintiffs' Motion in Limine #2, # 3 Exhibit 3 to Plaintiffs' Motion in Limine #2, # 4 Exhibit 4 to Plaintiffs' Motion in Limine #2)(Jeffries, Andrea) (Entered: 11/08/2019)
2019-11-08
1
SEALED DOCUMENT Memorandum in Support re MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, Order on Motion for Leave to File Document Under Seal 301 filed by Defendant Kite Pharma, Inc..(Lawton, Adam) (Entered: 11/08/2019)
2019-11-08
1
SEALED DOCUMENT Memorandum in Support re MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, Order on Motion for Leave to File Document Under Seal 301 filed by Defendant Kite Pharma, Inc..(Lawton, Adam) (Entered: 11/08/2019)
2019-11-08
1
SEALED DOCUMENT Exhibits 1-7, 9, and 16-19 re MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273, Order on Motion for Leave to File Document Under Seal 301 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 9, # 9 Exhibit 16, # 10 Exhibit 17, # 11 Exhibit 18, # 12 Exhibit 19)(Lawton, Adam) (Entered: 11/08/2019)
2019-11-08
1
Joint STIPULATION for Order Permit Supplemental Briefing on Kite's Motion in Limine No. 1 filed by Defendant-Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 11/08/2019)
2019-11-08
1
Joint STIPULATION for Order Permit Supplemental Briefing on Kite's Motion in Limine No. 1 filed by Defendant-Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 11/08/2019)
2019-11-08
2
SEALED DOCUMENT Memorandum in Support and Exhibits A, B, and C re Order on Motion for Leave to File Document Under Seal, 300, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum In Support of Motion to Exclude Dr. Mohan Rao's Testimony, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Tuan, Elizabeth) (Entered: 11/11/2019)
2019-11-11
1
SEALED DOCUMENT Joint Report re Order on Motion to Dismiss Party, 304 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Proposed Order)(Wells, Crawford) (Entered: 11/11/2019)
2019-11-11
1
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
1
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries, # 10 Exhibit I to the Declaration of Andrea W. Jeffries, # 11 Exhibit J to the Declaration of Andrea W. Jeffries, # 12 Exhibit K to the Declaration of Andrea W. Jeffries, # 13 Exhibit L to the Declaration of Andrea W. Jeffries, # 14 Exhibit M to the Declaration of Andrea W. Jeffries, # 15 Exhibit N to the Declaration of Andrea W. Jeffries, # 16 Exhibit O to the Declaration of Andrea W. Jeffries, # 17 Exhibit P to the Declaration of Andrea W. Jeffries, # 18 Exhibit Q to the Declaration of Andrea W. Jeffries, # 19 Exhibit R to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document (Exhibit D to Plaintiffs Opposition to Defendants Motion in Limine No. 3) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
1
APPLICATION to file document (Exhibit D to Plaintiffs Opposition to Defendants Motion in Limine No. 3) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document (Exhibit D to Plaintiffs Opposition to Defendants Motion in Limine No. 3) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document (Exhibit D to Plaintiffs Opposition to Defendants Motion in Limine No. 3) under seal 316 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration, 317 served on 11/12/2019. (Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
1
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
1
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
OPPOSITION re: MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Opposition, # 2 Exhibit A to the Declaration of Andrea W. Jeffries, # 3 Exhibit B to the Declaration of Andrea W. Jeffries, # 4 Exhibit C to the Declaration of Andrea W. Jeffries, # 5 Exhibit D to the Declaration of Andrea W. Jeffries, # 6 Exhibit E to the Declaration of Andrea W. Jeffries, # 7 Exhibit F to the Declaration of Andrea W. Jeffries, # 8 Exhibit G to the Declaration of Andrea W. Jeffries, # 9 Exhibit H to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/12/2019)
2019-11-12
2
JOINT Exhibit List filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research.. (Tuan, Elizabeth) (Entered: 11/12/2019)
2019-11-12
1
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
1
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
1
MEMORANDUM in Opposition to MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
1
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to MIL 1, # 3 Redacted Document Exhibit A to Opposition to MIL 1, # 4 Redacted Document Exhibit B to Opposition to MIL 1, # 5 Redacted Document Exhibit F to Opposition to MIL 1, # 6 Redacted Document Opposition to MIL 2, # 7 Redacted Document Exhibit A to Opposition to MIL 2, # 8 Redacted Document Exhibit D to Opposition to MIL 2, # 9 Redacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Defendant Kite Pharma, Inc.. (Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
1
DECLARATION of Katharine Rice In Support Of Kite's APPLICATION to file document Memorandum of Contentions of Law and Fact under seal 295 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order (Amended))(Gratzinger, Peter) (Entered: 11/12/2019)
2019-11-12
1
DECLARATION of Katharine Rice In Support Of Kite's APPLICATION to file document Memorandum of Contentions of Law and Fact under seal 295 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order (Amended))(Gratzinger, Peter) (Entered: 11/12/2019)
2019-11-12
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal 323 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Opposition to MIL 1, # 2 Unredacted Document Exhibit A to Opposition to MIL 1, # 3 Unredacted Document Exhibit B to Opposition to MIL 1, # 4 Unredacted Document Exhibit F to Opposition to MIL 1, # 5 Unredacted Document Opposition to MIL 2, # 6 Unredacted Document Exhibit A to Opposition to MIL 2, # 7 Unredacted Document Exhibit D to Opposition to MIL 2, # 8 Unredacted Document Exhibit F to Opposition to MIL 2)(Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
1
APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order Granting Application to File Under Seal, # 2 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 2, # 3 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 3, # 4 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 4)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
1
APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order Granting Application to File Under Seal, # 2 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 2, # 3 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 3, # 4 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 4)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order Granting Application to File Under Seal, # 2 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 2, # 3 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 3, # 4 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 4)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order Granting Application to File Under Seal, # 2 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 2, # 3 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 3, # 4 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 4)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order Granting Application to File Under Seal, # 2 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 2, # 3 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 3, # 4 Redacted Document Kite Pharma, Inc.'s Opposition to Motion in Limine No. 4)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal 327 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Memorandum in Opposition to Motion in Limine No. 2, # 2 Memorandum in Opposition to Motion in Limine No. 3, # 3 Memorandum in Opposition to Motion in Limine No. 4, # 4 Memorandum in Support of Kite's Motion in Limine No. 1 to Exclude Damages Opinions of Ryan Sullivan, Ph.D., # 5 Exhibit 1, # 6 Exhibit 2, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
1
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
1
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Opposition to MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3, # 2 Exhibit 4, # 3 Exhibit 10, # 4 Exhibit 19, # 5 Exhibit 35, # 6 Exhibit 36, # 7 Exhibit 37, # 8 Exhibit 38, # 9 Exhibit 39, # 10 Exhibit 40, # 11 Exhibit 41, # 12 Exhibit 42)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
DECLARATION of Vincent Ling in Support of MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 34)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
1
DECLARATION of Vincent Ling in Support of MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 34)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
NOTICE OF ERRATA filed by Defendant Kite Pharma, Inc.. correcting APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal 327 (Attachments: # 1 Memorandum in Support of Defendant Kite Pharma, Inc.'s Motion in Limine (No. 1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D.)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
1
NOTICE OF ERRATA filed by Defendant Kite Pharma, Inc.. correcting APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal 327 (Attachments: # 1 Memorandum in Support of Defendant Kite Pharma, Inc.'s Motion in Limine (No. 1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D.)(Ling, Vincent) (Entered: 11/12/2019)
2019-11-12
2
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,,, 326 served on 11/12/2019. (Heinrich, Alan) (Entered: 11/12/2019)
2019-11-12
1
Notice of Appearance or Withdrawal of Counsel: for attorney Markus A Brazill counsel for Counter Defendant Kite Pharma, Inc.. Adding Markus A. Brazill as counsel of record for Kite Pharma, Inc. for the reason indicated in the G-123 Notice. Filed by Defendant-Counterclaimant Kite Pharma, Inc.. (Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cd))(Brazill, Markus) (Entered: 11/13/2019)
2019-11-13
1
ORDER PERMITTING SUPPLEMENTAL BRIEFING ON KITES MOTION IN LIMINE NO. 1 (ECF NO. 270) REGARDING THE EFFECT OF THE COURTS NOVEMBER 6, 2019 ORDER ON STANDING 312 by Judge S. James Otero: Kite may file a supplemental brief in support of its Motion In Limine No. 1 of no more than 3 pages, on or before November 14, 2019.Plaintiffs may file a supplemental responsive brief of no more than 3 pages on or before November 21, 2019. (lc) (Entered: 11/13/2019)
2019-11-13
1
OBJECTIONS to Sealed Declaration in SupportDeclaration, 296, APPLICATION to file document Memorandum of Contentions of Law and Fact under seal 295 Plaintiffs' Objections and Response to Undisclosed Arguments in Defendant's Memorandum of Contentions of Fact and Law filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Objections and Response to Undisclosed Arguments in Defendant's Memorandum of Contentions of Fact and Law, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/13/2019)
2019-11-13
1
OBJECTIONS to Sealed Declaration in SupportDeclaration, 296, APPLICATION to file document Memorandum of Contentions of Law and Fact under seal 295 Plaintiffs' Objections and Response to Undisclosed Arguments in Defendant's Memorandum of Contentions of Fact and Law filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Objections and Response to Undisclosed Arguments in Defendant's Memorandum of Contentions of Fact and Law, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/13/2019)
2019-11-13
2
OBJECTIONS to Sealed Declaration in SupportDeclaration, 296, APPLICATION to file document Memorandum of Contentions of Law and Fact under seal 295 Plaintiffs' Objections and Response to Undisclosed Arguments in Defendant's Memorandum of Contentions of Fact and Law filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Objections and Response to Undisclosed Arguments in Defendant's Memorandum of Contentions of Fact and Law, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/13/2019)
2019-11-13
2
OBJECTIONS to Sealed Declaration in SupportDeclaration, 296, APPLICATION to file document Memorandum of Contentions of Law and Fact under seal 295 Plaintiffs' Objections and Response to Undisclosed Arguments in Defendant's Memorandum of Contentions of Fact and Law filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries in support of Plaintiffs' Objections and Response to Undisclosed Arguments in Defendant's Memorandum of Contentions of Fact and Law, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/13/2019)
2019-11-13
2
ORDER RE: JOINT REPORT ON PROPOSED REDACTIONS TO THE COURTS NOVEMBER 6, 2019 ORDER AND ASSOCIATED APPLICATION TO SEAL by Judge S. James Otero: The Court finds that compelling reasons exist to maintain under seal the portions of the Order requested. (lc) (Entered: 11/13/2019)
2019-11-13
1
ORDER GRANTING APPLICATION FOR LEAVE TO FILE UNDER SEAL KITES MEMORANDUM OF CONTENTIONS OF LAW AND FACT 295 by Judge S. James Otero (lc) (Entered: 11/14/2019)
2019-11-14
1
APPLICATION of Non-Resident Attorney John M. Michalik to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-24782884) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Letter Michalik Letter of Good Standing, # 2 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Jeffries, Andrea) (Entered: 11/14/2019)
2019-11-14
1
APPLICATION of Non-Resident Attorney John M. Michalik to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-24782884) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Letter Michalik Letter of Good Standing, # 2 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Jeffries, Andrea) (Entered: 11/14/2019)
2019-11-14
2
APPLICATION of Non-Resident Attorney John M. Michalik to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-24782884) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 Letter Michalik Letter of Good Standing, # 2 Proposed Order (PROPOSED) ORDER ON APPLICATION OF NON-RESIDENT ATTORNEY TO APPEAR IN A SPECIFIC CASE PRO HAC VICE) (Jeffries, Andrea) (Entered: 11/14/2019)
2019-11-14
2
NOTICE OF LODGING filed re Supplemental Memorandum of Points and Authorities in Support of Defendant Kite Pharma, Inc.s Motion in Limine (No. 1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. re Order, 334 (Ling, Vincent) (Entered: 11/14/2019)
2019-11-14
1
ORDER GRANTING APPLICATION of Non-Resident Attorney John M. Michalik to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. and designating Andrea Weiss Jeffries as local counsel 339 by Judge S. James Otero (lc) (Entered: 11/15/2019)
2019-11-15
1
SEALED DOCUMENT MEMORANDUM OF CONTENTIONS OF LAW AND FACT re Order on Motion for Leave to File Document Under Seal 338 filed by Defendant Kite Pharma, Inc..(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:dft))(Brazill, Markus) (Entered: 11/15/2019)
2019-11-15
1
Notice of Appearance or Withdrawal of Counsel: for attorney Ingrid Marie Haslund Petersen counsel for Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Adding Ingrid Petersen as counsel of record for Juno Therapeutics, Inc.; Memorial Sloan Kettering Cancer Center; and Sloan Kettering Institute for Cancer Research for the reason indicated in the G-123 Notice. Filed by Plaintiffs Juno Therapeutics, Inc.; Memorial Sloan Kettering Cancer Center; and Sloan Kettering Institute for Cancer Research. (Attorney Ingrid Marie Haslund Petersen added to party Juno Therapeutics, Inc.(pty:pla), Attorney Ingrid Marie Haslund Petersen added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Ingrid Marie Haslund Petersen added to party Sloan Kettering Institute for Cancer Research(pty:pla))(Petersen, Ingrid) (Entered: 11/15/2019)
2019-11-15
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal 327 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research.(Petersen, Ingrid) (Entered: 11/16/2019)
2019-11-16
1
PRETRIAL STIPULATION regarding Exhibits . (Attachments: # 1 Proposed Order)(Jeffries, Andrea) (Entered: 11/17/2019)
2019-11-17
1
PRETRIAL STIPULATION regarding Exhibits . (Attachments: # 1 Proposed Order)(Jeffries, Andrea) (Entered: 11/17/2019)
2019-11-17
2
DECLARATION of Katharine Rice in Support of APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal 323, APPLICATION to file document (Exhibit D to Plaintiffs Opposition to Defendants Motion in Limine No. 3) under seal 316, APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal 327 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Ling, Vincent) (Entered: 11/18/2019)
2019-11-18
1
DECLARATION of Katharine Rice in Support of APPLICATION to file document in connection with Plaintiffs' Opposition to Kite's Motions in Limine (Nos. 1 and 2) under seal 323, APPLICATION to file document (Exhibit D to Plaintiffs Opposition to Defendants Motion in Limine No. 3) under seal 316, APPLICATION to file document in Opposition to Plaintiffs' Motion in Limine and Supplemental Brief in Support of Motion in Limine to Exclude Damages Opinions of Ryan Sullivan, Ph.D. under seal 327 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Ling, Vincent) (Entered: 11/18/2019)
2019-11-18
2
APPLICATION to file document CONFIDENTIAL DOCUMENTS IN CONNECTION WITH KITE PHARMA, INC.S OPPOSITION TO PLAINTIFFS MOTION IN LIMINE (NO. 3) (DKT. NO. 328-2) under seal filed by Respondent Bristol-Myers Squibb Company. (Attachments: # 1 Declaration of Evan D. Diamond in Support of Bristol-Myers Squibb Company's Unopposed Application to File Documents Under Seal, # 2 Proposed Order Granting Bristol-Myers Squibb's Unopposed Application to File Confidential Documents Under Seal)(Akrotirianakis, Joseph) (Entered: 11/18/2019)
2019-11-18
1
APPLICATION to file document CONFIDENTIAL DOCUMENTS IN CONNECTION WITH KITE PHARMA, INC.S OPPOSITION TO PLAINTIFFS MOTION IN LIMINE (NO. 3) (DKT. NO. 328-2) under seal filed by Respondent Bristol-Myers Squibb Company. (Attachments: # 1 Declaration of Evan D. Diamond in Support of Bristol-Myers Squibb Company's Unopposed Application to File Documents Under Seal, # 2 Proposed Order Granting Bristol-Myers Squibb's Unopposed Application to File Confidential Documents Under Seal)(Akrotirianakis, Joseph) (Entered: 11/18/2019)
2019-11-18
2
APPLICATION to file document CONFIDENTIAL DOCUMENTS IN CONNECTION WITH KITE PHARMA, INC.S OPPOSITION TO PLAINTIFFS MOTION IN LIMINE (NO. 3) (DKT. NO. 328-2) under seal filed by Respondent Bristol-Myers Squibb Company. (Attachments: # 1 Declaration of Evan D. Diamond in Support of Bristol-Myers Squibb Company's Unopposed Application to File Documents Under Seal, # 2 Proposed Order Granting Bristol-Myers Squibb's Unopposed Application to File Confidential Documents Under Seal)(Akrotirianakis, Joseph) (Entered: 11/18/2019)
2019-11-18
2
REPLY in support of MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS OPPOSITIONS TO DEFENDANTS MOTIONS IN LIMINE 316 by Judge S. James Otero : Lines 67:17-68:24 of Exhibit D to the Declaration of Andrea W. Jeffries in support of Plaintiffs Opposition to Defendants Motion in Limine(No. 3) Regarding Evidence and Argument about the Inter Partes Review, excerpts from the transcript of the March 25, 2019 deposition of David Chang, M.D. (lc) (Entered: 11/19/2019)
2019-11-19
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS OPPOSITION TO DEFENDANT KITE PHARMA, INC.S MOTIONS IN LIMINE (NOS. 1 and 2) 323 by Judge S. James Otero (lc) (Entered: 11/19/2019)
2019-11-19
1
ORDER GRANTING APPLICATION FOR LEAVE TO FILE UNDER SEAL (1) DOCUMENTS IN OPPOSITION TO PLAINTIFFS MOTIONS IN LIMINE AND (2) SUPPLEMENTAL BRIEF IN SUPPORT OF MOTION IN LIMINE (NO. 1) TO EXCLUDE DAMAGES OPINIONS OF RYAN SULLIVAN, PH.D. 327 by Judge S. James Otero (lc) (Entered: 11/19/2019)
2019-11-19
1
REPLY in support of MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
REPLY in support of MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
Proposed Voir Dire Questions filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.. (Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
APPLICATION to file document s (Plaintiffs' Replies in support of Motions in Limine #2 and #3) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Reply in support of Motion in Limine #2, # 3 Redacted Document Plaintiffs' Reply in support of Motion in Limine #3)(Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
APPLICATION to file document s (Plaintiffs' Replies in support of Motions in Limine #2 and #3) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Reply in support of Motion in Limine #2, # 3 Redacted Document Plaintiffs' Reply in support of Motion in Limine #3)(Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
2
APPLICATION to file document s (Plaintiffs' Replies in support of Motions in Limine #2 and #3) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Reply in support of Motion in Limine #2, # 3 Redacted Document Plaintiffs' Reply in support of Motion in Limine #3)(Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
2
APPLICATION to file document s (Plaintiffs' Replies in support of Motions in Limine #2 and #3) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Reply in support of Motion in Limine #2, # 3 Redacted Document Plaintiffs' Reply in support of Motion in Limine #3)(Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document s (Plaintiffs' Replies in support of Motions in Limine #2 and #3) under seal 355 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Redacted Document Plaintiffs' Reply in support of Motion in Limine #2, # 2 Redacted Document Plaintiffs' Reply in support of Motion in Limine #3)(Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
REPLY in Support of MOTION IN LIMINE (#3) to Exclude Evidence and Argument About the Inter Partes Review 272 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
1
REPLY in Support of MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
1
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit L)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
1
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit L)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit L)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit L)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit L)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit L)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
DECLARATION of Adam R. Lawton in Support of MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit L)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
DECLARATION of Katharine Rice in Support of MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit F, # 2 Exhibit G)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
1
DECLARATION of Katharine Rice in Support of MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit F, # 2 Exhibit G)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
DECLARATION of Katharine Rice in Support of MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit F, # 2 Exhibit G)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
DECLARATION of M. Patricia Thayer in Support of MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit H, # 2 Exhibit I)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
1
DECLARATION of M. Patricia Thayer in Support of MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit H, # 2 Exhibit I)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
DECLARATION of M. Patricia Thayer in Support of MOTION IN LIMINE (#4) to Preclude Argument Referencing the Absence of Testimony from Witnesses Outside the Court's Subpoena Power 273 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit H, # 2 Exhibit I)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
APPLICATION to file document re: Motion in Limine Reply Briefing under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Kite's Reply in Support of Motion in Limine #1, # 3 Redacted Document Kite's Reply in Support of Motion in Limine #2)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
1
APPLICATION to file document re: Motion in Limine Reply Briefing under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Kite's Reply in Support of Motion in Limine #1, # 3 Redacted Document Kite's Reply in Support of Motion in Limine #2)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
APPLICATION to file document re: Motion in Limine Reply Briefing under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Kite's Reply in Support of Motion in Limine #1, # 3 Redacted Document Kite's Reply in Support of Motion in Limine #2)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
APPLICATION to file document re: Motion in Limine Reply Briefing under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Kite's Reply in Support of Motion in Limine #1, # 3 Redacted Document Kite's Reply in Support of Motion in Limine #2)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document re: Motion in Limine Reply Briefing under seal 362 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Kite's Reply in Support of Motion in Limine #1, # 2 Unredacted Document Kite's Reply in Support of Motion in Limine #2, # 3 Unredacted Document Exhibit J, # 4 Unredacted Document Exhibit K)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
1
SEALED OPPOSITION RE MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, Order on Motion for Leave to File Document Under Seal 350 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Opposition to Kite's MIL No. 1, # 2 Unredacted Document Exhibit A to Opposition to Kite's MIL No. 1, # 3 Unredacted Document Exhibit B to Opposition to Kite's MIL No. 1, # 4 Unredacted Document Exhibit F to Opposition to Kite's MIL No. 1, # 5 Unredacted Document Opposition to Kite's MIL No. 2, # 6 Unredacted Document Exhibit A to Opposition to Kite's MIL No. 2, # 7 Unredacted Document Exhibit D to Opposition to Kite's MIL No. 2, # 8 Unredacted Document Exhibit F to Opposition to Kite's MIL No. 2)(Petersen, Ingrid) (Entered: 11/19/2019)
2019-11-19
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,, 356 served on 11/19/2019. (Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
REPLY in Support of MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
1
REPLY in Support of MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
2
REPLY in Support of MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
2
REPLY in Support of MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
2
REPLY in Support of MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
2
APPLICATION to file document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony, # 3 Redacted Document Exhibit C to Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
1
APPLICATION to file document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony, # 3 Redacted Document Exhibit C to Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
2
APPLICATION to file document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony, # 3 Redacted Document Exhibit C to Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
2
APPLICATION to file document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony, # 3 Redacted Document Exhibit C to Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony under seal 367 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony, # 2 Unredacted Document Exhibit C to Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony)(Heinrich, Alan) (Entered: 11/19/2019)
2019-11-19
1
STATEMENT [Disputed] Joint Statement of the Case filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research (Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
Proposed Voir Dire Questions filed by defendant Kite Pharma, Inc... (Attachments: # 1 Attachment A, # 2 Attachment B, # 3 Attachment C)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
1
Proposed Voir Dire Questions filed by defendant Kite Pharma, Inc... (Attachments: # 1 Attachment A, # 2 Attachment B, # 3 Attachment C)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
Proposed Voir Dire Questions filed by defendant Kite Pharma, Inc... (Attachments: # 1 Attachment A, # 2 Attachment B, # 3 Attachment C)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
Proposed Voir Dire Questions filed by defendant Kite Pharma, Inc... (Attachments: # 1 Attachment A, # 2 Attachment B, # 3 Attachment C)(Lawton, Adam) (Entered: 11/19/2019)
2019-11-19
2
PROPOSED JURY INSTRUCTIONS filed by Joint Agreed Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.. (Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
PROPOSED JURY INSTRUCTIONS filed by Joint Disputed Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.. (Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, re Sealed Opposition,,, 364, Sealed Declaration in SupportDeclaration, 368 served on 11/19/2019. (Petersen, Ingrid) (Entered: 11/19/2019)
2019-11-19
1
NOTICE OF LODGING Proposed Pretrial Conference Order Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - Proposed Final Pretrial Conference Order)(Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
1
NOTICE OF LODGING Proposed Pretrial Conference Order Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit - Proposed Final Pretrial Conference Order)(Jeffries, Andrea) (Entered: 11/19/2019)
2019-11-19
2
MINUTES (IN CHAMBERS) by Judge S. James Otero: The Court denies without prejudice the Application to File Document Confidential Documents in Connection with Kite Pharma, Inc.s Opposition to Plaintiffs Motion in Limine (No. 3) under seal filed by Respondent Bristol-Myers Squibb Company 347 . To the extent any proposed confidential redactions are not addressed by the Court'sOrder on 327, non-party Bristol-Myers Squibb Company may file an amendedapplication. The Court notes that for future applications for leave to file under seal, all parties shall coordinate to submit one proposed order for each application to seal. A party submitting a declaration in support of another party's application to seal shall include its proposed portions to be sealed in the other party's proposed order. A party submitting a declaration in support of another party's application to seal shall not submit a separate proposed order. (lc) (Entered: 11/20/2019)
2019-11-19
1
SEALED OPPOSITION RE MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, Order on Motion for Leave to File Document Under Seal, 351 filed by Defendant Kite Pharma, Inc..(Ling, Vincent) (Entered: 11/20/2019)
2019-11-20
1
SEALED OPPOSITION RE MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, Order on Motion for Leave to File Document Under Seal, 351 filed by Defendant Kite Pharma, Inc..(Ling, Vincent) (Entered: 11/20/2019)
2019-11-20
1
SEALED OPPOSITION RE MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274, Order on Motion for Leave to File Document Under Seal, 351 filed by Defendant Kite Pharma, Inc..(Ling, Vincent) (Entered: 11/20/2019)
2019-11-20
1
SEALED DOCUMENT Supplemental Memorandum in Support re MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, Order, 334, Order on Motion for Leave to File Document Under Seal, 351 filed by Defendant Kite Pharma, Inc..(Ling, Vincent) (Entered: 11/20/2019)
2019-11-20
1
SEALED DOCUMENT Exhibits 1, 2, 5-9, 11-18, and 20-34 in Opposition re MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283, MOTION IN LIMINE (#1) to Exclude Evidence and Argument Relating to the Certificate of Correction 284, MOTION IN LIMINE (#2) to Exclude Evidence and Argument Relating to the Rocket Clinical Trial 276, MOTION IN LIMINE to Exclude Dr. Mohan Rao's Testimony Regarding Damages 274, Order on Motion for Leave to File Document Under Seal, 351 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 5, # 4 Exhibit 6, # 5 Exhibit 7, # 6 Exhibit 8, # 7 Exhibit 9, # 8 Exhibit 11, # 9 Exhibit 12, # 10 Exhibit 13, # 11 Exhibit 14, # 12 Exhibit 15, # 13 Exhibit 16, # 14 Exhibit 17, # 15 Exhibit 18, # 16 Exhibit 20, # 17 Exhibit 21, # 18 Exhibit 22, # 19 Exhibit 23, # 20 Exhibit 24, # 21 Exhibit 25, # 22 Exhibit 26, # 23 Exhibit 27, # 24 Exhibit 28, # 25 Exhibit 29, # 26 Exhibit 30, # 27 Exhibit 31, # 28 Exhibit 32, # 29 Exhibit 33, # 30 Exhibit 34)(Ling, Vincent) (Entered: 11/20/2019)
2019-11-20
1
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
1
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
Supplemental AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
NOTICE OF SUPPLEMENTAL EVIDENCE re MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Lawton, Adam) (Entered: 11/20/2019)
2019-11-20
1
NOTICE OF SUPPLEMENTAL EVIDENCE re MOTION IN LIMINE (#3) to Exclude Evidence and Argument Relating to the Pending BMS Acquisition 283 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Lawton, Adam) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
1
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. Exhibits 17 to Appendix 1 as to Amended Complaint/Petition,, 380 . (Attachments: # 1 Exhibit 17, # 2 Exhibit 18, # 3 Exhibit 19, # 4 Exhibit 20, # 5 Exhibit 21, # 6 Exhibit 22, # 7 Exhibit 23, # 8 Exhibit 24, # 9 Exhibit 25, # 10 Exhibit 26, # 11 Exhibit 27, # 12 Exhibit 28, # 13 Exhibit 29, # 14 Exhibit 30, # 15 Exhibit 31, # 16 Appendix 1)(Chu, Morgan) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
1
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
APPLICATION to file document Supplemental Complaint under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Supplemental Complaint, # 3 Redacted Document Exhibit 5, # 4 Redacted Document Exhibit 6, # 5 Redacted Document Exhibit 7, # 6 Redacted Document Exhibit 8, # 7 Redacted Document Exhibit 9, # 8 Redacted Document Exhibit 10, # 9 Redacted Document Exhibit 16, # 10 Redacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Supplemental Complaint under seal 384 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Exhibit 5, # 2 Unredacted Document Exhibit 6, # 3 Unredacted Document Exhibit 7, # 4 Unredacted Document Exhibit 8, # 5 Unredacted Document Exhibit 9, # 6 Unredacted Document Exhibit 10, # 7 Unredacted Document Exhibit 16, # 8 Unredacted Document Appendix 1)(Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,, 385 served on 11/20/2019. (Petersen, Ingrid) (Entered: 11/20/2019)
2019-11-20
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: "Supplemental" Amended Complaint/Petition,, 380 . The following error(s) was/were found: Caption of document is incomplete/incorrect. Case number is incorrect or missing. Leave of court required for filing. Other error(s) with document(s): 1) Caption of Listing all parties MISSING (et al..no applicable); 2) Case number Missing official Judge and Magistrate initials; should read as 2:17-cv-07639-SJO-KS; 3) Title of document is incomplete, reads ONLY as supplemental complaint, instead of Supplemental AMENDED complaint; 4) no order or proceeding to file it on record; 4) Clerk notes filer filed application to file "Supplemental Amended Complaint under seal (docket no. 384...the proposed under seal pleading is also entitled incorrectly and Missing caption naming all the parties), not applicable to this Redacted filing.. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 11/21/2019)
2019-11-21
1
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
1
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
MEMORANDUM in Opposition to Defendant's Motion in Limine No. 1 Re Dr. Sullivan filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
1
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Supplemental Opposition to Defendant's MIL No. 1, # 3 Redacted Document Exhibit 4, # 4 Redacted Document Exhibit 5, # 5 Redacted Document Exhibit 6, # 6 Redacted Document Exhibit 7, # 7 Redacted Document Exhibit 8, # 8 Redacted Document Exhibit 9, # 9 Redacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal 389 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Supplemental Opposition to Defendant's MIL No. 1, # 2 Unredacted Document Exhibit 4, # 3 Unredacted Document Exhibit 5, # 4 Unredacted Document Exhibit 6, # 5 Unredacted Document Exhibit 7, # 6 Unredacted Document Exhibit 8, # 7 Unredacted Document Exhibit 9, # 8 Unredacted Document Exhibit 10)(Heinrich, Alan) (Entered: 11/21/2019)
2019-11-21
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,, 390 served on 11/21/2019. (Petersen, Ingrid) (Entered: 11/21/2019)
2019-11-21
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Supplemental Complaint under seal 384 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Supplemental Amended Complaint)(Petersen, Ingrid) (Entered: 11/21/2019)
2019-11-21
1
TEXT ONLY ENTRY by Judge S. James Otero re: Stipulation re: Exhibits Pretrial Trial 345 . The Court denies the parties' PRETRIAL STIPULATION regarding Exhibits 345 for failure to comply with the Court's Order re Jury/Court Trial for Civil Cases Assigned to Judge S. James Otero. Section 1.B.5 requires "[n]ot later than 7 days before the PTC, the parties must prepare a pretrial exhibit stipulation containing each party's numbered list of all trial exhibits, with objections to each exhibit and the offering party's response.... Failure to so comply may constitute a waiver of all objections." THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (smo) (Entered: 11/22/2019)
2019-11-22
1
SEALED DOCUMENT (Exhibit D) re Objection/Opposition (Motion related),,,,,, 315, Order on Motion for Leave to File Document Under Seal, 349 filed by Counter Defendants Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Plaintiffs Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
1
EX PARTE APPLICATION to Strike Supplemental Complaint filed by Defendant Kite Pharma, Inc.. (Gratzinger, Peter) (Entered: 11/22/2019)
2019-11-22
1
APPLICATION to file document Exhibit 1 to Ex Parte Application to Strike under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 11/22/2019)
2019-11-22
1
APPLICATION to file document Exhibit 1 to Ex Parte Application to Strike under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 11/22/2019)
2019-11-22
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Exhibit 1 to Ex Parte Application to Strike under seal 396 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Gratzinger, Peter) (Entered: 11/22/2019)
2019-11-22
1
OBJECTIONS to Defendant's Attempts to Call Dr. Thomas Schuetz as a Trial Witness and Produce New Documents filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 5 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 6 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 7 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
1
OBJECTIONS to Defendant's Attempts to Call Dr. Thomas Schuetz as a Trial Witness and Produce New Documents filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 5 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 6 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 7 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
2
OBJECTIONS to Defendant's Attempts to Call Dr. Thomas Schuetz as a Trial Witness and Produce New Documents filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 5 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 6 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 7 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
2
OBJECTIONS to Defendant's Attempts to Call Dr. Thomas Schuetz as a Trial Witness and Produce New Documents filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 5 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 6 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 7 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
2
OBJECTIONS to Defendant's Attempts to Call Dr. Thomas Schuetz as a Trial Witness and Produce New Documents filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 5 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 6 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 7 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
2
OBJECTIONS to Defendant's Attempts to Call Dr. Thomas Schuetz as a Trial Witness and Produce New Documents filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 5 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 6 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 7 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
2
OBJECTIONS to Defendant's Attempts to Call Dr. Thomas Schuetz as a Trial Witness and Produce New Documents filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 5 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 6 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 7 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
2
OBJECTIONS to Defendant's Attempts to Call Dr. Thomas Schuetz as a Trial Witness and Produce New Documents filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 5 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 6 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 7 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
2
OBJECTIONS to Defendant's Attempts to Call Dr. Thomas Schuetz as a Trial Witness and Produce New Documents filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 5 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 6 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 7 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/22/2019)
2019-11-22
2
CERTIFICATE OF SERVICE filed by Defendant Kite Pharma, Inc., re Sealed Declaration in SupportDeclaration 397 served on 11/22/2019. (Gratzinger, Peter) (Entered: 11/22/2019)
2019-11-22
1
Text Only Scheduling Notice
2019-11-22
1
No Actions
Witness List filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center.. (Tuan, Elizabeth) (Entered: 11/23/2019)
2019-11-23
1
APPLICATION of Non-Resident Attorney Jennifer L. Swize to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-24839528) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 MD Certificate of Good Standing, # 2 DC Certificate of Good Standing, # 3 Proposed Order Proposed Order on Application of Non-Resident Attorney to Appear in a Specific Case Pro Hac Vice) (Jeffries, Andrea) (Entered: 11/24/2019)
2019-11-24
1
APPLICATION of Non-Resident Attorney Jennifer L. Swize to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-24839528) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 MD Certificate of Good Standing, # 2 DC Certificate of Good Standing, # 3 Proposed Order Proposed Order on Application of Non-Resident Attorney to Appear in a Specific Case Pro Hac Vice) (Jeffries, Andrea) (Entered: 11/24/2019)
2019-11-24
2
APPLICATION of Non-Resident Attorney Jennifer L. Swize to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-24839528) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 MD Certificate of Good Standing, # 2 DC Certificate of Good Standing, # 3 Proposed Order Proposed Order on Application of Non-Resident Attorney to Appear in a Specific Case Pro Hac Vice) (Jeffries, Andrea) (Entered: 11/24/2019)
2019-11-24
2
APPLICATION of Non-Resident Attorney Jennifer L. Swize to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. (Pro Hac Vice Fee - $400 Fee Paid, Receipt No. 0973-24839528) filed by Plaintiff Juno Therapeutics, Inc.. (Attachments: # 1 MD Certificate of Good Standing, # 2 DC Certificate of Good Standing, # 3 Proposed Order Proposed Order on Application of Non-Resident Attorney to Appear in a Specific Case Pro Hac Vice) (Jeffries, Andrea) (Entered: 11/24/2019)
2019-11-24
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,,, 398 (Attachments: # 1 Declaration of Peter Gratzinger, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Certificate of Service)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
1
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,,, 398 (Attachments: # 1 Declaration of Peter Gratzinger, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Certificate of Service)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,,, 398 (Attachments: # 1 Declaration of Peter Gratzinger, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Certificate of Service)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,,, 398 (Attachments: # 1 Declaration of Peter Gratzinger, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Certificate of Service)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,,, 398 (Attachments: # 1 Declaration of Peter Gratzinger, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Certificate of Service)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,,, 398 (Attachments: # 1 Declaration of Peter Gratzinger, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Certificate of Service)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,,, 398 (Attachments: # 1 Declaration of Peter Gratzinger, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Certificate of Service)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,,, 398 (Attachments: # 1 Declaration of Peter Gratzinger, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Certificate of Service)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,,, 398 (Attachments: # 1 Declaration of Peter Gratzinger, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Certificate of Service)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
2
NOTICE OF LODGING filed 11-25-2019 re EX PARTE APPLICATION to Strike Supplemental Complaint 395 (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
1
NOTICE OF LODGING filed 11-25-2019 re EX PARTE APPLICATION to Strike Supplemental Complaint 395 (Attachments: # 1 Proposed Order)(Gratzinger, Peter) (Entered: 11/25/2019)
2019-11-25
2
DECLARATION of Vincent Ling in Support of APPLICATION to file document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony under seal 367 filed by Defendant Kite Pharma, Inc.. (Ling, Vincent) (Entered: 11/25/2019)
2019-11-25
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Sealed Document, [ docket no 394]. The following error(s) was/were found: Title page is missing. Other error(s) with document(s): MISSING Formal title page and its LR-11-3.8 required filer, attorney, court and case information. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 11/25/2019)
2019-11-25
1
Witness List filed by Defendant Kite Pharma, Inc... (Lawton, Adam) (Entered: 11/25/2019)
2019-11-25
1
MINUTES (IN CHAMBERS) ORDER: (1) DENYING PLAINTIFFS' MOTION FOR PARTIAL RECONSIDERATION OF THE COURT'S ORDER OF SEPTEMBER 27, 2019 264 ; AND (2) DENYING DEFENDANT KITE PHARMA, INC.'S MOTION FOR PARTIAL RECONSIDERATION AND CLARIFICATION OF SUMMARY JUDGMENT ORDER 265 by Judge S. James Otero. The Court DENIES Plaintiffs' Motion and DENIES Defendant's Motion. See document for details. (smo) (Entered: 11/25/2019)
2019-11-25
1
OPPOSITION re: EX PARTE APPLICATION to Strike Supplemental Complaint 395 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
1
OPPOSITION re: EX PARTE APPLICATION to Strike Supplemental Complaint 395 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
2
OPPOSITION re: EX PARTE APPLICATION to Strike Supplemental Complaint 395 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
2
OPPOSITION re: EX PARTE APPLICATION to Strike Supplemental Complaint 395 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
2
OPPOSITION re: EX PARTE APPLICATION to Strike Supplemental Complaint 395 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
2
APPLICATION to file document s (Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint and Exhibits) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 3)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
1
APPLICATION to file document s (Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint and Exhibits) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 3)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
2
APPLICATION to file document s (Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint and Exhibits) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 3)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
2
APPLICATION to file document s (Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint and Exhibits) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 3)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
2
APPLICATION to file document s (Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint and Exhibits) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 3)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
2
APPLICATION to file document s (Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint and Exhibits) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2, # 5 Redacted Document Exhibit 3)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
2
Joint PRETRIAL STIPULATION regarding Exhibits . (Attachments: # 1 Proposed Order)(Tuan, Elizabeth) (Entered: 11/25/2019)
2019-11-25
1
Joint PRETRIAL STIPULATION regarding Exhibits . (Attachments: # 1 Proposed Order)(Tuan, Elizabeth) (Entered: 11/25/2019)
2019-11-25
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document s (Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint and Exhibits) under seal 409 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Opposition to Ex Parte Application to Strike Supplemental Complaint, # 2 Unredacted Document Exhibit 1, # 3 Unredacted Document Exhibit 2, # 4 Unredacted Document Exhibit 3)(Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,, 411 served on 11/25/2019. (Jeffries, Andrea) (Entered: 11/25/2019)
2019-11-25
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document re: Motion in Limine Reply Briefing under seal 362 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research.(Petersen, Ingrid) (Entered: 11/25/2019)
2019-11-25
1
ORDER GRANTING APPLICATION of Non-Resident Attorney Jennifer L. Swize to Appear Pro Hac Vice on behalf of Plaintiff Juno Therapeutics, Inc. and designating Andrea Weiss Jeffries as local counsel 401 by Judge S. James Otero (lc) (Entered: 11/26/2019)
2019-11-25
1
EX PARTE APPLICATION to Exclude Untimely Opinions of Dr. Mohan Rao filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3) (Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
1
EX PARTE APPLICATION to Exclude Untimely Opinions of Dr. Mohan Rao filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3) (Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
2
EX PARTE APPLICATION to Exclude Untimely Opinions of Dr. Mohan Rao filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3) (Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
2
EX PARTE APPLICATION to Exclude Untimely Opinions of Dr. Mohan Rao filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3) (Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
2
EX PARTE APPLICATION to Exclude Untimely Opinions of Dr. Mohan Rao filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3) (Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
2
EX PARTE APPLICATION to Exclude Untimely Opinions of Dr. Mohan Rao filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3) (Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
2
APPLICATION to file document Plaintiffs' Ex Parte Application to Exclude Untimely Opinions of Dr. Mohan Rao under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Exhibit 1)(Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
1
APPLICATION to file document Plaintiffs' Ex Parte Application to Exclude Untimely Opinions of Dr. Mohan Rao under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Exhibit 1)(Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
2
APPLICATION to file document Plaintiffs' Ex Parte Application to Exclude Untimely Opinions of Dr. Mohan Rao under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Exhibit 1)(Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Plaintiffs' Ex Parte Application to Exclude Untimely Opinions of Dr. Mohan Rao under seal 415 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Exhibit 1)(Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
1
CORPORATE DISCLOSURE STATEMENT filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research identifying Bristol-Myers Squibb as Corporate Parent. (Heinrich, Alan) (Entered: 11/26/2019)
2019-11-26
1
TEXT ONLY ENTRY by Judge S. James Otero. The Court denies as moot the MOTION to Strike First Amended Complaint Amended Complaint/Petition filed by Defendant-Counter-claimant Kite Pharma, Inc. 204 in light of the Court's Order re Motion to Dismiss for Lack of Standing 304 . THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (smo) (Entered: 11/26/2019)
2019-11-26
1
REPLY in support of EX PARTE APPLICATION to Strike Supplemental Complaint 395 filed by Defendant Kite Pharma, Inc.. (Gratzinger, Peter) (Entered: 11/26/2019)
2019-11-26
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS REPLY IN SUPPORT OF MOTION TO EXCLUDE DR. MOHAN RAOS TESTIMONY REGARDING DAMAGES 367 by Judge S. James Otero (lc) (Entered: 11/27/2019)
2019-11-26
1
MINUTES OF FINAL PRETRIAL CONFERENCE (CONTINUED) held before Judge S. James Otero: The Court states its views on the pretrial documents (SEE DOCUMENT FOR SPECIFICS AS APPLICABLE TO : WITNESS EXCLUSION ORDER; TRIAL LENGTH; WITNESS EXAMINATION; REALTIME TRANSCRIPTS, (Request for access to realtime report is Denied); WITNESS AVAILABILITY. RE DAUBERT MOTION HEARING: The Court heard argument from parties regarding Plaintiffs' Motion in Limine No. 4 and Defendant's Motions in Limine Nos. 1, 2. The Court shall issue a separate Order regarding these issues. The parties should be prepared to commence with opening statements without a final order on the issues. Court Reporter: Myra Ponce. (lc) (Entered: 12/05/2019)
2019-11-26
1
AMENDED MINUTES RE FINAL PRETRIAL CONFERENCE HELD 495 before Judge S. James Otero: The Court states its views on the pretrial documents (SEE DOCUMENT FOR SPECIFICS ). The parties shall provide an updated PTCO to the Court. DEFENDANT'S EX PARTE APPLICATION TO STRIKE AMENDED COMPLAINT 395 The Court recognizes this motion is tied to the merits of Defendant's Motion in Limine No. 1. The Court permits Defendant to file a 3-page reply to the motion to strike by November 27, 2019. PLAINTIFFS' MOTIONS IN LIMINENo. 1 to exclude Defendant's irrelevant and inappropriate evidence and argument regarding the certificate of correction 284 : GRANT-IN-PART, DENY-IN-PART. GRANT as to any testimony by Dr. Bot that the CoC is invalid. DENY as to any testimony by Dr. Bot (upon a showing that he is a POSITA) that a clerical error, and its correction, are not clearly evident. GRANT as to Defendant's use of Dr. Bot's testimony to show it did not act willfully. GRANT as to Dr. Junghans' opinion regarding the four-year wait. Defendant may, however, raise this argument not through an expert (for example, during closing argument).No. 2 regarding evidence and argument relating to the Rocket clinical trial 276 : GRANT-IN-PART, DENY-IN-PART. GRANT as to argument that the '190 patent construct caused the patient deaths. DENY as to evidence and argument that the patient deaths were due to some aspect of the Rocket clinical trial. To the extent Plaintiffs claim the '190 patent contributes to the success of Yescarta, Defendant may introduce evidence that other embodiments of the '190 patent do not produce a successful CAR-T therapy. Defendant may introduce evidence of the Root Cause Analysis. GRANT as to use of inflammatory language referring to the patient deaths, including the word "kill" or similar term. Defendant may state that the patients "died." GRANT as to state court litigation by the patients' families.No. 3 regarding evidence and argument relating to the pending BMS acquisition 283 : GRANT.No. 4 to exclude Dr. Mohan Rao's testimony re damages 274 : DEFER.DEFENDANT'S MOTIONS IN LIMINENo. 1 to exclude damages opinions of Ryan Sullivan, Ph.D. 270 : DEFER.No. 2 to exclude expert testimony of Mark Gilbert, M.D. 271 : DEFER.No. 3 to exclude evidence and argument about the inter partes review 272 : Plaintiffs shall file a supplemental brief, three pages maximum, identifying specifically all testimony (by which witness) and exhibits it seeks to introduce relating to the inter partes review, by December 2, 2019.No. 4 to preclude argument referencing the absence of testimony from witnesses outside the court's subpoena power 273 : GRANT. RE DAUBERT MOTION HEARINGThe Court defers the hearing on Plaintiffs' Motion in Limine No. 4 and Defendant's Motions in Limine Nos. 1 and 2 to December 2, 2019 at 10:30 am. (lc) (Entered: 12/09/2019)
2019-11-26
1
MINUTES OF FINAL PRETRIAL CONFERENCE held before Judge S. James Otero: SEE DOCUMENT RE PRETRIAL DOCUMENTS AND OTHER ISSUES AND RE SPECIFIC RULINGS RE MOTIONS IN LIMINE AND RE DAUBERT MOTION HEARING. Court Reporter: Myra Ponc. (lc) (Entered: 12/16/2019)
2019-11-26
1
NOTICE of Appearance filed by attorney Luke J Burton on behalf of Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research (Attorney Luke J Burton added to party Juno Therapeutics, Inc.(pty:pla), Attorney Luke J Burton added to party Juno Therapeutics, Inc.(pty:cd), Attorney Luke J Burton added to party Memorial Sloan Kettering Cancer Center(pty:cd), Attorney Luke J Burton added to party Memorial Sloan Kettering Cancer Center(pty:pla), Attorney Luke J Burton added to party Sloan Kettering Institute for Cancer Research(pty:pla), Attorney Luke J Burton added to party Sloan Kettering Institute for Cancer Research(pty:cd))(Burton, Luke) (Entered: 11/27/2019)
2019-11-27
1
TEXT ONLY ENTRY by Judge S. James Otero re: APPLICATION to file document Exhibit 1 to Ex Parte Application to Strike under seal 396 and APPLICATION to file document s (Plaintiffs' Replies in support of Motions in Limine #2 and #3) under seal 355 . Counsel are instructed to verify that all declarations in support of the aforementioned applications have been filed. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (smo) (Entered: 11/27/2019)
2019-11-27
1
TEXT ONLY ENTRY by Judge S. James Otero. In light of the Court's ruling on Plaintiff's Motion in Limine No. 3, the Court grants the EX PARTE APPLICATION to Exclude Untimely Opinions of Dr. Mohan Rao filed by Plaintiffs Juno Therapeutics, Inc. and Sloan Kettering Institute for Cancer Research 414 . THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (smo) (Entered: 11/27/2019)
2019-11-27
1
MINUTE ORDER IN CHAMBERS by Judge S. James Otero. Pursuant to the parties' [disputed] joint statement of the case 369, and the parties' arguments at the November 26, 2019 Pretrial Conference, the Court enters the following statement of the case: See document for details. (smo) (Entered: 11/27/2019)
2019-11-27
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Exhibit 1 to Ex Parte Application to Strike under seal 396 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.(Jeffries, Andrea) (Entered: 11/27/2019)
2019-11-27
1
NOTICE OF LODGING Proposed Pretrial Conference Order Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Jeffries, Andrea) (Entered: 11/27/2019)
2019-11-27
1
NOTICE OF LODGING Proposed Pretrial Conference Order Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Jeffries, Andrea) (Entered: 11/27/2019)
2019-11-27
2
ORDER GRANTING APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS REGARDING ITS REPLIES IN SUPPORT OF MOTIONS IN LIMINE 362 by Judge S. James Otero (lc) (Entered: 12/02/2019)
2019-11-27
1
PROPOSED] ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS REPLY IN SUPPORT OF MOTION TO EXCLUDE DR. MOHAN RAOS TESTIMONY REGARDING DAMAGES 367 by Judge S. James Otero (lc) (Entered: 12/02/2019)
2019-11-27
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS SUPPLEMENTAL COMPLAINT FOR PATENT INFRINGEMENT 384 by Judge S. James Otero (lc) (Entered: 12/02/2019)
2019-11-27
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS SUPPLEMENTAL OPPOSITION TO DEFENDANTS MOTION IN LIMINE (NO. 1) TO EXCLUDE DAMAGES OPINIONS OF RYAN SULLIVAN, PH.D. 389 by Judge S. James Otero (lc) (Entered: 12/02/2019)
2019-11-27
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH WITH PLAINTIFFS OPPOSITION TO DEFENDANTS EX PARTE APPLICATION TO STRIKE SUPPLEMENTAL COMPLAINT 409 by Judge S. James Otero (lc) (Entered: 12/02/2019)
2019-11-27
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS EX PARTE APPLICATION TO EXCLUDE UNTIMELY OPINIONS OF DR. MOHAN RAO 415 by Judge S. James Otero (lc) (Entered: 12/02/2019)
2019-11-27
1
Text Only Scheduling Notice
2019-11-27
1
No Actions
EX PARTE APPLICATION to Strike Untimely and Unreliable Opinions of Dr. Sullivan filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Peter Gratzinger) (Lawton, Adam) (Entered: 11/29/2019)
2019-11-29
1
EX PARTE APPLICATION to Strike Untimely and Unreliable Opinions of Dr. Sullivan filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Peter Gratzinger) (Lawton, Adam) (Entered: 11/29/2019)
2019-11-29
2
EX PARTE APPLICATION to Strike Untimely and Unreliable Opinions of Dr. Sullivan filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Declaration of Peter Gratzinger) (Lawton, Adam) (Entered: 11/29/2019)
2019-11-29
2
APPLICATION to file document Memorandum and Exhibit 1 in Support of Ex Parte Application to Strike under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Ex Parte Application to Strike)(Lawton, Adam) (Entered: 11/29/2019)
2019-11-29
1
APPLICATION to file document Memorandum and Exhibit 1 in Support of Ex Parte Application to Strike under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Ex Parte Application to Strike)(Lawton, Adam) (Entered: 11/29/2019)
2019-11-29
2
APPLICATION to file document Memorandum and Exhibit 1 in Support of Ex Parte Application to Strike under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Memorandum in Support of Ex Parte Application to Strike)(Lawton, Adam) (Entered: 11/29/2019)
2019-11-29
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Memorandum and Exhibit 1 in Support of Ex Parte Application to Strike under seal 429 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Memorandum in Support of Ex Parte Application to Strike, # 2 Unredacted Document Exhibit 1)(Lawton, Adam) (Entered: 11/29/2019)
2019-11-29
1
Witness List filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research.. (Tuan, Elizabeth) (Entered: 11/30/2019)
2019-11-30
1
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Ryan Sullivan, # 2 Declaration of Alan Heinrich, # 3 Exhibit 1, # 4 Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
1
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Ryan Sullivan, # 2 Declaration of Alan Heinrich, # 3 Exhibit 1, # 4 Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Ryan Sullivan, # 2 Declaration of Alan Heinrich, # 3 Exhibit 1, # 4 Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Ryan Sullivan, # 2 Declaration of Alan Heinrich, # 3 Exhibit 1, # 4 Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
2
MEMORANDUM in Opposition to MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Ryan Sullivan, # 2 Declaration of Alan Heinrich, # 3 Exhibit 1, # 4 Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
2
APPLICATION to file document Second Supplemental Opposition to Defendant's Motion in Limine No. 1 under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Second Supplemental Opposition Re Kite's MIL 1, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
1
APPLICATION to file document Second Supplemental Opposition to Defendant's Motion in Limine No. 1 under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Second Supplemental Opposition Re Kite's MIL 1, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
2
APPLICATION to file document Second Supplemental Opposition to Defendant's Motion in Limine No. 1 under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Second Supplemental Opposition Re Kite's MIL 1, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
2
APPLICATION to file document Second Supplemental Opposition to Defendant's Motion in Limine No. 1 under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Second Supplemental Opposition Re Kite's MIL 1, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
2
APPLICATION to file document Second Supplemental Opposition to Defendant's Motion in Limine No. 1 under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Second Supplemental Opposition Re Kite's MIL 1, # 3 Redacted Document Exhibit 1, # 4 Redacted Document Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Second Supplemental Opposition to Defendant's Motion in Limine No. 1 under seal 433 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Second Supplemental Opposition to Kite MIL 1, # 2 Unredacted Document Exhibit 1, # 3 Unredacted Document Exhibit 2)(Heinrich, Alan) (Entered: 11/30/2019)
2019-11-30
1
OBJECTIONS to MEMORANDUM in Opposition to Motion, 432 filed by Defendant Kite Pharma, Inc.. (Brazill, Markus) (Entered: 12/01/2019)
2019-12-01
1
PROPOSED JURY INSTRUCTIONS filed by (First Amended Disputed) submitted jointly by Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.. (Jeffries, Andrea) (Entered: 12/01/2019)
2019-12-01
1
Witness List filed by Defendant Kite Pharma, Inc... (Brazill, Markus) (Entered: 12/01/2019)
2019-12-01
1
Witness List filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research.. (Tuan, Elizabeth) (Entered: 12/01/2019)
2019-12-01
1
MEMORANDUM of Points and Authorities in Opposition Re: EX PARTE APPLICATION to Strike Untimely and Unreliable Opinions of Dr. Sullivan 428 (Attachments: # 1 Declaration of Alan Heinrich, # 2 Exhibit 1)(Heinrich, Alan) (Entered: 12/01/2019)
2019-12-01
1
MEMORANDUM of Points and Authorities in Opposition Re: EX PARTE APPLICATION to Strike Untimely and Unreliable Opinions of Dr. Sullivan 428 (Attachments: # 1 Declaration of Alan Heinrich, # 2 Exhibit 1)(Heinrich, Alan) (Entered: 12/01/2019)
2019-12-01
2
MEMORANDUM of Points and Authorities in Opposition Re: EX PARTE APPLICATION to Strike Untimely and Unreliable Opinions of Dr. Sullivan 428 (Attachments: # 1 Declaration of Alan Heinrich, # 2 Exhibit 1)(Heinrich, Alan) (Entered: 12/01/2019)
2019-12-01
2
APPLICATION to file document Opposition to Ex Parte Motion under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Ex Parte Motion, # 3 Redacted Document Exhibit 1)(Heinrich, Alan) (Entered: 12/01/2019)
2019-12-01
1
APPLICATION to file document Opposition to Ex Parte Motion under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Ex Parte Motion, # 3 Redacted Document Exhibit 1)(Heinrich, Alan) (Entered: 12/01/2019)
2019-12-01
2
APPLICATION to file document Opposition to Ex Parte Motion under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Ex Parte Motion, # 3 Redacted Document Exhibit 1)(Heinrich, Alan) (Entered: 12/01/2019)
2019-12-01
2
APPLICATION to file document Opposition to Ex Parte Motion under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Ex Parte Motion, # 3 Redacted Document Exhibit 1)(Heinrich, Alan) (Entered: 12/01/2019)
2019-12-01
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Opposition to Ex Parte Motion under seal 440 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Opposition to Ex Parte Application, # 2 Unredacted Document Exhibit 1)(Heinrich, Alan) (Entered: 12/01/2019)
2019-12-01
1
EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz, # 2 Proposed Order, # 3 Declaration of Andrea W. Jeffries, # 4 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 3 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
1
EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz, # 2 Proposed Order, # 3 Declaration of Andrea W. Jeffries, # 4 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 3 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz, # 2 Proposed Order, # 3 Declaration of Andrea W. Jeffries, # 4 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 3 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz, # 2 Proposed Order, # 3 Declaration of Andrea W. Jeffries, # 4 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 3 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz, # 2 Proposed Order, # 3 Declaration of Andrea W. Jeffries, # 4 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 3 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz, # 2 Proposed Order, # 3 Declaration of Andrea W. Jeffries, # 4 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 3 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz, # 2 Proposed Order, # 3 Declaration of Andrea W. Jeffries, # 4 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 3 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
APPLICATION to file document s (Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz and accompanying Exhibit 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
1
APPLICATION to file document s (Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz and accompanying Exhibit 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
APPLICATION to file document s (Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz and accompanying Exhibit 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
APPLICATION to file document s (Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz and accompanying Exhibit 2) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document s (Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz and accompanying Exhibit 2) under seal 449 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document, # 2 Unredacted Document)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,, 450 served on 12/2/19. (Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
1
SEALED REPLY RE MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, Order on Motion for Leave to File Document Under Seal 442 filed by Defendant Kite Pharma, Inc..(Ling, Vincent) (Entered: 12/02/2019)
2019-12-02
1
SEALED REPLY RE MOTION IN LIMINE (#2) to Exclude Expert Testimony of Mark Gilbert, M.D. 271, Order on Motion for Leave to File Document Under Seal 442 filed by Defendant Kite Pharma, Inc..(Ling, Vincent) (Entered: 12/02/2019)
2019-12-02
1
SEALED DOCUMENT Exhibits J and K in Support re MOTION IN LIMINE (#1) to Exclude Damages Opinions of Ryan Sullivan, Ph.D. 270, Order on Motion for Leave to File Document Under Seal 442 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit J, # 2 Exhibit K)(Ling, Vincent) (Entered: 12/02/2019)
2019-12-02
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS SUPPLEMENTAL BRIEF RE DEFENDANTS MOTION IN LIMINE (NO. 1) TO EXCLUDE DAMAGES OPINIONS OF RYAN SULLIVAN, PH.D 433 by Judge S. James Otero (lc) (Entered: 12/02/2019)
2019-12-02
1
ORDER GRANTING KITE PHARMA. INC.S APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENT REGARDING EX PARTE APPLICATION TO STRIKE SUPPLEMENTAL COMPLAINT 396 by Judge S. James Otero (lc) (Entered: 12/02/2019)
2019-12-02
1
SEALED DOCUMENT Exhibit 1 in Support re EX PARTE APPLICATION to Strike Supplemental Complaint 395, Order on Motion for Leave to File Document Under Seal 456 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Ling, Vincent) (Entered: 12/02/2019)
2019-12-02
1
OBJECTIONS to Kite's Trial Exhibits Relating to Dr. Bot's Homology Comparison in Light of the Court's MIL Rulings filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
1
OBJECTIONS to Kite's Trial Exhibits Relating to Dr. Bot's Homology Comparison in Light of the Court's MIL Rulings filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
OBJECTIONS to Kite's Trial Exhibits Relating to Dr. Bot's Homology Comparison in Light of the Court's MIL Rulings filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
OBJECTIONS to Kite's Trial Exhibits Relating to Dr. Bot's Homology Comparison in Light of the Court's MIL Rulings filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
OBJECTIONS to Kite's Trial Exhibits Relating to Dr. Bot's Homology Comparison in Light of the Court's MIL Rulings filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
OBJECTIONS to Kite's Trial Exhibits Relating to Dr. Bot's Homology Comparison in Light of the Court's MIL Rulings filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/02/2019)
2019-12-02
2
MINUTES OF FINAL PRETRIAL CONFERENCE (CONTINUED) held before Judge S. James Otero: The Court states its views on the pretrial documents (SEE DOCUMENT FOR SPECIFICS). DAUBERT MOTION HEARING The Court heard argument from parties regarding Plaintiffs' Motion in Limine No. 4 and Defendant's Motions in Limine Nos. 1, 2. The Court shall issue a separate Order regarding these issues. The parties should be prepared to commence with opening statements without a final order on the issues. The parties shall lodge a new amended pretrial order consistent with the courts rulings after the court rules on the pending motions in limine. The Court orders that an expedited transcript of todays proceeding shall be produced, costs to be shared by the parties. Court Reporter: Amy Diaz. (lc) (Entered: 12/09/2019)
2019-12-02
1
OBJECTIONS to Certain of Kite's Proposed Opening Demonstratives filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/03/2019)
2019-12-03
1
OBJECTIONS to Certain of Kite's Proposed Opening Demonstratives filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/03/2019)
2019-12-03
2
OBJECTIONS to Certain of Kite's Proposed Opening Demonstratives filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/03/2019)
2019-12-03
2
OBJECTIONS to Certain of Kite's Proposed Opening Demonstratives filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/03/2019)
2019-12-03
2
Amended Exhibit List filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research.. (Tuan, Elizabeth) (Entered: 12/03/2019)
2019-12-03
1
OBJECTIONS (Corrected) filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 12/03/2019)
2019-12-03
1
NOTICE OF ERRATA filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. correcting Objection,, 459 (Jeffries, Andrea) (Entered: 12/03/2019)
2019-12-03
1
OBJECTIONS to Plaintiffs' Proposed Opening Demonstratives filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1)(Ling, Vincent) (Entered: 12/03/2019)
2019-12-03
1
OBJECTIONS to Plaintiffs' Proposed Opening Demonstratives filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1)(Ling, Vincent) (Entered: 12/03/2019)
2019-12-03
2
OBJECTIONS to Plaintiffs' Proposed Opening Demonstratives filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1)(Ling, Vincent) (Entered: 12/03/2019)
2019-12-03
2
APPLICATION to file document re: Opposition to Ex Parte Application to Exclude Dr. Schuetz under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Opposition to Plaintiffs Ex Parte Application to Exclude Dr. Schuetz, # 2 Proposed Order)(Brazill, Markus) (Entered: 12/03/2019)
2019-12-03
1
APPLICATION to file document re: Opposition to Ex Parte Application to Exclude Dr. Schuetz under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Opposition to Plaintiffs Ex Parte Application to Exclude Dr. Schuetz, # 2 Proposed Order)(Brazill, Markus) (Entered: 12/03/2019)
2019-12-03
2
APPLICATION to file document re: Opposition to Ex Parte Application to Exclude Dr. Schuetz under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Opposition to Plaintiffs Ex Parte Application to Exclude Dr. Schuetz, # 2 Proposed Order)(Brazill, Markus) (Entered: 12/03/2019)
2019-12-03
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document re: Opposition to Ex Parte Application to Exclude Dr. Schuetz under seal 464 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Opposition to Ex Parte Application to Exclude Dr. Schuetz, # 2 Exhibit 3)(Brazill, Markus) (Entered: 12/03/2019)
2019-12-03
1
DECLARATION of Peter Gratzinger in Opposition to EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz 445 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Brazill, Markus) (Entered: 12/03/2019)
2019-12-03
1
DECLARATION of Peter Gratzinger in Opposition to EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz 445 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Brazill, Markus) (Entered: 12/03/2019)
2019-12-03
2
DECLARATION of Peter Gratzinger in Opposition to EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz 445 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Brazill, Markus) (Entered: 12/03/2019)
2019-12-03
2
SEALED - UNDER SEAL MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER RE: DAUBERT MOTIONS [ECF Nos. 270, 271, and 274]; DEFENDANT'S EX PARTE APPLICATION TO STRIKE SUPPLEMENTAL COMPLAINT [ECF No. 395]; DEFENDANT'S EX PARTE APPLICATION TO STRIKE UNTIMELY AND UNRELIABLE OPINIONS OF DR. SULLIVAN [ECF No. 428].(1) GRANTS-IN-PART and DENIES-IN-PART the Sullivan Motion;(2) GRANTS-IN-PART and DENIES-IN-PART the Gilbert Motion; (3) GRANTS-IN-PART and DENIES-IN-PART the Rao Motion; (4) GRANTS the Motion to Strike Complaint. Plaintiffs are ordered to file a supplemental Complaint within 24 hours; and(5) GRANTS the Motion to Strike Sullivan's Amended Report. (lc) (Entered: 12/04/2019)
2019-12-03
1
MINUTES OF Jury Trial - 1st Day held before Judge S. James Otero: Jury impaneled and sworn. Opening statements made. Jury Trial continued to 12/4/2019 08:30 AM. Court Reporter: Amy Diaz. (lc) (Entered: 12/04/2019)
2019-12-03
1
MINUTE ORDER IN CHAMBERS by Judge S. James Otero:ORDER RE: DAUBERT MOTIONS [ECF Nos. 270, 271, and 274]; DEFENDANT'S EX PARTE APPLICATION TO STRIKE SUPPLEMENTAL COMPLAINT [ECF No. 395]; DEFENDANT'S EX PARTE APPLICATION TO STRIKE UNTIMELY AND UNRELIABLE OPINIONS OF DR. SULLIVAN [ECF No. 428]. The Court: (1) GRANTS-IN-PART and DENIES-IN-PART the Sullivan Motion; (2) GRANTS-IN-PART and DENIES-IN-PART the Gilbert Motion; (3) GRANTS-IN-PART and DENIES-IN-PART the Rao Motion;(4) GRANTS the Motion to Strike Complaint. Plaintiffs are ordered to file a supplemental Complaint within 24 hours of entry of this Order; and (5) GRANTS the Motion to Strike Sullivan's Amended Report. (lc) (Entered: 12/11/2019)
2019-12-03
1
REPLY in support of EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz 445 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
1
APPLICATION to file document (Reply in support of Plaintiffs' Ex Parte Application to Exclue Testimony from Dr. Thomas Schuetz) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
1
APPLICATION to file document (Reply in support of Plaintiffs' Ex Parte Application to Exclue Testimony from Dr. Thomas Schuetz) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
2
APPLICATION to file document (Reply in support of Plaintiffs' Ex Parte Application to Exclue Testimony from Dr. Thomas Schuetz) under seal filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document (Reply in support of Plaintiffs' Ex Parte Application to Exclue Testimony from Dr. Thomas Schuetz) under seal 468 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,, 469 served on 12/4/2019. (Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
1
OBJECTIONS to Plaintiffs' Proposed Demonstratives for Direct Examinations of Dr. Mark Gilbert, Dr. Wayne Marasco, and Dr. Mark Robbins filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/04/2019)
2019-12-04
1
OBJECTIONS to Plaintiffs' Proposed Demonstratives for Direct Examinations of Dr. Mark Gilbert, Dr. Wayne Marasco, and Dr. Mark Robbins filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/04/2019)
2019-12-04
2
OBJECTIONS to Plaintiffs' Proposed Demonstratives for Direct Examinations of Dr. Mark Gilbert, Dr. Wayne Marasco, and Dr. Mark Robbins filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/04/2019)
2019-12-04
2
OBJECTIONS to Plaintiffs' Proposed Demonstratives for Direct Examinations of Dr. Mark Gilbert, Dr. Wayne Marasco, and Dr. Mark Robbins filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/04/2019)
2019-12-04
2
OBJECTIONS to Plaintiffs' Proposed Demonstratives for Direct Examinations of Dr. Mark Gilbert, Dr. Wayne Marasco, and Dr. Mark Robbins filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/04/2019)
2019-12-04
2
REQUEST for Relief from Opening Statement filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration Declaration of Andrea W. Jeffries In Support Of Request, # 2 Exhibit Exhibit 1) (Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
1
REQUEST for Relief from Opening Statement filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration Declaration of Andrea W. Jeffries In Support Of Request, # 2 Exhibit Exhibit 1) (Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
2
REQUEST for Relief from Opening Statement filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration Declaration of Andrea W. Jeffries In Support Of Request, # 2 Exhibit Exhibit 1) (Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
2
Witness List filed by Defendant Kite Pharma, Inc... (Brazill, Markus) (Entered: 12/04/2019)
2019-12-04
1
Amended PRETRIAL STIPULATION regarding Exhibits . (Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
1
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection,, 458 Regarding Exhibits Relating to Dr. Bot's Homology Analysis (Brazill, Markus) (Entered: 12/04/2019)
2019-12-04
1
DECLARATION of Markus Brazill re Response 477 to Objection Regarding Exhibits Relating to Dr. Bot's Homology Analysis filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Brazill, Markus) (Entered: 12/04/2019)
2019-12-04
1
DECLARATION of Markus Brazill re Response 477 to Objection Regarding Exhibits Relating to Dr. Bot's Homology Analysis filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Brazill, Markus) (Entered: 12/04/2019)
2019-12-04
2
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTSUNDER SEAL IN CONNECTION WITH PLAINTIFFS MOTION IN LIMINE REPLIES 355 by Judge S. James Otero (lc) (Entered: 12/04/2019)
2019-12-04
1
ORDER GRANTING KITE PHARMA. INC.S APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS RE: EX PARTE APPLICATION TO STRIKE UNTIMELY AND UNRELIABLE OPINIONS OF DR. RYAN SULLIVAN REGADRING THE HYPOTHETICAL NEGOTIATION 429 by Judge S. James Otero (lc) (Entered: 12/04/2019)
2019-12-04
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS MEMORANDUM OF POINTS AND AUTHORITIES IN OPPOSITION TO DEFENDANTS EX PARTE APPLICATION TO STRIKE OPINIONS OF DR. RYAN SULLIVAN 440 by Judge S. James Otero (lc) (Entered: 12/04/2019)
2019-12-04
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS EX PARTE APPLICATION TO EXCLUDE TESTIMONY FROM DR. THOMAS SCHUETZ 449 by Judge S. James Otero (lc) (Entered: 12/04/2019)
2019-12-04
1
ORDER GRANTING KITE PHARMA. INC.S APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS RE: OPPOSITION TO EX PARTE APPLICATION TO EXCLUDE TESTIMONY FROM DR. SCHUETZ 464 by Judge S. James Otero (lc) (Entered: 12/04/2019)
2019-12-04
1
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
1
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
SECOND AMENDED COMPLAINT against Defendant All Defendants amending Amended Complaint/Petition,, 174, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Appendix 1)(Chu, Morgan) (Entered: 12/04/2019)
2019-12-04
2
APPLICATION to file document Confidential Documents in Connection With Second Amended and Supplemental Complaint for Patent Infringement under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Exhibit 17)(Petersen, Ingrid) (Entered: 12/04/2019)
2019-12-04
1
APPLICATION to file document Confidential Documents in Connection With Second Amended and Supplemental Complaint for Patent Infringement under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Exhibit 17)(Petersen, Ingrid) (Entered: 12/04/2019)
2019-12-04
2
APPLICATION to file document Confidential Documents in Connection With Second Amended and Supplemental Complaint for Patent Infringement under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Exhibit 17)(Petersen, Ingrid) (Entered: 12/04/2019)
2019-12-04
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Confidential Documents in Connection With Second Amended and Supplemental Complaint for Patent Infringement under seal 485 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Exhibit 17)(Petersen, Ingrid) (Entered: 12/04/2019)
2019-12-04
1
OBJECTIONS to Kite's Designations of Marina Larson's Deposition Testimony filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
1
OBJECTIONS to Kite's Designations of Marina Larson's Deposition Testimony filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
2
OBJECTIONS to Kite's Designations of Marina Larson's Deposition Testimony filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
2
REPLY filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research to Objection,, 458 (Attachments: # 1 Declaration, # 2 Exhibit)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
1
REPLY filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research to Objection,, 458 (Attachments: # 1 Declaration, # 2 Exhibit)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
2
REPLY filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research to Objection,, 458 (Attachments: # 1 Declaration, # 2 Exhibit)(Jeffries, Andrea) (Entered: 12/04/2019)
2019-12-04
2
MINUTES OF Jury Trial - 2nd Day held before Judge S. James Otero: Witnesses called, sworn and testified. Exhibits identified and admitted. Jury Trial continued to 12/5/2019 08:30 AM. Court Reporter: Amy Diaz (AM) Terri Hourigan (PM). (lc) (Entered: 12/05/2019)
2019-12-04
1
OBJECTIONS to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, Including Exhibits and Testimony of Edward Dulac [Redacted] filed by Defendant Kite Pharma, Inc.. (Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
1
DECLARATION of Vincent Ling re Objection 489 to Plaintiffs' End Run Around Court's Damages-Related Daubert Order filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
1
DECLARATION of Vincent Ling re Objection 489 to Plaintiffs' End Run Around Court's Damages-Related Daubert Order filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
2
DECLARATION of Vincent Ling re Objection 489 to Plaintiffs' End Run Around Court's Damages-Related Daubert Order filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
2
DECLARATION of Vincent Ling re Objection 489 to Plaintiffs' End Run Around Court's Damages-Related Daubert Order filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
2
APPLICATION to file document re to Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, # 2 Proposed Order)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
1
APPLICATION to file document re to Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, # 2 Proposed Order)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
2
APPLICATION to file document re to Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, # 2 Proposed Order)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document re to Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal 491 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, # 2 Exhibit 1, # 3 Exhibit 3)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: REQUEST for Relief from Opening Statement 472 . The following error(s) was/were found: Proposed Document was not submitted as separate attachment. Other error(s) with document(s): Missing proposed order which should have been submitted as a separate attachment.. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 12/05/2019)
2019-12-05
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: SECOND Amended Complaint/Petition,, 484 . The following error(s) was/were found: Caption of document is incomplete/incorrect. Other error(s) with document(s): RE: FRCP 10, caption re plaintiffs has" ET AL". Clerk reviewed the plaintiffs named as filers and named in the body text and compared to Caption of the First Amended Complaint, and is unable to determine which of these TWO plaintiffs of the THREE plaintiffs in the First Amended Complaint remain. HOWEVER, Clerk NOTES: Filer indicates it was FILED PER COURT ORDER and "This Second Amended and Supplemental Complaint is in addition to, and is not intended to replace, Plaintiffs prior pleadings in this case". In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 12/05/2019)
2019-12-05
1
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE CONFIDENTIAL DOCUMENTS UNDER SEAL IN CONNECTION WITH SECOND AMENDED AND SUPPLEMENTAL COMPLAINT FOR PATENT INFRINGEMENT 485 by Judge S. James Otero (lc) (Entered: 12/05/2019)
2019-12-05
1
REQUEST for Relief from Improper Testimony Through a Curative Instruction filed by Defendant Kite Pharma, Inc.. (Brazill, Markus) (Entered: 12/05/2019)
2019-12-05
1
DECLARATION of Blanca Young in Support of REQUEST for Relief from Improper Testimony Through a Curative Instruction 498 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Brazill, Markus) (Entered: 12/05/2019)
2019-12-05
1
DECLARATION of Blanca Young in Support of REQUEST for Relief from Improper Testimony Through a Curative Instruction 498 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Brazill, Markus) (Entered: 12/05/2019)
2019-12-05
2
OBJECTIONS to Plaintiffs' Proposed Demonstratives for Direct Examination of Dr. Ryan Sullivan filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
1
OBJECTIONS to Plaintiffs' Proposed Demonstratives for Direct Examination of Dr. Ryan Sullivan filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
2
OBJECTIONS to Plaintiffs' Proposed Demonstratives for Direct Examination of Dr. Ryan Sullivan filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
2
OBJECTIONS to Plaintiffs' Proposed Demonstratives for Direct Examination of Dr. Ryan Sullivan filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2)(Ling, Vincent) (Entered: 12/05/2019)
2019-12-05
2
MINUTES OF Jury Trial - 3rd Day held before Judge S. James Otero: Witnesses called, sworn and testified. Exhibits identified and admitted. Jury Trial continued to 12/6/2019 08:30 AM. Court Reporter: Amy Diaz. (lc) (Entered: 12/06/2019)
2019-12-05
1
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto Sealed Declaration in SupportDeclaration, 492, Objection 489, Objection 500 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/06/2019)
2019-12-06
1
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto Sealed Declaration in SupportDeclaration, 492, Objection 489, Objection 500 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/06/2019)
2019-12-06
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto Sealed Declaration in SupportDeclaration, 492, Objection 489, Objection 500 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/06/2019)
2019-12-06
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Objection, 487 and Objections to Plaintiffs' Counter-Designations (Brazill, Markus) (Entered: 12/06/2019)
2019-12-06
1
APPLICATION to file document Exhibits in Support of Response to Plaintiffs Objections and Affirmative Objections to Certain Deposition Designations under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Brazill, Markus) (Entered: 12/06/2019)
2019-12-06
1
APPLICATION to file document Exhibits in Support of Response to Plaintiffs Objections and Affirmative Objections to Certain Deposition Designations under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Brazill, Markus) (Entered: 12/06/2019)
2019-12-06
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Exhibits in Support of Response to Plaintiffs Objections and Affirmative Objections to Certain Deposition Designations under seal 503 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Brazill, Markus) (Entered: 12/06/2019)
2019-12-06
1
REQUEST for Relief from Improper Questioning and Testimony Through Curative Instruction on Inter Partes Review filed by Defendant Kite Pharma, Inc.. (Ling, Vincent) (Entered: 12/06/2019)
2019-12-06
1
DECLARATION of Markus Brazill re Response 502 to Plaintiffs' Objection and Affirmative Counter Designations filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6)(Brazill, Markus) (Entered: 12/06/2019)
2019-12-06
1
DECLARATION of Markus Brazill re Response 502 to Plaintiffs' Objection and Affirmative Counter Designations filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6)(Brazill, Markus) (Entered: 12/06/2019)
2019-12-06
2
DECLARATION of Markus Brazill re Response 502 to Plaintiffs' Objection and Affirmative Counter Designations filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6)(Brazill, Markus) (Entered: 12/06/2019)
2019-12-06
2
DECLARATION of Markus Brazill re Response 502 to Plaintiffs' Objection and Affirmative Counter Designations filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6)(Brazill, Markus) (Entered: 12/06/2019)
2019-12-06
2
REQUEST for Relief from Improper Questioning and Testimony Through Curative Instruction on Inter Partes Review (Corrected) filed by Defendant Kite Pharma, Inc.. (Brazill, Markus) (Entered: 12/06/2019)
2019-12-06
1
PARTIAL TRANSCRIPT for proceedings held on 12/4/2019 1:00 p.m.. Court Reporter/Electronic Court Recorder: Terri Hourigan, phone number hourigan.terri@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 12/27/2019. Redacted Transcript Deadline set for 1/6/2020. Release of Transcript Restriction set for 3/5/2020. (Hourigan, Terri) (Entered: 12/06/2019)
2019-12-06
1
NOTICE OF FILING TRANSCRIPT filed for proceedings 12/04/2019 1:00 p.m. re Transcript 509 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Hourigan, Terri) TEXT ONLY ENTRY (Entered: 12/06/2019)
2019-12-06
1
REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Bench Brief Regarding Reference to the Court's Claim Construction Order, # 2 Proposed Order)(Ling, Vincent) (Entered: 12/06/2019)
2019-12-06
1
REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Bench Brief Regarding Reference to the Court's Claim Construction Order, # 2 Proposed Order)(Ling, Vincent) (Entered: 12/06/2019)
2019-12-06
2
REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Bench Brief Regarding Reference to the Court's Claim Construction Order, # 2 Proposed Order)(Ling, Vincent) (Entered: 12/06/2019)
2019-12-06
2
SEALED DECLARATION IN SUPPORT OF REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal 511 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Bench Brief Regarding Reference to the Court's Claim Construction Order, # 2 Exhibit 1, # 3 Exhibit 2)(Ling, Vincent) (Entered: 12/06/2019)
2019-12-06
1
MINUTES OF Jury Trial - 4th Day held before Judge S. James Otero: Witnesses called, sworn and testified. Exhibits identified and admitted. Jury Trial continued to 12/6/2019 09:45 AM. Court Reporter: Amy Diaz. (lc) (Entered: 12/09/2019)
2019-12-06
1
Notice of Filing Transcript
2019-12-06
1
No Actions
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST for Relief from Improper Questioning and Testimony Through Curative Instruction on Inter Partes Review (Corrected) 508, REQUEST for Relief from Improper Questioning and Testimony Through Curative Instruction on Inter Partes Review 505 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/07/2019)
2019-12-07
1
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST for Relief from Improper Questioning and Testimony Through Curative Instruction on Inter Partes Review (Corrected) 508, REQUEST for Relief from Improper Questioning and Testimony Through Curative Instruction on Inter Partes Review 505 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/07/2019)
2019-12-07
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST for Relief from Improper Questioning and Testimony Through Curative Instruction on Inter Partes Review (Corrected) 508, REQUEST for Relief from Improper Questioning and Testimony Through Curative Instruction on Inter Partes Review 505 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/07/2019)
2019-12-07
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST for Relief from Improper Testimony Through a Curative Instruction 498 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/07/2019)
2019-12-07
1
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST for Relief from Improper Testimony Through a Curative Instruction 498 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/07/2019)
2019-12-07
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST for Relief from Improper Testimony Through a Curative Instruction 498 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/07/2019)
2019-12-07
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST for Relief from Improper Testimony Through a Curative Instruction 498 (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 3 Exhibit 2 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/07/2019)
2019-12-07
2
SEALED DOCUMENT Joint Report re Order on Motion to Strike,,,,,, Order on Motion in Limine to Exclude,,,,,,,, 473 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Unredacted Document Exhibit 1)(Heinrich, Alan) (Entered: 12/08/2019)
2019-12-08
1
REPLY filed by Defendant Kite Pharma, Inc. to REQUEST for Relief from Improper Questioning and Testimony Through Curative Instruction on Inter Partes Review (Corrected) 508 (Cole, Graham) (Entered: 12/08/2019)
2019-12-08
1
DECLARATION of Graham Cole re Reply 516 In Support of Defendant Kite Pharma, Inc.'s Request for a Curative Instruction Regarding the Inter Partes Review filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Cole, Graham) (Entered: 12/08/2019)
2019-12-08
1
DECLARATION of Graham Cole re Reply 516 In Support of Defendant Kite Pharma, Inc.'s Request for a Curative Instruction Regarding the Inter Partes Review filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Cole, Graham) (Entered: 12/08/2019)
2019-12-08
2
OBJECTIONS to Certain of Plaintiffs Proposed Demonstratives For Direct Examination of Dr. Thomas Brocker filed by Defendant Kite Pharma, Inc.. (Brazill, Markus) (Entered: 12/08/2019)
2019-12-08
1
APPLICATION to file document in Support Of Objections to Certain of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Brazill, Markus) (Entered: 12/08/2019)
2019-12-08
1
APPLICATION to file document in Support Of Objections to Certain of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Brazill, Markus) (Entered: 12/08/2019)
2019-12-08
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document in Support Of Objections to Certain of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker under seal 519 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3)(Brazill, Markus) (Entered: 12/08/2019)
2019-12-08
1
DECLARATION of Lance Wyatt re Objection 518 to Certain Of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 4)(Brazill, Markus) (Entered: 12/08/2019)
2019-12-08
1
DECLARATION of Lance Wyatt re Objection 518 to Certain Of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 4)(Brazill, Markus) (Entered: 12/08/2019)
2019-12-08
2
DECLARATION of Lance Wyatt re Objection 518 to Certain Of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 4)(Brazill, Markus) (Entered: 12/08/2019)
2019-12-08
2
DECLARATION of Lance Wyatt re Objection 518 to Certain Of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 4)(Brazill, Markus) (Entered: 12/08/2019)
2019-12-08
2
NOTICE OF LODGING Proposed Pretrial Conference Order Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order [Proposed] Second Amended Final Pretrial Conference Order)(Jeffries, Andrea) (Entered: 12/08/2019)
2019-12-08
1
NOTICE OF LODGING Proposed Pretrial Conference Order Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Kite Pharma, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order [Proposed] Second Amended Final Pretrial Conference Order)(Jeffries, Andrea) (Entered: 12/08/2019)
2019-12-08
2
REQUEST for Relief in the form of Entry into Evidence of Kite's Damages Contentions Admissions filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
1
REQUEST for Relief in the form of Entry into Evidence of Kite's Damages Contentions Admissions filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
REQUEST for Relief in the form of Entry into Evidence of Kite's Damages Contentions Admissions filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
REQUEST for Relief in the form of Entry into Evidence of Kite's Damages Contentions Admissions filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
REQUEST for Relief in the form of Entry into Evidence of Kite's Damages Contentions Admissions filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries) (Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal 511, Sealed Declaration in SupportDeclaration, 512 [Plaintiffs' (1) Response to Defendant's Bench Brief Re: Dr. Quackenbush and (2) Cross-Request to Exclude All Claim Construction Dicta and Rationale] (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
1
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal 511, Sealed Declaration in SupportDeclaration, 512 [Plaintiffs' (1) Response to Defendant's Bench Brief Re: Dr. Quackenbush and (2) Cross-Request to Exclude All Claim Construction Dicta and Rationale] (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal 511, Sealed Declaration in SupportDeclaration, 512 [Plaintiffs' (1) Response to Defendant's Bench Brief Re: Dr. Quackenbush and (2) Cross-Request to Exclude All Claim Construction Dicta and Rationale] (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal 511, Sealed Declaration in SupportDeclaration, 512 [Plaintiffs' (1) Response to Defendant's Bench Brief Re: Dr. Quackenbush and (2) Cross-Request to Exclude All Claim Construction Dicta and Rationale] (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal 511, Sealed Declaration in SupportDeclaration, 512 [Plaintiffs' (1) Response to Defendant's Bench Brief Re: Dr. Quackenbush and (2) Cross-Request to Exclude All Claim Construction Dicta and Rationale] (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal 511, Sealed Declaration in SupportDeclaration, 512 [Plaintiffs' (1) Response to Defendant's Bench Brief Re: Dr. Quackenbush and (2) Cross-Request to Exclude All Claim Construction Dicta and Rationale] (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal 511, Sealed Declaration in SupportDeclaration, 512 [Plaintiffs' (1) Response to Defendant's Bench Brief Re: Dr. Quackenbush and (2) Cross-Request to Exclude All Claim Construction Dicta and Rationale] (Attachments: # 1 Proposed Order, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 4 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 5 Exhibit 3 to the Declaration of Andrea W. Jeffries, # 6 Exhibit 4 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
REQUEST for Relief from Ruling Sustaining Objection to DX48 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C) (Lawton, Adam) (Entered: 12/09/2019)
2019-12-09
1
REQUEST for Relief from Ruling Sustaining Objection to DX48 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C) (Lawton, Adam) (Entered: 12/09/2019)
2019-12-09
2
REQUEST for Relief from Ruling Sustaining Objection to DX48 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C) (Lawton, Adam) (Entered: 12/09/2019)
2019-12-09
2
REQUEST for Relief from Ruling Sustaining Objection to DX48 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C) (Lawton, Adam) (Entered: 12/09/2019)
2019-12-09
2
REQUEST for Relief from Ruling Sustaining Objection to DX48 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C) (Lawton, Adam) (Entered: 12/09/2019)
2019-12-09
2
OBJECTIONS to Kite's Desposition Designations and Exhibits filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration In Support of Plaintiffs Objections, # 2 Exhibit 1, # 3 Exhibit 2)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
1
OBJECTIONS to Kite's Desposition Designations and Exhibits filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration In Support of Plaintiffs Objections, # 2 Exhibit 1, # 3 Exhibit 2)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
OBJECTIONS to Kite's Desposition Designations and Exhibits filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration In Support of Plaintiffs Objections, # 2 Exhibit 1, # 3 Exhibit 2)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
OBJECTIONS to Kite's Desposition Designations and Exhibits filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration In Support of Plaintiffs Objections, # 2 Exhibit 1, # 3 Exhibit 2)(Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
2
REQUEST to Strike and to Admit Rebuttal Evidence filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1) (Ling, Vincent) (Entered: 12/09/2019)
2019-12-09
1
REQUEST to Strike and to Admit Rebuttal Evidence filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1) (Ling, Vincent) (Entered: 12/09/2019)
2019-12-09
2
REQUEST to Strike and to Admit Rebuttal Evidence filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1) (Ling, Vincent) (Entered: 12/09/2019)
2019-12-09
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto REQUEST for Relief from Ruling Sustaining Objection to DX48 525 (Jeffries, Andrea) (Entered: 12/09/2019)
2019-12-09
1
SCHEDULING NOTICE by Judge S. James Otero. The parties are reminded that when providing good cause or demonstrating compelling reasons why the strong presumption of public access should be overcome, [t]hat the information may have been designated confidential pursuant to a protective order is not sufficient justification for filing under seal. L.R. 79-5.2.2(a)(1). Each party seeking to seal information contained in 468, 491, 503, 511, and 519 shall file a single declaration for all aforementioned applications to seal, setting forth good cause or compelling reasons, no later than December 12, 2019. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 12/09/2019)
2019-12-09
1
OBJECTIONS to Improper Rebuttal Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Blanca F. Young, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
1
OBJECTIONS to Improper Rebuttal Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Blanca F. Young, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
2
OBJECTIONS to Improper Rebuttal Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Blanca F. Young, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
2
OBJECTIONS to Improper Rebuttal Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Blanca F. Young, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
2
OBJECTIONS to Improper Rebuttal Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Blanca F. Young, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
2
OBJECTIONS to Improper Rebuttal Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Blanca F. Young, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
2
OBJECTIONS to Improper Rebuttal Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Blanca F. Young, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
2
OBJECTIONS to Improper Rebuttal Testimony filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Blanca F. Young, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F)(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
2
NOTICE OF ERRATA filed by Defendant Kite Pharma, Inc.. correcting Objection, 533 (Attachments: # 1 Declaration of Blanca F. Young (Corrected))(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
1
NOTICE OF ERRATA filed by Defendant Kite Pharma, Inc.. correcting Objection, 533 (Attachments: # 1 Declaration of Blanca F. Young (Corrected))(Gratzinger, Peter) (Entered: 12/09/2019)
2019-12-09
2
MINUTES OF Jury Trial - 5th Day held before Judge S. James Otero: Witnesses called, sworn and testified. Exhibits identified and admitted. Jury Trial continued to 12/10/2019 08:30 AM. Court Reporter: Amy Diaz. (lc) (Entered: 12/11/2019)
2019-12-09
1
Text Only Scheduling Notice
2019-12-09
1
No Actions
MEMORANDUM of Points and Authorities in Opposition Re: REQUEST to Strike and to Admit Rebuttal Evidence 527 (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1)(Heinrich, Alan) (Entered: 12/10/2019)
2019-12-10
1
MEMORANDUM of Points and Authorities in Opposition Re: REQUEST to Strike and to Admit Rebuttal Evidence 527 (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1)(Heinrich, Alan) (Entered: 12/10/2019)
2019-12-10
2
MEMORANDUM of Points and Authorities in Opposition Re: REQUEST to Strike and to Admit Rebuttal Evidence 527 (Attachments: # 1 Declaration of Alan J. Heinrich, # 2 Exhibit 1)(Heinrich, Alan) (Entered: 12/10/2019)
2019-12-10
2
REQUEST for Order for Instruction filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1) (Heinrich, Alan) (Entered: 12/10/2019)
2019-12-10
1
REQUEST for Order for Instruction filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1) (Heinrich, Alan) (Entered: 12/10/2019)
2019-12-10
2
REQUEST for Order for Instruction filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1) (Heinrich, Alan) (Entered: 12/10/2019)
2019-12-10
2
REQUEST for Order for Instruction filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Declaration of Alan J. Heinrich, # 3 Exhibit 1) (Heinrich, Alan) (Entered: 12/10/2019)
2019-12-10
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto Objection, 533 (Attachments: # 1 Declaration, # 2 Exhibit, # 3 Exhibit)(Jeffries, Andrea) (Entered: 12/10/2019)
2019-12-10
1
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto Objection, 533 (Attachments: # 1 Declaration, # 2 Exhibit, # 3 Exhibit)(Jeffries, Andrea) (Entered: 12/10/2019)
2019-12-10
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto Objection, 533 (Attachments: # 1 Declaration, # 2 Exhibit, # 3 Exhibit)(Jeffries, Andrea) (Entered: 12/10/2019)
2019-12-10
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto Objection, 533 (Attachments: # 1 Declaration, # 2 Exhibit, # 3 Exhibit)(Jeffries, Andrea) (Entered: 12/10/2019)
2019-12-10
2
OBJECTIONS to Trial Exhibit PX0371 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/10/2019)
2019-12-10
1
OBJECTIONS to Trial Exhibit PX0371 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/10/2019)
2019-12-10
2
OBJECTIONS to Trial Exhibit PX0371 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/10/2019)
2019-12-10
2
OBJECTIONS to Trial Exhibit PX0371 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/10/2019)
2019-12-10
2
OBJECTIONS to Trial Exhibit PX0371 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Vincent Ling, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3)(Ling, Vincent) (Entered: 12/10/2019)
2019-12-10
2
RESPONSE filed by Defendant Kite Pharma, Inc.to REQUEST for Relief in the form of Entry into Evidence of Kite's Damages Contentions Admissions 523 (Brazill, Markus) (Entered: 12/10/2019)
2019-12-10
1
APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Brazill, Markus) (Entered: 12/10/2019)
2019-12-10
1
APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Brazill, Markus) (Entered: 12/10/2019)
2019-12-10
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal 540 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Brazill, Markus) (Entered: 12/10/2019)
2019-12-10
1
DECLARATION of Markus Brazill re Response 539 to Plaintiffs Request to Admit Kites Responsive Damages Contentions as Evidence filed by Defendant Kite Pharma, Inc.. (Brazill, Markus) (Entered: 12/10/2019)
2019-12-10
1
Offer of Proof (Cole, Graham) (Entered: 12/10/2019)
2019-12-10
1
APPLICATION to file document Documents Re: Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
1
APPLICATION to file document Documents Re: Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Documents Re: Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation under seal 544 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0013, # 2 Exhibit DX0018, # 3 Exhibit DX0182, # 4 Exhibit DX0188, # 5 Exhibit DX0342, # 6 Exhibit DX0481-1, # 7 Exhibit DX0481-2, # 8 Exhibit DX1730, # 9 Exhibit DX1731, # 10 Exhibit DX1869, # 11 Exhibit DX1883-1, # 12 Exhibit DX1883-2, # 13 Exhibit DX2029, # 14 Exhibit DX2033, # 15 Exhibit DX2063, # 16 Exhibit DX2157, # 17 Exhibit DX2158)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
1
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
1
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Memorandum Of Points And Authorities In Support Of Its Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0020, # 3 Exhibit DX0200, # 4 Exhibit DX0945, # 5 Exhibit DX1060, # 6 Exhibit DX1077, # 7 Exhibit DX1106, # 8 Exhibit DX1107, # 9 Exhibit DX1118, # 10 Exhibit DX2017, # 11 Exhibit DX2061)(Cole, Graham) (Entered: 12/10/2019)
2019-12-10
2
ORDER DENIED WITHOUT PREJUDICE DEFENDANT KITE PHARMA, INC.S APPLICATION FOR LEAVE TO FILE UNDER SEAL EXHIBITS IN SUPPORT OF ITS RESPONSE TO PLAINTIFFS REQUEST TO ADMIT KITES RESPONSIVE DAMAGES CONTENTIONS AS EVIDENCE 540 by Judge S. James Otero (lc) (Entered: 12/10/2019)
2019-12-10
1
ORDER DENYING DEFENDANT KITE PHARMA INC.'S APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS RE: OFFER OF PROOF REGARDING EVIDENCE EXCLUDED BASED ONSUSTAINED OBJECTIONS OR TIME ALLOCATION 544 by Judge S. James Otero (lc) (Entered: 12/11/2019)
2019-12-10
1
MINUTES OF Jury Trial - 6th Day held before Judge S. James Otero: Witnesses called, sworn and testified. Exhibits identified and admitted. Plaintiff rests. Defendant rests. Jury Trial continued to 12/11/2019 08:30 AM. Court Reporter: Amy Diaz. (lc) (Entered: 12/11/2019)
2019-12-10
1
OBJECTIONS and Proposals Regarding Certain Closing Jury Instructions filed by Defendant Kite Pharma, Inc.. (Ling, Vincent) (Entered: 12/11/2019)
2019-12-11
1
NOTICE OF LODGING filed (Plaintiffs' [Proposed] Modified Closing Jury Instruction #13) re Jury Instructions (Proposed) 436 (Attachments: # 1 Exhibit - [Proposed] Modified Closing Jury Instruction #13, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
NOTICE OF LODGING filed (Plaintiffs' [Proposed] Modified Closing Jury Instruction #13) re Jury Instructions (Proposed) 436 (Attachments: # 1 Exhibit - [Proposed] Modified Closing Jury Instruction #13, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF LODGING filed (Plaintiffs' [Proposed] Modified Closing Jury Instruction #13) re Jury Instructions (Proposed) 436 (Attachments: # 1 Exhibit - [Proposed] Modified Closing Jury Instruction #13, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF LODGING filed (Plaintiffs' [Proposed] Modified Closing Jury Instruction #13) re Jury Instructions (Proposed) 436 (Attachments: # 1 Exhibit - [Proposed] Modified Closing Jury Instruction #13, # 2 Declaration of Andrea W. Jeffries, # 3 Exhibit 1 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Plaintiffs' Rule 50(a) Motion for Judgment as a Matter of Law, # 2 Proposed Order) (Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Plaintiffs' Rule 50(a) Motion for Judgment as a Matter of Law, # 2 Proposed Order) (Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum of Points and Authorities in support of Plaintiffs' Rule 50(a) Motion for Judgment as a Matter of Law, # 2 Proposed Order) (Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
1
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Markus Brazill, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7SEALED DOCUMENT- Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Proposed Order) (Brazill, Markus) Modified on 1/3/2020 (lc). (Entered: 12/11/2019)
2019-12-11
2
Second APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Proposed Order)(Brazill, Markus) (Entered: 12/11/2019)
2019-12-11
1
Second APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Proposed Order)(Brazill, Markus) (Entered: 12/11/2019)
2019-12-11
2
Second APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Proposed Order)(Brazill, Markus) (Entered: 12/11/2019)
2019-12-11
2
Second APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Proposed Order)(Brazill, Markus) (Entered: 12/11/2019)
2019-12-11
2
SEALED DECLARATION IN SUPPORT OF Second APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal 552 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Brazill, Markus) (Entered: 12/11/2019)
2019-12-11
1
NOTICE OF LODGING filed (Plaintiffs' [Proposed] Amended Verdict Form) re Jury Instructions (Proposed) 436 (Attachments: # 1 Exhibit - Plaintiffs' [Proposed] Amended Verdict Form)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
NOTICE OF LODGING filed (Plaintiffs' [Proposed] Amended Verdict Form) re Jury Instructions (Proposed) 436 (Attachments: # 1 Exhibit - Plaintiffs' [Proposed] Amended Verdict Form)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
2
RESPONSE filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Researchto Objection 548 (Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
NOTICE OF LODGING filed (Notice of Lodging of Non-Paper Exhibit pursuant to L.R. 11-5.1) re Stipulation re: Exhibits Pretrial Trial 410 (Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT re APPLICATION to file document Reply in Support of Motion to Exclude Dr. Mohan Rao's Testimony under seal 367, Reply (Motion related), 366, Sealed Declaration in SupportDeclaration, 368, Order on Motion for Leave to File Document Under Seal 422, Order 443 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit C)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT (Supplemental Opposition to Defendant's Motion in Limine No. 1 and exhibits) re APPLICATION to file document Supplemental Opposition to Defendant's Motion in Limine (No. 1) under seal 389, MEMORANDUM in Opposition to Motion, 388, Sealed Declaration in SupportDeclaration,, 390, Order on Motion for Leave to File Document Under Seal, 446 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 4, # 2 Exhibit 5, # 3 Exhibit 6, # 4 Exhibit 7, # 5 Exhibit 8, # 6 Exhibit 9, # 7 Exhibit 10)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT (Second Supplemental Opposition to Defendant's MIL No. 1 and exhibits) re APPLICATION to file document Second Supplemental Opposition to Defendant's Motion in Limine No. 1 under seal 433, Sealed Declaration in SupportDeclaration, 434, MEMORANDUM in Opposition to Motion, 432, Order on Motion for Leave to File Document Under Seal, 455 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT (Opposition to Ex Parte Application to Strike Opinions of Dr. Sullivan and exhibit) re Sealed Declaration in SupportDeclaration, 441, Memorandum of Points and Authorities in Opposition 439, APPLICATION to file document Opposition to Ex Parte Motion under seal 440, Order on Motion for Leave to File Document Under Seal, 481 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT (Exhibit 1 to Ex Parte Application to Exclude Untimely Opinions of Dr. Mohan Rao) re EX PARTE APPLICATION to Exclude Untimely Opinions of Dr. Mohan Rao 414, Sealed Declaration in SupportDeclaration, 416, APPLICATION to file document Plaintiffs' Ex Parte Application to Exclude Untimely Opinions of Dr. Mohan Rao under seal 415, Order on Motion for Leave to File Document Under Seal 448 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT (Exhibit 17 to Second Amended and Supplemental Complaint) re Amended Complaint/Petition,, 484, Sealed Declaration in SupportDeclaration, 486, APPLICATION to file document Confidential Documents in Connection With Second Amended and Supplemental Complaint for Patent Infringement under seal 485, Order on Motion for Leave to File Document Under Seal 497 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document re to Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal 491, APPLICATION to file document in Support Of Objections to Certain of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker under seal 519, REQUEST to file document Bench Brief Regarding Reference to the Court's Claim Construction Order under seal 511, APPLICATION to file document Exhibits in Support of Response to Plaintiffs Objections and Affirmative Objections to Certain Deposition Designations under seal 503 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research.(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT (Plaintiffs' Replies in support of MILs #2 and #3) re Reply (Motion related), 348, Reply (Motion related), 353, APPLICATION to file document s (Plaintiffs' Replies in support of Motions in Limine #2 and #3) under seal 355, Sealed Declaration in SupportDeclaration,, 356, Order on Motion for Leave to File Document Under Seal 479 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT (Opposition to Ex Parte Application to Strike Complaint and Exhibits) re Sealed Declaration in SupportDeclaration,, 411, APPLICATION to file document s (Plaintiffs' Opposition to Ex Parte Application to Strike Supplemental Complaint and Exhibits) under seal 409, Objection/Opposition (Motion related),, 408, Order on Motion for Leave to File Document Under Seal 447 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT s (Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz and accompanying Exhibit 2) re Sealed Declaration in SupportDeclaration,, 450, EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz 445, APPLICATION to file document s (Memorandum of Points and Authorities in support of Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz and accompanying Exhibit 2) under seal 449, Order on Motion for Leave to File Document Under Seal 482 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1)(Jeffries, Andrea) (Entered: 12/11/2019)
2019-12-11
1
SEALED DOCUMENT Memorandum of Points and Authorities in Support, and Exhibit 1 re EX PARTE APPLICATION to Strike Untimely and Unreliable Opinions of Dr. Sullivan 428, Order on Motion for Leave to File Document Under Seal, 480 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1)(Ling, Vincent) (Entered: 12/11/2019)
2019-12-11
1
SEALED OPPOSITION RE EX PARTE APPLICATION to Exclude Testimony from Dr. Thomas Schuetz 445, Order on Motion for Leave to File Document Under Seal 483 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 3)(Ling, Vincent) (Entered: 12/11/2019)
2019-12-11
1
CERTIFICATE OF SERVICE filed by Defendant Kite Pharma, Inc. re: Sealed Opposition 572, Sealed Document, 571 (Ling, Vincent) (Entered: 12/11/2019)
2019-12-11
1
MINUTES OF Jury Trial - 7th Day held before Judge S. James Otero: Exhibits identified and admitted. Closing arguments made by plaintiff and defendant. Court instructs Jury.Defendant shall complete closing argument to be followed by Plaintiffs rebuttal tomorrow. Jury Trial continued to 12/12/2019 08:30 AM. Court Reporter: Amy Diaz. (lc) (Entered: 12/12/2019)
2019-12-11
1
MINUTES OF Jury Trial - 7th Day held before Judge S. James Otero: Exhibits identified and admitted. Closing arguments made.Defendant shall complete closing argument to be followed by Plaintiffs rebuttal tomorrow. Court instructs Jury. Jury Trial continued to 12/12/2019 08:30 AM. Court Reporter: Amy Diaz. (lc) (Entered: 12/12/2019)
2019-12-11
1
REQUEST for Relief from Improper Closing Argument and for Curative Instruction Pursuant to 35 U.S.C. Section 298 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit 1) (Lawton, Adam) (Entered: 12/12/2019)
2019-12-12
1
REQUEST for Relief from Improper Closing Argument and for Curative Instruction Pursuant to 35 U.S.C. Section 298 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit 1) (Lawton, Adam) (Entered: 12/12/2019)
2019-12-12
2
REQUEST for Relief from Improper Closing Argument and for Curative Instruction Pursuant to 35 U.S.C. Section 298 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration of Adam R. Lawton, # 2 Exhibit 1) (Lawton, Adam) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Markus Brazill re Second APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal 552 filed by Defendant Kite Pharma, Inc.. (Brazill, Markus) (Entered: 12/12/2019)
2019-12-12
1
Second APPLICATION to file document Defendant Kite Pharma, Inc.s Second Application For Leave To File Under Seal Documents Re: Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
1
Second APPLICATION to file document Defendant Kite Pharma, Inc.s Second Application For Leave To File Under Seal Documents Re: Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
SEALED DECLARATION IN SUPPORT OF Second APPLICATION to file document Defendant Kite Pharma, Inc.s Second Application For Leave To File Under Seal Documents Re: Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation under seal 576 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0188, # 2 Exhibit DX0342, # 3 Exhibit DX1869, # 4 Exhibit DX2029, # 5 Exhibit DX2033, # 6 Exhibit DX2063, # 7 Exhibit DX2158)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
1
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
1
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
DECLARATION of Graham Cole re Miscellaneous Document 543 Declaration Of Graham Cole In Support Of Defendant Kite Pharma, Inc.s Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0012, # 2 Exhibit DX0013, # 3 Exhibit DX0018, # 4 Exhibit DX0020, # 5 Exhibit DX0200, # 6 Exhibit DX0945, # 7 Exhibit DX1060, # 8 Exhibit DX1077, # 9 Exhibit DX1106, # 10 Exhibit DX1107, # 11 Exhibit DX1118, # 12 Exhibit DX1730, # 13 Exhibit DX1731, # 14 Exhibit DX2017, # 15 Exhibit DX2061, # 16 Exhibit DX2157)(Cole, Graham) (Entered: 12/12/2019)
2019-12-12
2
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Kite Pharma, Inc Miscellaneous Document 573 . The following error(s) was/were found: Incorrect event selected. Correct event to be used is: Proof of Service (subsequent documents). Other error(s) with document(s): Note: To assist in a search for correct events, please use the "SEARCH" option for a "key word" to narrow the selection process. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 12/12/2019)
2019-12-12
1
NOTICE OF ERRATA filed by Defendant Kite Pharma, Inc.. correcting Sealed Declaration in SupportDeclaration, 577 Sealed Declaration of Graham Cole (Cole, Graham) (Entered: 12/12/2019)
2019-12-12
1
SECOND AMENDED FINAL PRETRIAL CONFERENCE ORDER approved by Judge S. James Otero (lc) (Entered: 12/13/2019)
2019-12-12
1
MINUTES OF Jury Trial - 8th Day held before Judge S. James Otero: Closing arguments made by plaintiff and defendant; Baliff sworn. Jury retires to deliberate. Defendant's motion for mistrial is Denied. Jury Trial continued to 12/13/2019 08:30 AM. Court Reporter: Amy Diaz. (lc) (Entered: 12/13/2019)
2019-12-12
1
Jury Trial - Held and Continued
2019-12-12
1
No Actions
MINUTES (IN CHAMBERS) by Judge S. James Otero:ORDER RE: PARTIES' REQUESTS [ECF Nos. 445, 472, 498, 505, 508, 523, 525, 527, 536, 574]; DEFENDANT'S ORDER OF PROOF [ECF No. 543]; DEFENDANT'S ORAL MOTION FOR MISTRIAL; PARTIES' AMENDED PRETRIAL EXHIBIT STIPULATION [ECF No. 476]. For all of the reasons stated by the Court on the record, the Court has made the following rulings on the parties' requests: The Court DENIES WITHOUT PREJUDICE Plaintiffs' Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz 445 . The Court GRANTS-IN-PART Plaintiffs' Request for a Curative Instruction 472 . The Court read the designated portion of the parties' joint stipulation into the record. The Court DENIES AS MOOT Defendant's Request for a Curative Instruction on Dr. Yashodhara Dash's Improper Testimony 498 . The Court DENIES AS MOOT in light of ECF No. 508 Defendant's Request for Relief for Curative Instruction Regarding Inter Parties Review 505 . The Court GRANTS-IN-PART Defendant's Corrected Request for Curative Instruction Regarding the Inter Partes Review 508 . The Court read the modified instruction and included the modified instruction in the closing instructions. The Court DENIES AS MOOT Plaintiffs' Request to Enter into Evidence Kite's Damages Contentions Admissions 523 . The Court DENIES Defendant's Request to Admit DX48 525 . The Court DENIES Defendant's Request to Strike and to Admit Rebuttal Evidence 527 .The Court GRANTS Plaintiffs' Request for an Order Instructing Defendant to Not Use Certain Terms During Closing Statement 536 . The Court DENIES Defendant's Request for a Curative Instruction Pursuant to 35 U.S.C. § 298 574 .RE: Defendant's Offer of Proof 543, the Court notes the following regarding the length of trial. The Court's view is that Defendant was allotted sufficient time at trial.(see document for detailed discussion). RE: Regarding Defendant's oral Motion for Mistrial on December 12, 2019, the Court does not find that Defendant's Motion for Mistrial bears merit, (see document for detailed discussion). RE: the parties' Amended Pretrial Exhibit Stipulation 476, as noted by the Court at the parties' Pretrial Conference, in order to preserve objections to exhibits, the Court requires parties to state objections on the record during trial. Any objection presented only in the Amended Pretrial Exhibit Stipulation is not preserved. (lc) (Entered: 12/13/2019)
2019-12-13
1
MINUTES OF Jury Trial - 9th Day held and completed before Judge S. James Otero: Verdict reached. Jury FINDS: Plaintiff. Jury polled. Filed witness and exhibit lists, jury notes and jury instructions. Court Reporter: Amy Diaz. (lc) (Entered: 12/13/2019)
2019-12-13
1
REDACTED Jury Notes # 1 filed. (lc) Modified on 12/13/2019 (lc). (Entered: 12/13/2019)
2019-12-13
1
SEALED UNREDACTED Jury Note No. 1 filed re: Jury Notes 1 587 (lc) (Entered: 12/13/2019)
2019-12-13
1
REDACTED Jury Notes # 2 filed. (lc) (Entered: 12/13/2019)
2019-12-13
1
SEALED UNREDACTED Jury Note No. 2 filed (lc) (Entered: 12/13/2019)
2019-12-13
1
JURY INSTRUCTIONS (Given) by Judge S. James Otero. (lc) (Entered: 12/13/2019)
2019-12-13
1
REDACTED JURY VERDICT Filed. (lc) (Entered: 12/17/2019)
2019-12-13
1
SEALED UNREDACTED Jury Verdict filed re: REDACTED Jury Verdict 593 (lc) (Entered: 12/17/2019)
2019-12-13
1
TRIAL EXHIBIT LIST filed. (Attachments: # 1 Part 2)(lc) (Entered: 12/18/2019)
2019-12-13
1
TRIAL EXHIBIT LIST filed. (Attachments: # 1 Part 2)(lc) (Entered: 12/18/2019)
2019-12-13
2
STATUS REPORT [Joint] Regarding Post-Verdict Submissions filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 12/17/2019)
2019-12-17
1
TRANSCRIPT for proceedings held on December 2, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 2, 2019 re Transcript 596 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
TRANSCRIPT for proceedings held on December 3, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 3, 2019 re Transcript 598 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
PARTIAL TRANSCRIPT for proceedings held on December 4, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 4, 2019 re Transcript 600 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
TRANSCRIPT for proceedings held on December 5, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 5, 2019 re Transcript 602 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
TRANSCRIPT for proceedings held on December 6, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 6, 2019 re Transcript 605 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
TRANSCRIPT for proceedings held on December 9, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 9, 2019 re Transcript 607 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
TRANSCRIPT for proceedings held on December 10, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 10, 2019 re Transcript 609 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
TRANSCRIPT for proceedings held on December 11, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 11, 2019 re Transcript 611 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
TRANSCRIPT for proceedings held on December 12, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 12, 2019 re Transcript 613 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
TRANSCRIPT for proceedings held on December 13, 2019. Court Reporter/Electronic Court Recorder: Amy Diaz, phone number amyfcrr@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/8/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/17/2020. (Diaz, Amy) (Entered: 12/18/2019)
2019-12-18
1
NOTICE OF FILING TRANSCRIPT filed for proceedings December 13, 2019 re Transcript 615 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Diaz, Amy) TEXT ONLY ENTRY (Entered: 12/18/2019)
2019-12-18
1
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
1
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
ANSWER to Amended Complaint/Petition,, 484, COUNTERCLAIM against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant and Counterclaimant Kite Pharma, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M)(Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc))(Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
2
APPENDIX filed by Counter Claimant Kite Pharma, Inc., Defendant Kite Pharma, Inc.. Re: Answer to Complaint (Attorney Civil Case Opening),,, Counterclaim,, 617 Redline Version of Kite Pharma, Inc.'s Answer to Plaintiffs' Second Amended Complaint and Counterclaims (Brazill, Markus) (Entered: 12/18/2019)
2019-12-18
1
Notice of Filing Transcript
2019-12-18
1
No Actions
TRANSCRIPT for proceedings held on 11/26/2019 at 9:15 a.m. Court Reporter/Electronic Court Recorder: Myra L. Ponce, CSR, RDR, CRR, e-mail address myraponce@sbcglobal.net. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 1/10/2020. Redacted Transcript Deadline set for 1/21/2020. Release of Transcript Restriction set for 3/19/2020. (Ponce, Myra) (Entered: 12/20/2019)
2019-12-20
1
NOTICE OF FILING TRANSCRIPT filed for proceedings 11/26/2019 at 9:15 a.m. re Transcript 620 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Ponce, Myra) TEXT ONLY ENTRY (Entered: 12/20/2019)
2019-12-20
1
Notice of Filing Transcript
2019-12-20
1
No Actions
ANSWER to Answer to Complaint (Attorney Civil Case Opening),,, Counterclaim,, 617 filed by Plaintiffs and Counterclaim Defendants Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research.(Attorney Andrea Weiss Jeffries added to party Juno Therapeutics, Inc.(pty:cd), Attorney Andrea Weiss Jeffries added to party Sloan Kettering Institute for Cancer Research(pty:cd))(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
1
APPENDIX filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. Re: Answer to Counterclaim, 622 (Redline Version of Plaintiffs and Counterclaim Defendants' Answer to Counterclaims) (Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
1
NOTICE OF LODGING filed (of Proposed Judgment and Proposed Order Setting Post-Trial Briefing Schedule) re Jury Verdict 593, Status Report 595 (Attachments: # 1 Exhibit A - Proposed Judgment, # 2 Exhibit A1 - L.R. 58-7 Memorandum, # 3 Exhibit B - Proposed Order Setting Post-Trial Briefing Schedule, # 4 Memorandum iso Plaintiffs' Proposed Judgment and Post-Trial Briefing Schedule, # 5 Declaration of Andrea W. Jeffries, # 6 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
1
NOTICE OF LODGING filed (of Proposed Judgment and Proposed Order Setting Post-Trial Briefing Schedule) re Jury Verdict 593, Status Report 595 (Attachments: # 1 Exhibit A - Proposed Judgment, # 2 Exhibit A1 - L.R. 58-7 Memorandum, # 3 Exhibit B - Proposed Order Setting Post-Trial Briefing Schedule, # 4 Memorandum iso Plaintiffs' Proposed Judgment and Post-Trial Briefing Schedule, # 5 Declaration of Andrea W. Jeffries, # 6 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
2
NOTICE OF LODGING filed (of Proposed Judgment and Proposed Order Setting Post-Trial Briefing Schedule) re Jury Verdict 593, Status Report 595 (Attachments: # 1 Exhibit A - Proposed Judgment, # 2 Exhibit A1 - L.R. 58-7 Memorandum, # 3 Exhibit B - Proposed Order Setting Post-Trial Briefing Schedule, # 4 Memorandum iso Plaintiffs' Proposed Judgment and Post-Trial Briefing Schedule, # 5 Declaration of Andrea W. Jeffries, # 6 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
2
NOTICE OF LODGING filed (of Proposed Judgment and Proposed Order Setting Post-Trial Briefing Schedule) re Jury Verdict 593, Status Report 595 (Attachments: # 1 Exhibit A - Proposed Judgment, # 2 Exhibit A1 - L.R. 58-7 Memorandum, # 3 Exhibit B - Proposed Order Setting Post-Trial Briefing Schedule, # 4 Memorandum iso Plaintiffs' Proposed Judgment and Post-Trial Briefing Schedule, # 5 Declaration of Andrea W. Jeffries, # 6 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
2
NOTICE OF LODGING filed (of Proposed Judgment and Proposed Order Setting Post-Trial Briefing Schedule) re Jury Verdict 593, Status Report 595 (Attachments: # 1 Exhibit A - Proposed Judgment, # 2 Exhibit A1 - L.R. 58-7 Memorandum, # 3 Exhibit B - Proposed Order Setting Post-Trial Briefing Schedule, # 4 Memorandum iso Plaintiffs' Proposed Judgment and Post-Trial Briefing Schedule, # 5 Declaration of Andrea W. Jeffries, # 6 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
2
NOTICE OF LODGING filed (of Proposed Judgment and Proposed Order Setting Post-Trial Briefing Schedule) re Jury Verdict 593, Status Report 595 (Attachments: # 1 Exhibit A - Proposed Judgment, # 2 Exhibit A1 - L.R. 58-7 Memorandum, # 3 Exhibit B - Proposed Order Setting Post-Trial Briefing Schedule, # 4 Memorandum iso Plaintiffs' Proposed Judgment and Post-Trial Briefing Schedule, # 5 Declaration of Andrea W. Jeffries, # 6 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
2
NOTICE OF LODGING filed (of Proposed Judgment and Proposed Order Setting Post-Trial Briefing Schedule) re Jury Verdict 593, Status Report 595 (Attachments: # 1 Exhibit A - Proposed Judgment, # 2 Exhibit A1 - L.R. 58-7 Memorandum, # 3 Exhibit B - Proposed Order Setting Post-Trial Briefing Schedule, # 4 Memorandum iso Plaintiffs' Proposed Judgment and Post-Trial Briefing Schedule, # 5 Declaration of Andrea W. Jeffries, # 6 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
2
NOTICE OF LODGING filed (of Proposed Judgment and Proposed Order Setting Post-Trial Briefing Schedule) re Jury Verdict 593, Status Report 595 (Attachments: # 1 Exhibit A - Proposed Judgment, # 2 Exhibit A1 - L.R. 58-7 Memorandum, # 3 Exhibit B - Proposed Order Setting Post-Trial Briefing Schedule, # 4 Memorandum iso Plaintiffs' Proposed Judgment and Post-Trial Briefing Schedule, # 5 Declaration of Andrea W. Jeffries, # 6 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
2
NOTICE OF LODGING filed (of Proposed Judgment and Proposed Order Setting Post-Trial Briefing Schedule) re Jury Verdict 593, Status Report 595 (Attachments: # 1 Exhibit A - Proposed Judgment, # 2 Exhibit A1 - L.R. 58-7 Memorandum, # 3 Exhibit B - Proposed Order Setting Post-Trial Briefing Schedule, # 4 Memorandum iso Plaintiffs' Proposed Judgment and Post-Trial Briefing Schedule, # 5 Declaration of Andrea W. Jeffries, # 6 Exhibit 1 to the Declaration of Andrea W. Jeffries, # 7 Exhibit 2 to the Declaration of Andrea W. Jeffries, # 8 Exhibit 3 to the Declaration of Andrea W. Jeffries)(Jeffries, Andrea) (Entered: 12/23/2019)
2019-12-23
2
RESPONSE filed by Defendant Kite Pharma, Inc.to Notice of Lodging,, 624 (Lawton, Adam) (Entered: 12/24/2019)
2019-12-24
1
REQUEST for Order for a Briefing Schedule on Plaintiffs Post-Verdict Motion and Deferring Entry of Judgment filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration Markus Brazill, # 2 Exhibit 1, # 3 Proposed Order) (Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc)) (Brazill, Markus) (Entered: 12/27/2019)
2019-12-27
1
REQUEST for Order for a Briefing Schedule on Plaintiffs Post-Verdict Motion and Deferring Entry of Judgment filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration Markus Brazill, # 2 Exhibit 1, # 3 Proposed Order) (Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc)) (Brazill, Markus) (Entered: 12/27/2019)
2019-12-27
2
REQUEST for Order for a Briefing Schedule on Plaintiffs Post-Verdict Motion and Deferring Entry of Judgment filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration Markus Brazill, # 2 Exhibit 1, # 3 Proposed Order) (Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc)) (Brazill, Markus) (Entered: 12/27/2019)
2019-12-27
2
REQUEST for Order for a Briefing Schedule on Plaintiffs Post-Verdict Motion and Deferring Entry of Judgment filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Declaration Markus Brazill, # 2 Exhibit 1, # 3 Proposed Order) (Attorney Markus A Brazill added to party Kite Pharma, Inc.(pty:cc)) (Brazill, Markus) (Entered: 12/27/2019)
2019-12-27
2
SEALED DECLARATION IN SUPPORT OF Second APPLICATION to file document Defendant Kite Pharma, Inc.s Second Application For Leave To File Under Seal Documents Re: Offer Of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation under seal 576, Second APPLICATION to file document Exhibits In Support Of Its Response To Plaintiffs Request To Admit Kites Responsive Damages Contentions As Evidence under seal 552 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research.(Petersen, Ingrid) (Entered: 12/27/2019)
2019-12-27
1
REPLY filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research to Notice of Lodging,, 624, REQUEST for Order for a Briefing Schedule on Plaintiffs Post-Verdict Motion and Deferring Entry of Judgment 626 (Jeffries, Andrea) (Entered: 12/30/2019)
2019-12-30
1
MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER DENYING WITHOUT PREJUDICE APPLICATIONS TO SEAL 468, 491, 503, 511, 519, 544 (SEE DOCUMENT FOR SPECIFICS).If any of the denied applications are re-filed within five days of entry of this order, no printed chambers copies need be delivered. (lc) (Entered: 01/02/2020)
2020-01-02
1
ORDER GRANTING DEFENDANT KITE PHARMA, INC.S RENEWED APPLICATION FOR LEAVE TO FILE UNDER SEAL EXHIBITS IN SUPPORT OF ITS RESPONSE TO PLAINTIFFS REQUEST TO ADMIT KITES RESPONSIVE DAMAGES CONTENTIONS AS EVIDENCE 552 by Judge S. James Otero (lc) (Entered: 01/02/2020)
2020-01-02
1
ORDER GRANTING DEFENDANT KITE PHARMA, INC.S SECOND APPLICATION FOR LEAVE TO FILE UNDER SEAL DOCUMENTS RE: ITS OFFER OF PROOF REGARDING EVIDENCE EXCLUDED BASED ON SUSTAINED OBJECTIONS OR TIME ALLOCATION 576 by Judge S. James Otero (lc) (Entered: 01/02/2020)
2020-01-02
1
SEALED DOCUMENT Kite Pharma, Inc.'s Sealed Exhibits In Support of Its Response to Plaintiffs Request to Admit Kites Responsive Damages Contentions as Evidence re Response 539, Order on Motion for Leave to File Document Under Seal 630 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Brazill, Markus) (Entered: 01/03/2020)
2020-01-03
1
APPLICATION to file document Exhibit 6 In Support of Its Rule 50(A) Motion under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 6, # 2 Proposed Order)(Brazill, Markus) (Entered: 01/03/2020)
2020-01-03
1
APPLICATION to file document Exhibit 6 In Support of Its Rule 50(A) Motion under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 6, # 2 Proposed Order)(Brazill, Markus) (Entered: 01/03/2020)
2020-01-03
2
APPLICATION to file document Exhibit 6 In Support of Its Rule 50(A) Motion under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 6, # 2 Proposed Order)(Brazill, Markus) (Entered: 01/03/2020)
2020-01-03
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Exhibit 6 In Support of Its Rule 50(A) Motion under seal 633 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 6)(Brazill, Markus) (Entered: 01/03/2020)
2020-01-03
1
SEALED DOCUMENT Defendant Kite Pharma, Inc.s Sealed Exhibits In Support of Its Offer of Proof Regarding Evidence Excluded Based On Sustained Objections Or Time Allocation re Order on Motion for Leave to File Document Under Seal 631, Miscellaneous Document 543 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit DX0188, # 2 Exhibit DX0342, # 3 Exhibit DX1869, # 4 Exhibit DX2029, # 5 Exhibit DX2033, # 6 Exhibit DX2063, # 7 Exhibit DX2158)(Cole, Graham) (Entered: 01/03/2020)
2020-01-03
1
CERTIFICATE OF SERVICE filed by Defendant Kite Pharma, Inc., re Sealed Document, 632 served on January 3, 2020. (Brazill, Markus) (Entered: 01/03/2020)
2020-01-03
1
SCHEDULING NOTICE by Judge S. James Otero. At Defendants request, the Court seals ECF No. 551-7. Defendant shall file a public amended version of ECF No. 551-7 by January 6, 2020. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 01/06/2020)
2020-01-06
1
NOTICE of Intent to Request Redaction from Court Reporter Amy Diaz filed by Defendant Kite Pharma, Inc., re Transcript 607 . (Attachments: # 1 Proposed Order)(Brazill, Markus) (Entered: 01/06/2020)
2020-01-06
1
NOTICE of Intent to Request Redaction from Court Reporter Amy Diaz filed by Defendant Kite Pharma, Inc., re Transcript 607 . (Attachments: # 1 Proposed Order)(Brazill, Markus) (Entered: 01/06/2020)
2020-01-06
2
Text Only Scheduling Notice
2020-01-06
1
No Actions
MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER RE: (1) PLAINTIFFS' MOTION FOR JUDGMENT AS A MATTER OF LAW 550 ; (2) DEFENDANT'S MOTION FOR JUDGMENT AS AMATTER OF LAW 551 ; AND (3) PROPOSED JUDGMENT AND POST-TRIAL BRIEFING SCHEDULE 624 . The Court DENIES AS MOOT Plaintiffs' JMOL 550, DEFERS Defendant's JMOL 551, SETS the parties' post-trial briefing schedule and page limits as noted below and DEFERS entry of judgment 624 . ( SEE DOCUMENT FOR OTHER SPECIFICS). (lc) (Entered: 01/07/2020)
2020-01-07
1
ORDER GRANTING DEFENDANT KITE PHARMA, INC.S REQUEST by Judge S. James Otero, re Notice of Intent to Request Redaction from Court Reporter Amy Diaz 638 (lc) (Entered: 01/07/2020)
2020-01-07
1
ORDER GRANTING DEFENDANT KITE PHARMA, INC.S APPLICATION FOR LEAVE TO FILE UNDER SEAL EXHIBIT 6 IN SUPPORT OF ITS RULE 50(A) MOTION 633 by Judge S. James Otero (lc) (Entered: 01/07/2020)
2020-01-07
1
REDACTED TRANSCRIPT for proceedings held on December 9, 2019, re: Transcript 607 . Redaction Request due 1/30/2020. Redacted Transcript Deadline set for 2/10/2020. Release of Transcript Restriction set for 4/8/2020. (Diaz, Amy) (Entered: 01/09/2020)
2020-01-09
1
EXHIBIT Filed filed by Defendant Kite Pharma, Inc.. in Support of Its Response to Plaintiffs Objection and Affirmative Objections to Certain Deposition Designations as to Response 502 . (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
1
EXHIBIT Filed filed by Defendant Kite Pharma, Inc.. in Support of Its Response to Plaintiffs Objection and Affirmative Objections to Certain Deposition Designations as to Response 502 . (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
EXHIBIT Filed filed by Defendant Kite Pharma, Inc.. in Support of Its Response to Plaintiffs Objection and Affirmative Objections to Certain Deposition Designations as to Response 502 . (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
EXHIBIT Filed filed by Defendant Kite Pharma, Inc.. in Support of Its Response to Plaintiffs Objection and Affirmative Objections to Certain Deposition Designations as to Response 502 . (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
EXHIBIT Filed filed by Defendant Kite Pharma, Inc.. in Support of Its Objections to Certain Of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker as to Objection 518 . (Attachments: # 1 Exhibit 3)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
1
EXHIBIT Filed filed by Defendant Kite Pharma, Inc.. in Support of Its Objections to Certain Of Plaintiffs Proposed Demonstratives for Direct Examination of Dr. Thomas Brocker as to Objection 518 . (Attachments: # 1 Exhibit 3)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. : (Plaintiffs' Unredacted Reply in support of Plaintiffs' Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz) as to Order on Motion for Leave to File Document Under Seal,,,,,,,,,,, 629, Sealed Declaration in SupportDeclaration,, 469, Reply (Motion related), 467, APPLICATION to file document (Reply in support of Plaintiffs' Ex Parte Application to Exclue Testimony from Dr. Thomas Schuetz) under seal 468 . (Attachments: # 1 Exhibit 1)(Jeffries, Andrea) (Entered: 01/14/2020)
2020-01-14
1
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. : (Plaintiffs' Unredacted Reply in support of Plaintiffs' Ex Parte Application to Exclude Testimony from Dr. Thomas Schuetz) as to Order on Motion for Leave to File Document Under Seal,,,,,,,,,,, 629, Sealed Declaration in SupportDeclaration,, 469, Reply (Motion related), 467, APPLICATION to file document (Reply in support of Plaintiffs' Ex Parte Application to Exclue Testimony from Dr. Thomas Schuetz) under seal 468 . (Attachments: # 1 Exhibit 1)(Jeffries, Andrea) (Entered: 01/14/2020)
2020-01-14
2
NOTICE OF LODGING filed Regarding Deposition Excerpts Played During Trial re Transcript (CV),, 609, Transcript (CV),, 607, Redacted Transcript (CV) 642, Transcript (CV),, 605 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
1
NOTICE OF LODGING filed Regarding Deposition Excerpts Played During Trial re Transcript (CV),, 609, Transcript (CV),, 607, Redacted Transcript (CV) 642, Transcript (CV),, 605 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
NOTICE OF LODGING filed Regarding Deposition Excerpts Played During Trial re Transcript (CV),, 609, Transcript (CV),, 607, Redacted Transcript (CV) 642, Transcript (CV),, 605 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
NOTICE OF LODGING filed Regarding Deposition Excerpts Played During Trial re Transcript (CV),, 609, Transcript (CV),, 607, Redacted Transcript (CV) 642, Transcript (CV),, 605 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
NOTICE OF LODGING filed Regarding Deposition Excerpts Played During Trial re Transcript (CV),, 609, Transcript (CV),, 607, Redacted Transcript (CV) 642, Transcript (CV),, 605 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
NOTICE OF LODGING filed Regarding Deposition Excerpts Played During Trial re Transcript (CV),, 609, Transcript (CV),, 607, Redacted Transcript (CV) 642, Transcript (CV),, 605 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
NOTICE OF LODGING filed Regarding Deposition Excerpts Played During Trial re Transcript (CV),, 609, Transcript (CV),, 607, Redacted Transcript (CV) 642, Transcript (CV),, 605 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Brazill, Markus) (Entered: 01/14/2020)
2020-01-14
2
Second APPLICATION to file document re Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, # 2 Proposed Order)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
1
Second APPLICATION to file document re Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, # 2 Proposed Order)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
2
Second APPLICATION to file document re Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Redacted Document Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, # 2 Proposed Order)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
2
SEALED DECLARATION IN SUPPORT OF Second APPLICATION to file document re Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal 647 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, # 2 Unredacted Document Exhibit 1)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
1
EXHIBIT Filed filed by Defendant Kite Pharma, Inc.. in Support of Its Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order as to Objection 489, Declaration, 490 . (Attachments: # 1 Exhibit 3)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
1
EXHIBIT Filed filed by Defendant Kite Pharma, Inc.. in Support of Its Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order as to Objection 489, Declaration, 490 . (Attachments: # 1 Exhibit 3)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
2
NOTICE OF LODGING filed re Kite's Bench Brief Regarding Reference to the Court's Claim Construction Decision re Sealed Declaration in SupportDeclaration, 512 (Attachments: # 1 Bench Brief Regarding Reference to the Court's Claim Construction Decision, # 2 Declaration of Vincent Ling, # 3 Exhibit 1, # 4 Exhibit 2)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
1
NOTICE OF LODGING filed re Kite's Bench Brief Regarding Reference to the Court's Claim Construction Decision re Sealed Declaration in SupportDeclaration, 512 (Attachments: # 1 Bench Brief Regarding Reference to the Court's Claim Construction Decision, # 2 Declaration of Vincent Ling, # 3 Exhibit 1, # 4 Exhibit 2)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
2
NOTICE OF LODGING filed re Kite's Bench Brief Regarding Reference to the Court's Claim Construction Decision re Sealed Declaration in SupportDeclaration, 512 (Attachments: # 1 Bench Brief Regarding Reference to the Court's Claim Construction Decision, # 2 Declaration of Vincent Ling, # 3 Exhibit 1, # 4 Exhibit 2)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
2
NOTICE OF LODGING filed re Kite's Bench Brief Regarding Reference to the Court's Claim Construction Decision re Sealed Declaration in SupportDeclaration, 512 (Attachments: # 1 Bench Brief Regarding Reference to the Court's Claim Construction Decision, # 2 Declaration of Vincent Ling, # 3 Exhibit 1, # 4 Exhibit 2)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
2
NOTICE OF LODGING filed re Kite's Bench Brief Regarding Reference to the Court's Claim Construction Decision re Sealed Declaration in SupportDeclaration, 512 (Attachments: # 1 Bench Brief Regarding Reference to the Court's Claim Construction Decision, # 2 Declaration of Vincent Ling, # 3 Exhibit 1, # 4 Exhibit 2)(Ling, Vincent) (Entered: 01/15/2020)
2020-01-15
2
SEALED DECLARATION IN SUPPORT OF Second APPLICATION to file document re Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order under seal 647 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research.(Jeffries, Andrea) (Entered: 01/15/2020)
2020-01-15
1
ORDER GRANTING KITE PHARMA. INC.S SECOND APPLICATION FOR LEAVE TO FILE UNDER SEAL EXHIBIT 1 IN SUPPORT OF BENCH BRIEF REGARDING REFERENCE TO THE COURTS CLAIM CONSTRUCTION DECISION 647 by Judge S. James Otero (lc) (Entered: 01/17/2020)
2020-01-17
1
SEALED DOCUMENT Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, and Exhibit 1 re Objection 489, Order on Motion for Leave to File Document Under Seal 652 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Kite's Emergency Objections to Plaintiffs' End Run Around Court's Damages-Related Daubert Order, # 2 Exhibit 1)(Ling, Vincent) (Entered: 01/20/2020)
2020-01-20
1
APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document, # 4 Redacted Document, # 5 Redacted Document)(McCarthy, Kevin) (Entered: 01/21/2020)
2020-01-21
1
APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document, # 4 Redacted Document, # 5 Redacted Document)(McCarthy, Kevin) (Entered: 01/21/2020)
2020-01-21
2
APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document, # 4 Redacted Document, # 5 Redacted Document)(McCarthy, Kevin) (Entered: 01/21/2020)
2020-01-21
2
APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document, # 4 Redacted Document, # 5 Redacted Document)(McCarthy, Kevin) (Entered: 01/21/2020)
2020-01-21
2
APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document, # 4 Redacted Document, # 5 Redacted Document)(McCarthy, Kevin) (Entered: 01/21/2020)
2020-01-21
2
APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document, # 3 Redacted Document, # 4 Redacted Document, # 5 Redacted Document)(McCarthy, Kevin) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
1
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of A. Jeffries in support of Consolidated Post-Trial Motion, # 2 Exhibit - 1 (SEALED), # 3 Exhibit - 2 (REDACTED Sullivan Report), # 4 Exhibit - 2A (Jury Verdict Form), # 5 Exhibit - 2AA (SEALED), # 6 Exhibit - 2B (Prime Rate), # 7 Exhibit - 2C (Investopedia), # 8 Exhibit - 2D (Sidak 2016), # 9 Exhibit - 2E (BMS Press Release), # 10 Exhibit - 2F (Gilead Press Release), # 11 Exhibit - 2G (clinicaltrials.gov), # 12 Exhibit - 2H (Wiezorek Depo Excerpts), # 13 Exhibit - 2I (SEALED), # 14 Exhibit - 2J (SEALED), # 15 Exhibit - 2K (SEALED), # 16 Exhibit - 2L (Amaroso Depo), # 17 Exhibit - 2M (Gilead 2017 10-K), # 18 Exhibit - 2N (Gilead 2018 10-K), # 19 Exhibit - 2O (Gilead 2019 10-Q), # 20 Exhibit - 2P (GILD Stick Quote), # 21 Exhibit - 2Q (SEALED), # 22 Exhibit - 2R (SEALED), # 23 Exhibit - 2S (SEALED), # 24 Exhibit - 2T (SEALED), # 25 Exhibit - 2U (SEALED), # 26 Exhibit - 2V (Monthly Prime Rates), # 27 Exhibit - 2W (SEALED), # 28 Exhibit - 2X (SEALED), # 29 Exhibit - 2Y (Kite 2016 10-K), # 30 Exhibit - 2Z (Kite 2017 10-Q), # 31 Exhibit - 3 (SEALED), # 32 Exhibit - 4 (PX0002 Excerpts), # 33 Exhibit - 5 (PX718), # 34 Exhibit - 6 (PX1185), # 35 Exhibit - 7 (SEALED), # 36 Exhibit - 8 (SEALED), # 37 Exhibit - 9 (SEALED), # 38 Exhibit - 10 (SEALED), # 39 Exhibit - 11 (SEALED), # 40 Exhibit - 12 (SEALED), # 41 Exhibit - 13 (PX0002 Excerpts), # 42 Exhibit - 14 (SEALED), # 43 Exhibit - 15 (PX0026), # 44 Exhibit - 16 (Belldegrun Depo), # 45 Exhibit - 17 (DX0239c Excerpt), # 46 Exhibit - 18 (SEALED), # 47 Exhibit - 19 (SEALED), # 48 Exhibit - 20 (PX240 Excerpt), # 49 Exhibit - 21 (SEALED), # 50 Exhibit - 22 (Schuetz Depo), # 51 Exhibit - 23 (Gilead 2017 10-Q Excerpt), # 52 Exhibit - 24 (Gilead 2019 10-Q Excerpt), # 53 Exhibit - 25 (Law 360 Article), # 54 Exhibit - 26 (PX0072), # 55 Exhibit - 27 (BMS Press Release), # 56 Exhibit - 28 (Gilead Press Release), # 57 Exhibit - 29 (Wiezorek Depo), # 58 Exhibit - 30 (ClinicalTrials.gov)) (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
MEMORANDUM in Support of NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 [REDACTED] filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal 654 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Memorandum, # 2 Unredacted Document Proposed Judgment, # 3 Unredacted Document Rule 58-7 Memorandum, # 4 Unredacted Document Exhibit 1, # 5 Unredacted Document Exhibit 2, # 6 Unredacted Document Exhibit 2-I, # 7 Unredacted Document Exhibit 2-J, # 8 Unredacted Document Exhibit 2-K, # 9 Unredacted Document Exhibit 2-Q, # 10 Unredacted Document Exhibit 2-R, # 11 Unredacted Document Exhibit 2-S, # 12 Unredacted Document Exhibit 2-T, # 13 Unredacted Document Exhibit 2-U, # 14 Unredacted Document Exhibit 2-W, # 15 Unredacted Document Exhibit 2-X, # 16 Unredacted Document Exhibit 2-AA, # 17 Unredacted Document Exhibit 3, # 18 Unredacted Document Exhibit 7, # 19 Unredacted Document Exhibit 8, # 20 Unredacted Document Exhibit 9, # 21 Unredacted Document Exhibit 10, # 22 Unredacted Document Exhibit 11, # 23 Unredacted Document Exhibit 12, # 24 Unredacted Document Exhibit 14, # 25 Unredacted Document Exhibit 18, # 26 Unredacted Document Exhibit 19, # 27 Unredacted Document Exhibit 21)(McCarthy, Kevin) (Entered: 01/21/2020)
2020-01-21
1
PROPOSED JUDGMENT re NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 [REDACTED] filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum - Local Rule 58-7 Memo re Pre- and Post-Judgment Interest [REDACTED])(Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
1
PROPOSED JUDGMENT re NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 [REDACTED] filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum - Local Rule 58-7 Memo re Pre- and Post-Judgment Interest [REDACTED])(Jeffries, Andrea) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law, NOTICE OF MOTION AND MOTION for Judgment NOV, NOTICE OF MOTION AND MOTION for New Trial filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Affidavit of Patrick E. Odell, # 2 Affidavit of Blanca Young, # 3 Declaration of Peter E. Gratzinger, # 4 Exhibit 1, # 5 Exhibit 2) (Lawton, Adam) (Entered: 01/21/2020)
2020-01-21
1
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law, NOTICE OF MOTION AND MOTION for Judgment NOV, NOTICE OF MOTION AND MOTION for New Trial filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Affidavit of Patrick E. Odell, # 2 Affidavit of Blanca Young, # 3 Declaration of Peter E. Gratzinger, # 4 Exhibit 1, # 5 Exhibit 2) (Lawton, Adam) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law, NOTICE OF MOTION AND MOTION for Judgment NOV, NOTICE OF MOTION AND MOTION for New Trial filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Affidavit of Patrick E. Odell, # 2 Affidavit of Blanca Young, # 3 Declaration of Peter E. Gratzinger, # 4 Exhibit 1, # 5 Exhibit 2) (Lawton, Adam) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law, NOTICE OF MOTION AND MOTION for Judgment NOV, NOTICE OF MOTION AND MOTION for New Trial filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Affidavit of Patrick E. Odell, # 2 Affidavit of Blanca Young, # 3 Declaration of Peter E. Gratzinger, # 4 Exhibit 1, # 5 Exhibit 2) (Lawton, Adam) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law, NOTICE OF MOTION AND MOTION for Judgment NOV, NOTICE OF MOTION AND MOTION for New Trial filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Affidavit of Patrick E. Odell, # 2 Affidavit of Blanca Young, # 3 Declaration of Peter E. Gratzinger, # 4 Exhibit 1, # 5 Exhibit 2) (Lawton, Adam) (Entered: 01/21/2020)
2020-01-21
2
NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law, NOTICE OF MOTION AND MOTION for Judgment NOV, NOTICE OF MOTION AND MOTION for New Trial filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Affidavit of Patrick E. Odell, # 2 Affidavit of Blanca Young, # 3 Declaration of Peter E. Gratzinger, # 4 Exhibit 1, # 5 Exhibit 2) (Lawton, Adam) (Entered: 01/21/2020)
2020-01-21
2
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,,,,, 657 served on January 21, 2020. (McCarthy, Kevin) (Entered: 01/21/2020)
2020-01-21
1
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
1
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
DECLARATION of Markus Brazill NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX0503, # 2 DX0731, # 3 DX0766, # 4 DX0811c, # 5 DX0936c, # 6 DX1054, # 7 DX1795, # 8 DX2004, Part 1, # 9 DX2004, Part 2, # 10 DX2004, Part 3, # 11 DX2011c, # 12 DX2093, # 13 DX2149c, # 14 DX2160, # 15 PX0001, # 16 PX0002, Part 1, # 17 PX0002, Part 2, # 18 PX0040, # 19 PX0041, # 20 PX0072, # 21 PX0241, Part 1, # 22 PX0241, Part 2, # 23 PX0401, # 24 PX0924, # 25 PX0928, # 26 PX1032, # 27 PX1185, # 28 PX1304, # 29 PX1305, # 30 PX1306)(Brazill, Markus) (Entered: 01/21/2020)
2020-01-21
2
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE:Juno Therapeutics, Inc., Sloan Kettering Institute Motion Related Document, 658 . The following error(s) was/were found: Proposed Document was not submitted as separate attachment. Other error(s) with document(s): pdf document is a proposed judgment, which should have been submitted as a separate attachment. As an alternative, prepare and e-file a formal Notice of Lodging, to be docketed only under its specific event: Notice of Lodging, to which the formal proposed order is submitted as Separate Attachment thereto.. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 01/22/2020)
2020-01-22
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Kite Pharma, Inc NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 . The following error(s) was/were found: Hearing information is missing, incorrect, or not timely. Other error(s) with document(s): Motion not set for hearing on Judge's moiton calender; Missing formal LR 6.1 formal Notice of Motion text re hearing date, time, Judge and courtroom, information. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 01/22/2020)
2020-01-22
1
DECLARATION of Katharine Rice in Support of APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal 654 filed by Defendant Kite Pharma, Inc.. (Ling, Vincent) (Entered: 01/27/2020)
2020-01-27
1
ORDER GRANTING-IN-PART PLAINTIFFS APPLICATION TO FILE DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS CONSOLIDATED POST-TRIAL MOTION 654 by Judge S. James Otero (lc) (Entered: 01/31/2020)
2020-01-30
1
PARTIAL TRANSCRIPT for proceedings held on 12/04/2019 1:00 p.m.. Court Reporter/Electronic Court Recorder: Terri Hourigan, phone number hourigan.terri@gmail.com. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Electronic Court Recorder before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Notice of Intent to Redact due within 7 days of this date. Redaction Request due 2/24/2020. Redacted Transcript Deadline set for 3/3/2020. Release of Transcript Restriction set for 5/1/2020. (Hourigan, Terri) (Entered: 02/01/2020)
2020-02-01
1
NOTICE OF CLERICAL ERROR: Due to clerical error Re: Transcript (CV),, 509 (Hourigan, Terri) (Entered: 02/01/2020)
2020-02-01
1
NOTICE OF FILING TRANSCRIPT filed for proceedings 12/4/2019 1:00 p.m. re Transcript 666 THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (Hourigan, Terri) TEXT ONLY ENTRY (Entered: 02/01/2020)
2020-02-01
1
Notice of Filing Transcript
2020-02-02
1
No Actions
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
1
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Order on Motion for Leave to File Document Under Seal 665, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 . (Attachments: # 1 Exhibit 3, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 14, # 9 Exhibit 18, # 10 Exhibit 19, # 11 Exhibit 21)(Burton, Luke) (Entered: 02/09/2020)
2020-02-09
2
Notice of Appearance or Withdrawal of Counsel: for attorney Kevin V McCarthy counsel for Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. Christopher J. Harnett is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, and Sloan Kettering Institute for Cancer Research. (McCarthy, Kevin) (Entered: 02/10/2020)
2020-02-10
1
OBJECTIONS to Motion Related Document,, 658 Plaintiffs' Proposed Final Judgment filed by Defendant Kite Pharma, Inc., Counter Claimant Kite Pharma, Inc.. (Brazill, Markus) (Entered: 02/10/2020)
2020-02-10
1
APPLICATION to file document Opposition to Plaintiffs' Post-Trial Motion and Documents in Support under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Plaintiffs' Post-Trial Motion)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
1
APPLICATION to file document Opposition to Plaintiffs' Post-Trial Motion and Documents in Support under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Plaintiffs' Post-Trial Motion)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
APPLICATION to file document Opposition to Plaintiffs' Post-Trial Motion and Documents in Support under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Opposition to Plaintiffs' Post-Trial Motion)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
1
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28, # 30 Exhibit 29, # 31 Exhibit 30, # 32 Exhibit 31, # 33 Exhibit 32, # 34 Exhibit 33, # 35 Exhibit 34, # 36 Exhibit 35, # 37 Exhibit 36, # 38 Exhibit 37, # 39 Exhibit 38, # 40 Exhibit 39, # 41 Exhibit 40, # 42 Exhibit 41, # 43 Exhibit 42, # 44 Exhibit 43, # 45 Exhibit 44)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Opposition to Plaintiffs' Post-Trial Motion and Documents in Support under seal 672 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Declaration of Mohan Rao, Ph.D., # 2 Unredacted Document Exhibit 2, # 3 Unredacted Document Exhibit 3, # 4 Unredacted Document Exhibit 4, # 5 Unredacted Document Exhibit 5, # 6 Unredacted Document Exhibit 6, # 7 Unredacted Document Exhibit 14, # 8 Unredacted Document Exhibit 15, # 9 Unredacted Document Exhibit 16, # 10 Unredacted Document Exhibit 17, # 11 Unredacted Document Exhibit 18, # 12 Unredacted Document Exhibit 19, # 13 Unredacted Document Exhibit 20, # 14 Unredacted Document Exhibit 21, # 15 Unredacted Document Exhibit 22, # 16 Unredacted Document Exhibit 23, # 17 Unredacted Document Exhibit 24, # 18 Unredacted Document PX156, # 19 Unredacted Document DX2011c, # 20 Unredacted Document Opposition to Plaintiffs' Post-Trial Motion)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
1
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
1
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Graham Cole in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 7, # 3 Exhibit 8, # 4 Exhibit 9, # 5 Exhibit 10, # 6 Exhibit 11, # 7 Exhibit 12, # 8 Exhibit 13, # 9 PX14, # 10 PX39, # 11 PX140, # 12 PX718, # 13 PX782, # 14 PX1205, # 15 PX1286, # 16 PX1287, # 17 DX595)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
DECLARATION of Brian Sander in Opposition to NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
1
DECLARATION of Samantak Ghosh in Support of APPLICATION to file document Opposition to Plaintiffs' Post-Trial Motion and Documents in Support under seal 672 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
1
APPLICATION to file document Exhibit 41 to the Declaration of Andrea W. Jeffries under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Exhibit 41)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
1
APPLICATION to file document Exhibit 41 to the Declaration of Andrea W. Jeffries under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Exhibit 41)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
APPLICATION to file document Exhibit 41 to the Declaration of Andrea W. Jeffries under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Exhibit 41)(Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Exhibit 41 to the Declaration of Andrea W. Jeffries under seal 678 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Exhibit 41 to the Declaration of Andrea W. Jeffries)(Attorney Luke J Burton added to party Juno Therapeutics, Inc.(pty:cd), Attorney Luke J Burton added to party Sloan Kettering Institute for Cancer Research(pty:cd))(Burton, Luke) (Entered: 02/10/2020)
2020-02-10
1
Second APPLICATION to file document Documents in Support of Opposition to Plaintiffs' Post-Trial Motion under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
1
Second APPLICATION to file document Documents in Support of Opposition to Plaintiffs' Post-Trial Motion under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
2
CERTIFICATE OF SERVICE filed by Defendant Kite Pharma, Inc., re Sealed Declaration in SupportDeclaration,,,, 674 served on 2/10/2020. (Lawton, Adam) (Entered: 02/10/2020)
2020-02-10
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,, 679 served on 02/10/2020. (Burton, Luke) (Entered: 02/10/2020)
2020-02-10
1
Corrected OPPOSITION re: NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
1
NOTICE OF ERRATA filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. correcting Objection/Opposition (Motion related),,,,, 673 (Jeffries, Andrea) (Entered: 02/10/2020)
2020-02-10
1
SEALED DOCUMENT Memorandum in support of Plaintiffs' Consolidated Post-Trial Motion and Supporting Exhibits re Memorandum in Support of Motion, 656, APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal 654, NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655, Sealed Declaration in SupportDeclaration,,,,, 657, Order on Motion for Leave to File Document Under Seal 665 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 2-I, # 4 Exhibit 2-J, # 5 Exhibit 2-K, # 6 Exhibit 2-Q, # 7 Exhibit 2-R, # 8 Exhibit 2-S, # 9 Exhibit 2-T, # 10 Exhibit 2-U, # 11 Exhibit 2-W, # 12 Exhibit 2-X, # 13 Exhibit 2-AA)(Jeffries, Andrea) (Entered: 02/11/2020)
2020-02-11
1
SEALED DOCUMENT Plaintiffs' Proposed Judgment and Rule 58-7 Memorandum re Sealed Declaration in SupportDeclaration,,,,, 657, Motion Related Document,, 658, APPLICATION to file document Plaintiffs' Memorandum and Supporting Documents under seal 654, Order on Motion for Leave to File Document Under Seal 665 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Memorandum Rule 58-7 Memorandum)(Jeffries, Andrea) (Entered: 02/11/2020)
2020-02-11
1
NOTICE OF ERRATA filed by Defendant Kite Pharma, Inc.. correcting Sealed Declaration in SupportDeclaration,,,, 674 (Cole, Graham) (Entered: 02/13/2020)
2020-02-13
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Opposition to Plaintiffs' Post-Trial Motion and Documents in Support under seal 672 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research.(Burton, Luke) (Entered: 02/14/2020)
2020-02-14
1
MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER RE: PLAINTIFFS' APPLICATION TO FILE DOCUMENTS UNDER SEAL IN CONNECTION WITH PLAINTIFFS OPPOSITION TO DEFENDANT'S MOTION FOR JMOL AND/OR A NEW TRIAL 678 . Local Rule 79-5.2.2(b)(i) required Defendant to file a declaration by February 14, 2020, showing good cause or demonstrating compelling reasons why the strong presumption of public access in civil cases should be overcome and Exhibit 41 sealed. Given Defendant did not file a declaration, and given Exhibit 41 was admitted and used during a public portion of trial, the Court DENIES Plaintiffs' Application. (lc) (Entered: 02/18/2020)
2020-02-18
1
ORDER GRANTING KITE PHARMA, INC.S APPLICATIONS FOR LEAVE TO FILE UNDER SEAL DOCUMENTS IN SUPPORT OF OPPOSITION TO PLAINTIFFS CONSOLIDATED POST-TRIAL MOTION 680 by Judge S. James Otero (lc) (Entered: 02/19/2020)
2020-02-18
1
NOTICE OF ERRATA filed by Defendant Kite Pharma, Inc.. correcting NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 (Attachments: # 1 Exhibit Redline)(Cole, Graham) (Entered: 02/20/2020)
2020-02-20
1
NOTICE OF ERRATA filed by Defendant Kite Pharma, Inc.. correcting NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 (Attachments: # 1 Exhibit Redline)(Cole, Graham) (Entered: 02/20/2020)
2020-02-20
2
DEFENDANT KITE PHARMA, INC.S CORRECTED MEMORANDUM IN SUPPORT OF MOTION FOR JUDGMENT AS A MATTER OF LAW PURSUANT TO FED. R. CIV. P. 50(B) AND/OR A NEW TRIAL PURSUANT TO FED. R. CIV. P. 59 re NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Cole, Graham) (Entered: 02/20/2020)
2020-02-20
1
SEALED OPPOSITION RE NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655, Order on Motion for Leave to File Document Under Seal, 690 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 14, # 7 Exhibit 15, # 8 Exhibit 16, # 9 Exhibit 17, # 10 Exhibit 18, # 11 Exhibit 19, # 12 Exhibit 20, # 13 Exhibit 21, # 14 Exhibit 22, # 15 Exhibit 23, # 16 Exhibit 24, # 17 PX156, # 18 DX2011c, # 19 Declaration of Mohan Rao, # 20 Certificate of Service)(Lawton, Adam) (Entered: 02/20/2020)
2020-02-20
1
REPLY in support of NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
1
REPLY in support of NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
REPLY in support of NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
REPLY in support of NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
REPLY in support of NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
REPLY in support of NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
REPLY in support of NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
REPLY in support of NOTICE OF MOTION AND MOTION for Damages (Through Trial, Pre-judgment Interest, Enhanced Damages, and Ongoing Royalties) 655 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Declaration of Andrea W. Jeffries, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
REPLY filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research to Objection 671 (Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
1
APPLICATION to file document Reply in support of Plaintiffs' Consolidated Post-Trial Motion under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Redacted Reply in support of Plaintiffs' Consolidated Post-Trial Motion)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
1
APPLICATION to file document Reply in support of Plaintiffs' Consolidated Post-Trial Motion under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Redacted Reply in support of Plaintiffs' Consolidated Post-Trial Motion)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
APPLICATION to file document Reply in support of Plaintiffs' Consolidated Post-Trial Motion under seal filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order, # 2 Redacted Document Redacted Reply in support of Plaintiffs' Consolidated Post-Trial Motion)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document Reply in support of Plaintiffs' Consolidated Post-Trial Motion under seal 696 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Unredacted Document Reply in support of Plaintiffs' Consolidated Post-Trial Motion)(Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
1
CERTIFICATE OF SERVICE filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, re Sealed Declaration in SupportDeclaration,, 697 served on 02/24/2020. (Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
1
APPLICATION to file document re: Reply in Support of Motion for JMOL and/or a New Trial under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion for JMOL and/or a New Trial)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
1
APPLICATION to file document re: Reply in Support of Motion for JMOL and/or a New Trial under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion for JMOL and/or a New Trial)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
APPLICATION to file document re: Reply in Support of Motion for JMOL and/or a New Trial under seal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order, # 2 Redacted Document Reply in Support of Motion for JMOL and/or a New Trial)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document re: Reply in Support of Motion for JMOL and/or a New Trial under seal 699 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Unredacted Document Reply in Support of Motion for JMOL and/or a New Trial, # 2 Unredacted Document DX125c)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
1
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
1
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Markus Brazill in Support of NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 DX302, # 4 DX573, # 5 DX954c, # 6 PX106, # 7 PX107, # 8 PX304, # 9 PX707, # 10 PX1011, # 11 PX1017, # 12 PX1029, # 13 PX1041)(Lawton, Adam) (Entered: 02/24/2020)
2020-02-24
2
APPLICATION for Costs against Kite Pharma, Inc. filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Proposed Order) (Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
1
APPLICATION for Costs against Kite Pharma, Inc. filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Proposed Order) (Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
APPLICATION for Costs against Kite Pharma, Inc. filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Proposed Order) (Jeffries, Andrea) (Entered: 02/24/2020)
2020-02-24
2
DECLARATION of Samantak Ghosh re APPLICATION to file document Reply in support of Plaintiffs' Consolidated Post-Trial Motion under seal 696, APPLICATION to file document re: Reply in Support of Motion for JMOL and/or a New Trial under seal 699 filed by Defendant Kite Pharma, Inc.. (Cole, Graham) (Entered: 02/26/2020)
2020-02-26
1
Opposition to re: APPLICATION for Costs against Kite Pharma, Inc. 702 filed by Defendant Kite Pharma, Inc.. (Brazill, Markus) (Entered: 02/26/2020)
2020-02-26
1
SEALED DECLARATION IN SUPPORT OF APPLICATION to file document re: Reply in Support of Motion for JMOL and/or a New Trial under seal 699 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research.(Burton, Luke) (Entered: 02/27/2020)
2020-02-27
1
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Objection/Opposition (Motion related),,,,, 673, Order on Motion for Leave to File Document Under Seal,, 689 . (Attachments: # 1 Exhibit 41)(Burton, Luke) (Entered: 02/27/2020)
2020-02-27
1
EXHIBIT Filed filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research. as to Objection/Opposition (Motion related),,,,, 673, Order on Motion for Leave to File Document Under Seal,, 689 . (Attachments: # 1 Exhibit 41)(Burton, Luke) (Entered: 02/27/2020)
2020-02-27
2
ORDER GRANTING PLAINTIFFS APPLICATION TO FILE DOCUMENTS UNDER SEAL INCONNECTION WITH PLAINTIFFS REPLY IN SUPPORT OF PLAINTIFFS CONSOLIDATEDPOST-TRIAL MOTION 696 by Judge S. James Otero (lc) (Entered: 03/03/2020)
2020-03-03
1
ORDER GRANTING DEFENDANT KITE PHARMA, INC.S APPLICATION FOR LEAVE TO FILE UNDER SEAL RE: REPLY IN SUPPORT OF MOTION FOR JUDGMENT AS A MATTER OF LAW PURSUANT TOFED. R. CIV. P. 50(B) AND/OR A NEW TRIAL PURSUANT TO FED. R. CIV. P. 59 699 by Judge S. James Otero (lc) (Entered: 03/03/2020)
2020-03-03
1
SEALED REPLY RE NOTICE OF MOTION AND MOTION for Judgment as a Matter of Law NOTICE OF MOTION AND MOTION for Judgment NOV NOTICE OF MOTION AND MOTION for New Trial 659, Order on Motion for Leave to File Document Under Seal, 708 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 DX125c)(Lawton, Adam) (Entered: 03/03/2020)
2020-03-03
1
CERTIFICATE OF SERVICE filed by Defendant Kite Pharma, Inc., re Sealed Reply, 709 served on 3/3/2020. (Lawton, Adam) (Entered: 03/03/2020)
2020-03-03
1
REPLY In Support Of APPLICATION for Costs against Kite Pharma, Inc. 702 filed by Plaintiffs Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research. (Jeffries, Andrea) (Entered: 03/03/2020)
2020-03-03
1
SEALED DOCUMENT Reply in support of Plaintiffs' Consolidated Post-Trial Motion re Reply (Motion related),, 694, Order on Motion for Leave to File Document Under Seal 707 filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Counter Defendants Juno Therapeutics, Inc., Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research, Sloan Kettering Institute for Cancer Research.(Jeffries, Andrea) (Entered: 03/06/2020)
2020-03-06
1
NOTICE of Supplemental Authority filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit A)(Jeffries, Andrea) (Entered: 03/10/2020)
2020-03-10
1
NOTICE of Supplemental Authority filed by Plaintiffs Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Exhibit A)(Jeffries, Andrea) (Entered: 03/10/2020)
2020-03-10
2
MINUTE ORDER IN CHAMBERS by Judge S. James Otero:The Court denies Dkt. 626 as moot in light of Dkt. 639 . (lc) Modified on 3/11/2020 (lc). (Entered: 03/11/2020)
2020-03-11
1
RESPONSE filed by Defendant Kite Pharma, Inc.to Notice (Other) 713 Kite Pharma, Inc.s Response To Plaintiffs Notice of Supplemental Authority (Cole, Graham) (Entered: 03/12/2020)
2020-03-12
1
(UNSEALED PER 3/30/2020 MINUTES, DOCKET NO. 719). UNDER SEAL MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER RE: DEFENDANT'S MOTION FOR JUDGMENT AS A MATTER OF LAW PURSUANT TO FED. R. CIV. P. 50(B) AND/OR A NEW TRIAL PURSUANT TO FED. R. CIV. P. 59 (ECF No. 659). (lc) Modified on 3/30/2020 (lc). (Entered: 03/24/2020)
2020-03-24
1
JOINT REPORT of the Parties Regarding ECF No. 716 filed by Defendant Kite Pharma, Inc. re: Order on Motion for Judgment as a Matter of Law,, Order on Motion for Judgment Not Withstanding the Verdict (JNOV),, Order on Motion for New Trial, 716 (Ling, Vincent) (Entered: 03/27/2020)
2020-03-27
1
NOTICE TO FILER OF DEFICIENCIES in Electronically Filed Documents RE: Miscellaneous Document, 717 . The following error(s) was/were found: Incorrect event selected. Correct event to be used is: status report. Other error(s) with document(s): Note: To assist in a search for correct events, please use the "SEARCH" option for a "key word" to narrow the selection process. In response to this notice, the Court may: (1) order an amended or correct document to be filed; (2) order the document stricken; or (3) take other action as the Court deems appropriate. You need not take any action in response to this notice unless and until the Court directs you to do so. (lc) (Entered: 03/30/2020)
2020-03-30
1
MINUTE ORDER IN CHAMBERS by Judge S. James Otero:The Court directs the Clerks office to UNSEAL document ECF No. 716. (lc) (Entered: 03/30/2020)
2020-03-30
1
SEALED -UNDER SEAL MINUTES (IN CHAMBERS)ORDER RE PLAINTIFFS CONSOLIDATED POST TRIAL MOTION by Judge S. James Otero (lc) (Entered: 04/02/2020)
2020-04-02
1
MINUTES (IN CHAMBERS) by Judge S. James Otero: ORDER RE: PLAINTIFFS' APPLICATION FOR COSTS OF VISUAL AIDS PURSUANT TO CIVIL LOCAL RULE 54-3.12 702 . The Court GRANTS Plaintiffs' Application for Costs of Visual Aids Pursuant to Civil Local Rule 54-3.12. The Court approves Plaintiffs' taxation for costs for visualaids in the amount of $190,677.15. (lc) (Entered: 04/02/2020)
2020-04-02
1
SCHEDULING NOTICE by Judge S. James Otero. The Court requests the parties jointly file by April 7, 2020 an updated version of Plaintiffs Proposed Final Judgment (ECF No. 658). The only revisions shall be to figures, based on the Courts Order re Plaintiffs Consolidated Post-Trial Motion for Damages. Specifically, the amounts listed in Sections 6(2) and 6(3) should be revised, the interest rate in Section 7 should be entered, and the royalty in Section 8 should be revised, all assuming Final Judgment will be entered on April 8, 2020. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (vcr) TEXT ONLY ENTRY (Entered: 04/02/2020)
2020-04-02
1
ORDER OF THE CHIEF JUDGE (#20-60) approved by Judge Virginia A. Phillips. IT IS ORDERED, with the concurrence of the Case Management and Assignment Committee, that the following cases be reassigned from the calendar of Judge S. James Otero to the calendar of Judge Philip S. Gutierrez for all further proceedings. The case number will now reflect the initials of the transferee Judge 2:17-cv-07639 PSG (KSx). (mrgo) (Entered: 04/03/2020)
2020-04-02
1
MINUTE ORDER (in chambers): ORDER RE: PLAINTIFFS' CONSOLIDATED POST-TRIAL MOTION [ECF No. 655] by Judge Philip S. Gutierrez: For the foregoing reasons, the Court GRANTS-IN-PART Plaintiffs' Consolidated Post-Trial Motion [ECF No. 655]. Specifically, the following is held: (1) Plaintiffs are awarded $778,343,501 on the jury verdict for Defendant's infringement from October 18, 2017 through December 12, 2019; (2) The Treasury bill rate, compounded quarterly, is awarded for prejudgment interest, which shall not apply to the enhancement award; (3) The damages award is enhanced by 50 percent; and (4) A 27.6 percent running royalty is awarded. Final Judgment to follow. IT IS SO ORDERED. (bm) (Entered: 04/08/2020)
2020-04-02
1
Text Only Scheduling Notice
2020-04-02
1
No Actions
NOTICE TO PARTIES OF COURT-DIRECTED ADR PROGRAM filed. (wm) (Entered: 04/06/2020)
2020-04-06
1
STATUS REPORT of the Parties Regarding ECF No. 720 filed by Defendant Kite Pharma, Inc.. (Ling, Vincent) (Entered: 04/07/2020)
2020-04-07
1
NOTICE OF LODGING filed re Text Only Scheduling Notice,, 722 (Attachments: # 1 Proposed Order Proposed Final Judgment)(Jeffries, Andrea) (Entered: 04/07/2020)
2020-04-07
1
NOTICE OF LODGING filed re Text Only Scheduling Notice,, 722 (Attachments: # 1 Proposed Order Proposed Final Judgment)(Jeffries, Andrea) (Entered: 04/07/2020)
2020-04-07
2
FINAL JUDGMENT by Judge Philip S. Gutierrez, in favor of Juno Therapeutics, Inc., Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute for Cancer Research against Kite Pharma, Inc.: NOW THEREFORE, IT IS ORDERED, ADJUDGED, AND DECREED THAT JUDGMENT IS HEREBY ENTERED IN THIS MATTER AS FOLLOWS: Kite has infringed claims 3, 5, 9, and 11 of United States Patent No. 7,446,190. Judgment is entered against Kite on its counterclaims of non-infringement and invalidity. Plaintiffs shall recover: (1) $778,343,501 on the jury verdict, comprising (a) a $585,000,000 upfront payment; and (b) $193,343,501, calculated as a 27.6 percent running royalty on each of (i) Kite's net revenues from sales o Yescarta from October 18, 2017 through September 30, 2019, which were $603,650,765; and (ii) Kite's net revenues from sales of Yescarta from October 1, 2019 to December 12, 2019, which were $96,869,167; (2) pre-judgment interest on the jury's verdict in the amount of $32,807,300, and (3) enhanced damages of $389,171,750.50. (see document for further details) (bm) (Entered: 04/08/2020)
2020-04-08
1
REPORT ON THE DETERMINATION OF AN ACTION Regarding a Patent or Trademark. (Closing) (bm) (Entered: 04/09/2020)
2020-04-09
1
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
1
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
APPLICATION to the Clerk to Tax Costs against Defendant Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
1
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc. re: Judgment,,,, 728, Order on Motion for Costs, 721, filed by Plaintiffs Sloan Kettering Institute for Cancer Research, Juno Therapeutics, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C.1, # 4 Exhibit C.2, # 5 Exhibit D.1, # 6 Exhibit D.2, # 7 Exhibit D.3, # 8 Exhibit E.1, # 9 Exhibit E.2, # 10 Exhibit E.3, # 11 Exhibit E.4, # 12 Exhibit E.5, # 13 Exhibit E.6, # 14 Exhibit F.1, # 15 Exhibit F.2) (Jeffries, Andrea) (Entered: 04/13/2020)
2020-04-13
2
Joint STIPULATION for Extension of Time to File Ongoing Royalty Reporting Procedure Pursuant to Paragraph 8 of the Judgment filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 04/17/2020)
2020-04-17
1
Joint STIPULATION for Extension of Time to File Ongoing Royalty Reporting Procedure Pursuant to Paragraph 8 of the Judgment filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 04/17/2020)
2020-04-17
2
ORDER EXTENDING TIME TO FILE ONGOING ROYALTY REPORTING PROCEDURES by Judge Philip S. Gutierrez, re Stipulation for Extension of Time to File 732 : IT IS HEREBY ORDERED that the deadline to submit to the Court proposed terms for inspection and reporting procedures pursuant to paragraph 8 of the judgment (ECF No. 728) be extended by 7 days, to and including April 27, 2020. (bm) (Entered: 04/20/2020)
2020-04-20
1
NOTICE OF APPEAL to the Federal Circuit Court of Appeals filed by Defendant Kite Pharma, Inc.. Appeal of Judgment,,,, 728 . (Appeal Fee - $505 Fee Paid, Receipt No. ACACDC-26198755.) (Lawton, Adam) (Entered: 04/23/2020)
2020-04-23
1
TRANSMISSION of the Notice of Appeal, Docket Sheet, Judgment and or order e-mailed to the US Court of Appeals for the Federal Circuit re: Notice of Appeal to Federal Circuit Court of Appeals 734. (mat)
2020-04-23
1
No Actions
TRANSMISSION of the Notice of Appeal, Docket Sheet, Judgment and or order e-mailed to the US Court of Appeals for the Federal Circuit re: Notice of Appeal to Federal Circuit Court of Appeals 734 . (mat)
2020-04-23
1
No Actions
Joint STIPULATION for Costs against Kite Pharma, Inc. filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 04/27/2020)
2020-04-27
1
Joint STIPULATION for Costs against Kite Pharma, Inc. filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 04/27/2020)
2020-04-27
2
Joint STIPULATION for Order regarding Ongoing Royalty Reporting, Payment, and Inspection Procedures filed by Joint Juno Therapeutics, Inc., Kite Pharma, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Jeffries, Andrea) (Entered: 04/27/2020)
2020-04-27
1
Joint STIPULATION for Order regarding Ongoing Royalty Reporting, Payment, and Inspection Procedures filed by Joint Juno Therapeutics, Inc., Kite Pharma, Inc., Sloan Kettering Institute for Cancer Research. (Attachments: # 1 Proposed Order)(Jeffries, Andrea) (Entered: 04/27/2020)
2020-04-27
2
ORDER RE: TAXABLE COSTS by Judge Philip S. Gutierrez, re: APPLICATION to the Clerk to Tax Costs 730, Corrected APPLICATION to the Clerk to Tax Costs against Defendant Kite Pharma, Inc., 731, Stipulation for Costs 735 : Upon consideration of the parties' Joint Stipulation re: Taxable Costs, IT IS HEREBY ORDERED as follows: 1. Costs pursuant to Federal Rule of Civil Procedure 54(d) are taxed in favor of Plaintiffs in the amount of $350,000.00. 2. Plaintiffs Application to the Clerk to Tax Costs (ECF No. 730) and Plaintiffs' Corrected Application to the Clerk to Tax Costs (ECF No. 731) are denied as moot. (bm) (Entered: 04/28/2020)
2020-04-27
1
ORDER REGARDING ONGOING ROYALTY REPORTING, PAYMENT, AND INSPECTION PROCEDURES by Judge Philip S. Gutierrez, re Stipulation 736 : IT IS SO ORDERED. (bm) (Entered: 04/28/2020)
2020-04-28
1
Joint STIPULATION for Order Extending Stay Under Fed. R. Civ. P. 62(a) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 05/01/2020)
2020-05-01
1
Joint STIPULATION for Order Extending Stay Under Fed. R. Civ. P. 62(a) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 05/01/2020)
2020-05-01
2
NOTIFICATION from Federal Circuit Court of Appeals of case number assigned and briefing schedule. Appeal Docket No. 2020-1758 assigned to Notice of Appeal to Federal Circuit Court of Appeals 734 as to defendant Kite Pharma, Inc.. (mat) (Entered: 05/01/2020)
2020-05-01
1
ORDER CONTINUING STAY PROVIDED BY RULE 62(a) UNTIL MAY 22,2020 OR FURTHER ORDER OF COURT 739 by Judge Philip S. Gutierrez (lc) (Entered: 05/05/2020)
2020-05-04
1
Joint STIPULATION for Order Further Extending Stay Under Fed. R. Civ. P. 62(a) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 05/19/2020)
2020-05-19
1
Joint STIPULATION for Order Further Extending Stay Under Fed. R. Civ. P. 62(a) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 05/19/2020)
2020-05-19
2
ORDER FURTHER CONTINUING STAY PROVIDED BY RULE 62(a) by Judge Philip S. Gutierrez, re Stipulation 742 : Upon consideration of the parties' Joint Stipulation to Further Continue Stay Provided by Rule 62(a), IT IS HEREBY ORDERED as follows: 1. The stay provided under Rule 62(a), as extended by the order dated May 4, 2020 (ECF No. 741), is continued until June 5, 2020, or further order of the Court. 2. No Plaintiff will make any attempt or effort to execute on or enforce the Final Judgment (including payment of accruing ongoing royalties, and interest which has accrued and shall continue to accrue) or the costs award (ECF No. 737) (and interest) before June 5, 2020. (bm) (Entered: 05/21/2020)
2020-05-21
1
Joint STIPULATION for Order Further Extending Stay Under Fed. R. Civ. P. 62(a) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 06/03/2020)
2020-06-03
1
Joint STIPULATION for Order Further Extending Stay Under Fed. R. Civ. P. 62(a) filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 06/03/2020)
2020-06-03
2
ORDER FURTHER CONTINUING STAY PROVIDED BY RULE 62(a) by Judge Philip S. Gutierrez, re Stipulation 744 : Upon consideration of the parties' Joint Stipulation to Further Continue Stay Provided by Rule 62(a), IT IS HEREBY ORDERED as follows: 1. The stay provided under Rule 62(a), as extended by the orders dated May 4 and 21, 2020 (ECF Nos. 741, 743), is continued until June 12, 2020, or further order of the Court. 2. No Plaintiff will make any attempt or effort to execute on or enforce the Final Judgment (including payment of accruing ongoing royalties, and interest which has accrued and shall continue to accrue) or the costs award (ECF No. 737) (and interest) before June 12, 2020. (bm) (Entered: 06/04/2020)
2020-06-04
1
Joint STIPULATION for Order Regarding Supersedeas Bond and Stay of Judgment Execution/Enforcement Pending Appeal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 06/11/2020)
2020-06-11
1
Joint STIPULATION for Order Regarding Supersedeas Bond and Stay of Judgment Execution/Enforcement Pending Appeal filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 06/11/2020)
2020-06-11
2
ORDER REGARDING SUPERSEDEAS BOND AND STAY OF EXECUTION ON JUDGMENT by Judge Philip S. Gutierrez, re Stipulation 746 (bm) (Entered: 06/12/2020)
2020-06-12
1
OPINION from Federal Circuit Court of Appeals filed Re: NOTICE OF APPEAL to the Federal Circuit Court of Appeals, CCA # 2020-1758. Decision is Reversed. [See document for more details.](mat) (Entered: 08/26/2021)
2021-08-26
1
Judgment from Federal Circuit Court of Appeals filed Re: NOTICE OF APPEAL to the Federal Circuit Court of Appeals, CCA # 2020-1758. THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: REVERSED (mat) (Entered: 08/26/2021)
2021-08-26
1
Joint STIPULATION for Extension of Time to File Defendant's Bill of Costs filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 09/01/2021)
2021-09-01
1
Notice of Electronic Filing re USCA Memorandum/Opinion/Order 749, USCA Memorandum/Opinion/Order 748, Stipulation for Extension of Time to File 750 e-mailed to Emily Whitcher bounced due to No longer with firm. The primary e-mail address associated with the attorney record has been deleted. Pursuant to Local Rules it is the attorneys obligation to maintain all personal contact information including e-mail address in the CM/ECF system. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (lmh) TEXT ONLY ENTRY (Entered: 09/02/2021)
2021-09-02
1
ORDER EXTENDING TIME FOR DEFENDANT TO FILE A BILL OF COSTS by Judge Philip S. Gutierrez, re Stipulation for Extension of Time to File 750 . IT IS HEREBY ORDERED that the deadline for Defendant Kite Pharma, Inc. to file a bill of costs in this Court is extended until 21 days after the final termination of all appeals in this action (including a petition, or the expiration of time to file a petition, to the Supreme Court for a writ of certiorari). (mrgo) (Entered: 09/02/2021)
2021-09-02
1
Text Only Bounced Notice of Electronic Filing E-mail
2021-09-02
1
No Actions
Notice of Appearance or Withdrawal of Counsel: for attorney Ingrid Marie Haslund Petersen counsel for Plaintiff Juno Therapeutics, Inc.. Ingrid Petersen is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Plaintiff Juno Therapeutics, Inc.. (Petersen, Ingrid) (Entered: 01/14/2022)
2022-01-14
1
ORDER from Federal Circuit Court of Appeals filed. CCA # 2020-1758. Upon consideration thereof, IT IS ORDERED THAT: The petition for panel rehearing is denied. The petition for rehearing en banc is denied. The mandate of the court will issue on January 21, 2022. (mat) (Entered: 01/14/2022)
2022-01-14
1
MANDATE of Federal Circuit Court of Appeals filed re: 734 NOTICE OF APPEAL to the Federal Circuit Court of Appeals CCA # 2020-1758. In accordance with the judgment of this Court, entered August 26, 2021, and pursuant to Rule 41 of the Federal Rules of Appellate Procedure, the formal mandate is hereby issued. [See USCA Memorandum JUDGMENT 749, USCA OPINION 748 Decision is Reversed.](mat) (Entered: 01/24/2022)
2022-01-21
1
NOTICE OF REASSIGNMENT OF CASE upon Receipt of Mandate filed. This case having been returned on a mandate from the 9th CCA, reversing the decision of Judge Philip S. Gutierrez, this case has been reassigned to Judge George H. Wu for all further proceedings. Case number will now read 2:17-cv-07639 GW(KSx). (rn) (Entered: 01/24/2022)
2022-01-24
1
MINUTES (IN CHAMBERS) COURT ORDER by Judge George H. Wu. The Court sets a status conference for February 3, 2022 at 8:30 a.m. The parties are ordered to file a joint report by February 1, 2022 as to what, if any, further proceedings should take place in this litigation in the district court following the federal circuit's decision in Juno Therapeutics, Inc. v. Kite Pharma, Inc., 10 F. 4th 1330 (Fed. Cir. 2021). (iv) (Entered: 01/27/2022)
2022-01-27
1
STATUS REPORT [Joint] pursuant to order of January 27, 2022 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 02/01/2022)
2022-02-01
1
TEXT-ONLY ENTRY - IN CHAMBERS: by Judge George H. Wu: Counsel are to appear telephonically for Thursday's 02/03/2022 status conference at 8:30 a.m. by contacting the court clerk at javier_gonzalez@cacd.uscourts.gov for dial-in information. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (jag) TEXT ONLY ENTRY (Entered: 02/01/2022)
2022-02-01
1
Text Only Scheduling Notice
2022-02-01
1
No Actions
MINUTE ORDER IN CHAMBERS - COURT ORDER by Judge George H. Wu: A status conference is currently set for February 3, 2022 in regards to further proceedings in this case following the Federal Circuit's decision in Juno Therapeutics, Inc. v. Kite Pharma, Inc., 10 F. 4th 1330 (Fed. Cir. 2021). See ECF No. 757. The Court has received the parties' Joint Status Report (ECF No. 758). Based thereon, the Court continues the February 3 status conference to April 21, 2022 at 8:30 a.m., in case the Plaintiffs file a petition for certiorari. The parties are to file a joint report by April 18. (bm) (Entered: 02/02/2022)
2022-02-02
1
Notice of Electronic Filing re Status Report 758, Text Only Scheduling Notice, 759, Minutes of In Chambers Order/Directive - no proceeding held,,, Set/Reset Deadlines/Hearings,, 760 e-mailed to Markus A Brazill at markus.brazill@mto.com bounced due to Invalid Recipient. The primary e-mail address associated with the attorney record has been deleted. Pursuant to Local Rules it is the attorneys obligation to maintain all personal contact information including e-mail address in the CM/ECF system. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ir) TEXT ONLY ENTRY (Entered: 02/03/2022)
2022-02-03
1
Notice of Electronic Filing re Text Only Bounced Notice of Electronic Filing E-mail,, 761, Status Report 758, Text Only Scheduling Notice, 759, Minutes of In Chambers Order/Directive - no proceeding held,,, Set/Reset Deadlines/Hearings,, 760 e-mailed to Luke J Burton at lburton@jonesday.com bounced due to Unknown user. The primary e-mail address associated with the attorney record has been deleted. Pursuant to Local Rules it is the attorneys obligation to maintain all personal contact information including e-mail address in the CM/ECF system. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ir) TEXT ONLY ENTRY (Entered: 02/03/2022)
2022-02-03
1
Notice of Electronic Filing re Text Only Bounced Notice of Electronic Filing E-mail,, 761, Status Report 758, Text Only Scheduling Notice, 759, Text Only Bounced Notice of Electronic Filing E-mail,, 762, Minutes of In Chambers Order/Directive - no proceeding held,,, Set/Reset Deadlines/Hearings,, 760 e-mailed to Graham Berres Cole at graham.cole@mto.com bounced due to Invalid Recipient. The primary e-mail address associated with the attorney record has been deleted. Pursuant to Local Rules it is the attorneys obligation to maintain all personal contact information including e-mail address in the CM/ECF system. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ir) TEXT ONLY ENTRY (Entered: 02/03/2022)
2022-02-03
1
Text Only Bounced Notice of Electronic Filing E-mail
2022-02-03
1
No Actions
Notice of Appearance or Withdrawal of Counsel: for attorney Adam R Lawton counsel for Defendant Kite Pharma, Inc.. Markus A. Brazill is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 04/14/2022)
2022-04-14
1
Notice of Appearance or Withdrawal of Counsel: for attorney Adam R Lawton counsel for Defendant Kite Pharma, Inc.. Graham B. Cole is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 04/14/2022)
2022-04-14
1
STATUS REPORT [Joint] pursuant to order of February 2, 2022 filed by Defendant Kite Pharma, Inc.. (Lawton, Adam) (Entered: 04/14/2022)
2022-04-14
1
TEXT-ONLY ENTRY - IN CHAMBERS: by Judge George H. Wu: Counsel are to appear telephonically for Thursday's 04/21/2022 status conference at 8:30 a.m. by contacting the court clerk at javier_gonzalez@cacd.uscourts.gov for dial-in information. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (jag) TEXT ONLY ENTRY (Entered: 04/18/2022)
2022-04-18
1
Text Only Scheduling Notice
2022-04-18
1
No Actions
MINUTE ORDER IN CHAMBERS - COURT ORDER by Judge George H. Wu: This matter is currently scheduled for a status conference on April 21, 2022 regarding whether Plaintiffs will be seeking to file a petition for certiorari to the Supreme Court from the reversal by the Federal Circuit of this Court's Judgment issued following a jury trial. Based thereon, the Court orders: (1) the April 21 status conference be continued to June 16, 2022 at 8:30 a.m.; (2) the parties are to file a joint status report by noon on June 14; and (3) if Plaintiffs file a petition for writ of certiorari, the parties are to file by June 14 (and in lieu of a joint status report) a stipulation to continue the June 16 status conference to a date (on a Monday or Thursday) when it is expected that the Supreme Court will have decided the petition for certiorari. (bm) (Entered: 04/19/2022)
2022-04-19
1
Joint STIPULATION to Continue Status Conference from June 16, 2022 to November 17, 2022 filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 06/14/2022)
2022-06-14
1
ORDER CONTINUING STATUS CONFERENCE by Judge George H. Wu. Upon consideration of the parties' Joint Stipulation to Continue Status Conference, IT IS HEREBY ORDERED as follows: 1. The status conference currently scheduled for June 16, 2022, is continued to November 17, 2022, at 8:30 A.M.; and 2. The parties are to file a joint status report by November 14, 2022. RE Stipulation to Continue 769 . (aco) (Entered: 06/16/2022)
2022-06-15
1
Notice of Appearance or Withdrawal of Counsel: for attorney Geoffrey D Biegler counsel for Counter Claimant Kite Pharma, Inc.. Grant T. Rice is no longer counsel of record for the aforementioned party in this case for the reason indicated in the G-123 Notice. Filed by Defendant Kite Pharma, Inc.. (Biegler, Geoffrey) (Entered: 06/17/2022)
2022-06-17
1
Joint STIPULATION to Reschedule 11/17/2022 status conference, Joint STIPULATION for Extension of Time to File bill of costs filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 11/14/2022)
2022-11-14
1
ORDER VACATING STATUS CONFERENCE AND EXTENDING TIME TO FILE BILL OF COSTS by Judge George H. Wu. IT IS HEREBY ORDERED as follows: 1. The status conference currently scheduled for November 17, 2022, is rescheduled for January 26, 2023 at 8:30 a.m.; and 2. The deadline for Defendant Kite Pharma, Inc. to file a bill of costs in this Court is extended until 21 days after (a) the resolution of Plaintiffs' petition for rehearing, or (b) the expiration of time for Plaintiffs to file a petition for rehearing, if no petition for rehearing is filed. RE: Stipulation to Reschedule, Stipulation for Extension of Time to File 772 . (aco) (Entered: 11/15/2022)
2022-11-15
1
TEXT-ONLY ENTRY - IN CHAMBERS: by Judge George H. Wu: Counsel are to appear telephonically for Thursday's 01/26/2023 status conference at 8:30 a.m. by contacting the court clerk at javier_gonzalez@cacd.uscourts.gov for dial-in information. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (jag) TEXT ONLY ENTRY (Entered: 01/24/2023)
2023-01-24
1
Joint STIPULATION to Vacate 1/26/2023 Status Conference and Joint Status Report filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 01/24/2023)
2023-01-24
1
Text Only Scheduling Notice
2023-01-24
1
No Actions
MINUTES IN CHAMBERS - COURT ORDER by Judge George H. Wu. In light of the parties' Joint Status Report (ECF No. 775), the January 26, 2023 status conference is taken off-calendar. Except for the possible filing of a bill of costs, "the parties agree that no further proceedings in this matter are necessary." Id. Therefore, this action is closed. (aco) (Entered: 01/25/2023)
2023-01-25
1
Joint STIPULATION for Extension of Time to File Bill of Costs filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 01/30/2023)
2023-01-30
1
ORDER GRANTING FURTHER EXTENSION OF TIME TO FILE BILL OF COSTS 777 by Judge George H. Wu. IT IS HEREBY ORDERED that the deadline for Defendant Kite Pharma, Inc. to file a bill of costs in this Court is extended until February 6, 2023. (lom) (Entered: 01/31/2023)
2023-01-31
1
Joint STIPULATION for Costs against Juno Therapeutics, Inc., Sloan Kettering Institute for Cancer Research filed by Defendant Kite Pharma, Inc.. (Attachments: # 1 Proposed Order)(Lawton, Adam) (Entered: 02/06/2023)
2023-02-06
1
ORDER RE: TAXABLE COSTS by Judge George H. Wu. IT IS HEREBY ORDERED that costs pursuant to Federal Rule of Civil Procedure 54(d) are taxed in favor of Defendant Kite Pharma, Inc. ("Kite") in the amount of $230,000, to be paid to Kite within 45 days of this order. RE: Stipulation for Costs 779 . (aco) (Entered: 02/07/2023)
2023-02-06
1
Notice of Electronic Filing re Order, 780 e-mailed to Garth T Vincent at garth.vincent@mto.com bounced due to Invalid Recipient. The primary e-mail address associated with the attorney record has been deleted. Pursuant to Local Rules it is the attorneys obligation to maintain all personal contact information including e-mail address in the CM/ECF system. THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (ir) TEXT ONLY ENTRY (Entered: 02/07/2023)
2023-02-07
1
Text Only Bounced Notice of Electronic Filing E-mail
2023-02-07
1
No Actions